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1. Introduction 
1.1. Overview on the male reproduction system 
1.1.1. Structure of the testis 
The testes (testicles) are the primary male reproductive organs, which serve two key 
functions: spermatogenesis and steroid synthesis, particularly the male hormone 
testosterone. Each testis is covered by a multi-layered tunica of connective tissue 
called the tunica albuginea, from which partitions of fibrous tissue subdivide the 
testis into approximately 300 small sections or lobes. Each lobule contains three to 
four tightly coiled seminiferous tubules, in which spermatogenesis takes place. 
Tubules are enclosed by a basal lamina, which are surrounded by 3-4 layers of 
peritubular myoid cells, also called peritubular cells. Tubules are covered with 
seminiferous epithelium, which is formed of two general types of cells: germ cells 
and Sertoli cells. Spermatogonia and Sertoli cells reside at the basal part of the 
seminiferous tubules, whereas spermatocytes, spermatids and spermatozoa are in 
the adluminal compartment. Sertoli cells within the seminiferous tubules are attached 
with the neighboring Seroli cell through a tight junction. They possess a significant 
role in spermatogenesis, providing support for germ cells to grow and to develop into 
mature spermatozoa. Leydig cells also called interstitial cells and are located in the 
interstitial spaces between the seminiferous tubules, which also contain blood 
vessels, lymphatic elements, fibroblasts and macrophages. They occur in clusters 
and constitute to the endocrine component of the testis, responsible for hormone 
secretion. 
 
1.1.2. Regulation of testicular function 
1.1.2.1. Endocrine regulation of the testicular function 
The hypothalamic–pituitary–testis axis (HPT) plays a crucial role in reproduction and 
steroid hormone secretion. Gonadotropin-releasing hormone (GnRH), which is 
synthesized in the hypothalamus by  neurons, is transported via the pituitary portal 
veins to the anterior pituitary gland to facilitate the production of gonadotropic 
hormones: luteinizing hormone (LH) and follicle stimulating hormone (FSH) 
(Matsumoto and Bremner 1987). Development and maintenance of testis depends 
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on the concerted action of the two gonadotropins: FSH and LH. LH activates the 
receptors expressed on Leydig cells to stimulate testosterone secretion, whereas 
FSH supports the function of Sertoli cells for spermatogenesis. Sertoli cells produce 
a protein called androgen-binding protein, binding the active form of testosterone 
(DHT) as well as inhibin and activin, which act as paracrine factors in testis. The 
combination of FSH and testosterone are essential for induction and maintenance of 
a qualitatively and quantitatively normal sperm production. Increased levels of 
testosterone, its aromatized product estradiol and inhibin  cause a negative feedback 
on the pituitary gland and hypothalamus, inhibiting the production of the LH and thus 
testosterone production. A reduced testosterone level leads to the GnRH and 
secretion, thus acting as classic feedback regulator of hypothalamic and pituitary 
output (Dunkel, et al. 1993; Ellis, et al. 1983; Matsumoto and Bremner 1989; 
O'Shaughnessy, et al. 2005; Roser 2008).  
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Figure 1. Hypothalamic-pituitary- testicular axis ((Chase 2007). 
GnRH is synthesized from the hypothalamus, which stimulates the secretion of LH and FSH 
by the pituitary gland. LH through LH-receptor stimulates mainly the production of 
testosterone by Leydig cells in the testis. FSH through FSH receptor supports the function of 
Sertoli cells for spermatogenesis, stimulates Sertoli cells to produce ABP, inhibin, DHT. 
Testosterone, its aromatized product estradiol, inhibin and other local products of the 
somatic cells of testis are acting as classic negative feedback regulator of hypothalamic and 
pituitary glands.  
 
1.1.2.2. Local, paracrine and autocrine regulation of testicular function 
In addition to the endocrine regulation of testicular function and spermatogenesis, 
there are paracrine and autocrine factors that regulate testicular cell differentiation 
and function locally in the testis depending on their concentration and overall 
composition (Saez 1994; Sharpe 1990; Skinner, et al. 1991; Spiteri-Grech and 
Nieschlag 1993). Paracrine factors are produced by one cell and act on a 
neighboring cell type, whereas autocrine factors are produced by a specific cell and 
act on the same cell type. There are different  paracrine and autocrine regulators 
with proven significant influence on testicular function and spermatogenesis, 
including testosterone, estrogen, inhibin, activin, growth factors like transforming 
growth factor,  alpha and beta (TGFα and β), insulin-like growth factor 1(IGF-1), 
cytokines (IL-1α and IL-1β), GnRH-like peptides, prostaglandins, oxytocin, 
vasopressin, insulin like peptide 3 (INSL3) and PmodS, a paracrine factor secreted 
from peritubular myoid cells that modulates Sertoli cell function.                                             
The endocrine-paracrine-autocrine system modulates cell to cell communication 
within testis. For normal testicular function interactions of  Leydig-Leydig cell, Setoli-
Leydig cell, Sertoli–germ cell, Sertoli-peritubular cell are necessary (Roser 2008). 
 
1.1.3. Overview on structure and function of Leydig cells in testis 
1.1.3.1. Morphology and development of Leydig cell 
The interstitial testicular cells were first described by Franz Leydig born in 1821, in 
Rothenburg ob der Tauber, Germany. His article in 1850 was mainly about the male 
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reproductive tract and its accessory glands (Leydig 1850). His remarks on the testis 
referred to clusters of what appeared to be cells, found between the seminiferous 
tubules. Thereafter, they were characterized as round cells with enriched smooth 
endoplasmatic reticulum (ER), mitochondria, different numbers of lipid droplets and a 
large centrally located nucleus (Christensen 1965; Christensen and Fawcett 1966). 
Over decades, researchers discovered that Leydig cells have endocrine function 
producing androgens essential for the correct function of the male reproductive tract, 
spermatogenesis as well as for the development of male secondary sexual 
characteristics. In all mammals, during the normal testicular development, two 
different populations are identified in the testis: fetal Leydig cells and adult Leydig 
cells. (Lejeune, et al. 1998; Saez 1994). Fetal Leydig cells appear immediately after 
the formation of testicular cords (embryonic day 12.5 or E12.5 in mice) originating 
from mesenchymal fibroblasts. In comparison to adult Leydig cells they contain 
larger lipid droplets and a less-developed Golgi apparatus (Haider, et al. 1995; 
Kuopio, et al. 1989). Fetal Leydig cells secrete androgens and insulin-like factor 3 
(INSL3 or relaxin-like factor), regulating differentiation of the Wolffian duct, external 
genitalia and the testis descent. A decline of fetal Leydig cells is noted after birth, 
which suggested that they undergo degeneration (Kuopio et al. 1989; Lording and 
De Kretser 1972).However, some of them persist in testis together with adult Leydig 
cells or transform into adult Leydig cell population (Kerr and Knell 1988; Siril 
Ariyaratne, et al. 2000). 
Adult Leydig cells are formed during pubertal development from the stem Leydig 
cells, which ultimate origin remains a topic of active research. Most investigators 
inclined to think that they originate from mesenchymal cells derived from the 
primitive kidney (mesonephros), but others support the idea that sources can include 
the neural crest and coelomic epithelium (Davidoff, et al. 2002; Davidoff, et al. 2009). 
It is known that LH, growth factors produced locally by Sertoli as well as androgens, 
produced by fetal Leydig cells are playing an important role for stimulation of the 
transition from stem to later stage Leydig cells and for initial development of adult 
Leydig cells. The cytoplasm of mouse Leydig cells contain a large amount of smooth 
endoplasmatic reticulum (sER) and tubulovesicular mitochondria, a well-
differentiated Golgi apparatus and small lipid droplets. Abundant peroxisomes are 
also present in steroid producing cells, which are often tubular, elongated and 
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sometimes are larger than dilated segments of SER (Mendis-Handagama, et al. 
1990b; Nenicu 2010; Nenicu, et al. 2007; Reddy and Svoboda 1972a, b). Like 
mitochondria and lipids, peroxisomes are often closely related to sER (Russel and 
Burguet 1977; Schulze 1984).  
 
1.1.4. Steroidogenesis 
I. Signal Transduction 
As stated above, LH is a key regulator of the development, maintenance and proper 
function of Leydig cells. Steroid hormone biosynthesis is initiated in the testis after 
stimulation of the LH-receptor by LH or human chorionic gonadotropin (hCG). The 
LH-receptor is coupled with a G-protein, which stimulates adenylate cyclase activity 
to form the main second messenger of its signal transduction; cyclic adenosine                      
3',5'-cyclic monophosphate (cAMP). An increased intracellular level of cAMP 
stimulates protein kinase A (PKA), which initiates cholesterol biosynthesis and 
cholesterol transport protein synthesis (Ascoli, et al. 2002; Cooke, et al. 1992; Dufau 
1988; Saez 1994; Stocco 1999a; Stocco, et al. 2005). It is well known, that the 
cAMP/PKA pathway is the major signaling cascade necessary for LH-stimulated 
steroid synthesis. However, there are less than 1% of cAMP/PKA-independent 
pathways not involving cAMP for the steroidogenesis, e.g. protein kinase B (PKB), 
protein kinase C (PKC), mitogen-activated protein kinases (MAPKs), and intracellular 
Ca2+ signaling proteins (Cooke 1999; Manna, et al. 2006). A number of factors 
including, transforming growth factor (TGF), insulin-like growth factor-I (IGF-I), 
epidermal growth factor (EGF), fibroblast growth factor, interleukin-1 (IL-1), 
macrophage-derived factors, chloride ions, and calcium (Ca2+) stimulate 
steroidogenesis through the cAMP-independent signaling.  
II. Cholesterol Synthesis, Uptake and Transport 
Cholesterol is the common substrate for the formation of all steroid hormones. There 
are two potential sources of cholesterol for steroidogenesis in steroidogenic cells. 
Cellular cholesterol can be synthesized de novo from acetate or can be imported via 
lipoprotein receptors and receptor-mediated endocytosis from the circulating 
lipoprotein particles in the blood. Cholesterol synthesis takes place primarily in the 
smooth ER through a series of enzymatic reactions involving five phases. The first 
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chain of reactions of intracellular biosynthesis of cholesterol from acetyl-CoA to the 
HMG-CoA and can take place in the cytosol, mitochondria or peroxisomes (Kovacs, 
et al. 2002). As mentioned above, steroid producing cells contain a high number of 
peroxisomes and they are also involved in the biosynthesis and metabolism of 
cholesterol. 
Two mechanisms were described for cholesterol import: uptake of circulating low-
density lipoproteins (LDL) by the LDL receptors on the cell surface and uptake of 
high density lipoproteins (HDL) via scavenger receptor B1 (SR-B1).  Human 
steroidogenic cells mostly take up cholesterol through receptor mediated 
endocytosis of LDL, whereas rodent cells mostly get through SR-B1. Free 
cholesterol can be utilized directly for steroid synthesis or can be esterified by acetyl-
CoA transferase for storage in lipid droplets. Further, cholesterol esters can be 
broken down by activation of cholesterol esterase. It has been shown in cell culture 
models, for example in MLTC-1(mouse Leydig tumor cells) free cholesterol 
necessary for steroid synthesis can also be derived from the plasma membrane as 
well (Epstein and Orme-Johnson 1991b).   
Under LH stimulation through the LH receptor rapid utilization of newly synthesized 
or stored cholesterol (ester hydrolysis) takes place in lipid droplets. The transport of 
intracellular cholesterol to the inner mitochondrial membrane can be divided into two 
important steps: mobilization of intracellular cholesterol to the outer mitochondrial 
membrane (OMM) and the transfer of cholesterol from OMM to the inner 
mitochondrial membrane (IMM) (Jefcoate, et al. 1992; Stocco 2000).  
Factors and mechanisms directing the transport of cholesterol to OMM are not yet 
clearly understood. It may involve vesicular transport, where cholesterol can be 
incorporated into vesicular membranes such as lysosomes, endosomes, 
peroxisomes which may act as an intracellular delivery system. Cholesterol can be 
also delivered through passive aqueous diffusion, nonvesicular carrier-mediated 
transfer, cytoskeletal elements and transport proteins (Feuilloley and Vaudry 1996; 
Prinz 2002).There are number of studies revealing the role of sterol carrier protein 2 
(SCP2) in cholesterol intracellular transfer. It was shown that SCP-2 is able to bind 
different lipids (cholesterol, fatty acids, fatty acyl-CoA) (Frolov, et al. 1996; Murphy 
1998). SCP-2 has a peroxisomal targeting signal at the C terminus, suggesting its 
peroxisomal localization (Gallegos, et al. 2001), which might transfer the fatty acids 
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across the peroxisomal membrane (Stolowich, et al. 1997). Nevertheless, different 
studies also showed its extraperoxisomal localization in ER, mitochondrial or 
cytosolic fractions. Moreover, the study with LH treatment in the rat revealed an 
increase in the volume of peroxisomes and intraperoxisomal content of SCP2 in 
Leydig cells (Mendis-Handagama, et al. 1992, 1998; Mendis-Handagama, et al. 
1990a; Nussdorfer, et al. 1980), suggesting their role in steroid synthesis. 
III. Steroidogenic acute regulatory protein (StAR) 
Acute steroidogenic responses are regulated by cholesterol transport from the OMM 
to IMM, which is the rate limiting step for steroidogenesis triggered by the 
steroidogenic acute regulatory protein (StAR). Cholesterol, being hydrophobic, is not 
able to pass through the aqueous intermembrane space of the mitochondria, 
requiring the help of cholesterol transfer proteins (Jefcoate et al. 1992; Stocco 2000). 
Moreover, mitochondrial membranes, particularly IMM, in comparison to other 
subcellular membranes are cholesterol-poor, which enables steroidogenic cells to 
control the steroid synthesis via the rate of cholesterol transport to IMM rather than 
via enzyme activities. 
After the cholesterol transfer via StAR to the inner mitochondrial membrane, 
cytochrome P450 enzyme converts cholesterol to pregnenolone. StAR mediates a 
rapid stimulation of steroid synthesis induced by LH in the testis, adrenal and ovary. 
Mutation in the PKA phosphorylation sites of StAR resulted in the inhibition of steroid 
synthesis by 85% (Fleury, et al. 2004), consequently only 10-15% of steroid 
synthesis is regulated by StAR-independent mechanisms (Clark, et al. 1997; Lin, et 
al. 1995; Manna et al. 2006; Manna, et al. 2001). The significant role of StAR was 
verified by when mutation in the StAR gene leads to the development of the lipoid 
congenital adrenal hyperplasia; an autosomal recessive disorder, where steroid 
synthesis is dramatically impaired (Miller 1997). 
The StAR protein involved in cholesterol intramitochondrial movement was initially 
discovered by Orme-Johnson and colleagues in rat and mouse adrenocortical cells 
and Leydig cells (Alberta, et al. 1989; Epstein and Orme-Johnson 1991a, b; Krueger 
and Orme-Johnson 1983; Pon, et al. 1986).  Later the cDNA was cloned and this 
protein was named steroidogenic acute regulatory protein described by Stocco and 
colleagues in hormone stimulated MA-10 mouse Leydig tumor cells and in human 
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cells  (Clark, et al. 1994; Lin et al. 1995; Stocco and Clark 1996b; Sugawara, et al. 
1995). StAR is synthesized as cytoplasmic 37kDa protein containing a N-terminal 
mitochondrial targeting sequence and the C-terminal StAR-related lipid transfer 
domain and is cleaved during mitochondrial import into an intramitochondrial 30 kDa 
form. The mechanisms of StAR-mediated cholesterol transport from the OMM to the 
IMM are still not completely understood. Initially it has been shown that mitochondrial 
import of StAR generates “contact sites” between the OMM and IMM, thus permitting 
cholesterol to flow down from OMM to IMM via a chemical concentration gradient 
(Stocco and Clark 1996a; Stocco and Sodeman 1991). The rapid cleavage of the 37-
kDa cytoplasmic form of StAR to the 30kDa intramitochondrial form suggests that the 
37 kDa form is a precursor whereas the 30 kDa protein is the mature form (King and 
Stocco 1996) and the role of the mature 30-kDa protein in transferring cholesterol to 
IMM is considered (Stocco and Clark 1996a). 
After discovering a cholesterol binding pocket in the structure of StAR it was 
suggested, that StAR in the mitochondrial intramembranous space (IMS) could 
shuttle cholesterol one molecule at a time from the OMM to the IMM (Tsujishita and 
Hurley 2000).  The accuracy of these models was questioned, since the deletion of 
mitochondrial leader N-terminal of the StAR protein had no effect on Star’s activity 
on cholesterol transfer or steroid production in transfected MA-10 or COS-1 cells 
(Arakane, et al. 1996).  On the contrary, by  deletion of 28 C-terminal residues, the 
capacity to induce the steroid production was lost, indicating that  a region in the C 
terminus is important for cholesterol transfer (Arakane et al. 1996). It was shown that 
cholesterol was imported when StAR acts only on the OMM but not at the IMM or 
intermembrane space (IMS) and its activity depends on how long it remains on the 
OMM (Arakane et al. 1996; Bose, et al. 2002). 
It was also shown that StAR undergoes pH-induced conformational changes when 
interacts with charged phospholipids on the OMM, thus allowing cholesterol access 
(Baker, et al. 2005; Bose, et al. 1999; Bose, et al. 2009a; Bose, et al. 2009b; Song, 
et al. 2001). 
A multi-protein complex has been described to interact with StAR on the OMM for 
cholesterol transport to the IMM for pregnenolone synthesis (Bose, et al. 2008; 
Papadopoulos and Miller 2012; Rone, et al., 2012), which involves the TSPO, 
voltage-dependent anion channel (VDAC-1), acyl coenzyme A-binding domain 
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containing A or TSPO-associated protein 7 (PAP7, ACBD3) and protein kinase A 
regulatory subunit 1𝛼 (PKARalpha)(Liu, et al. 2006; Martin, et al. 2016; Miller 2013; 
Miller and Bose 2011; Rone, et al. 2009). Nevertheless, the exact composition and 
the function of this complex is still controversial.  
IV. Enzymatic conversions for steroid synthesis 
Leydig cells express all enzymes necessary for the synthesis of testosterone: the 
major sexual hormone produced in the testis. The enzymes involved in steroid 
synthesis can be divided into two main groups: Cytochrome P450 enzymes such as 
P450scc, P450 17-hydroxylase/C17 - 20 lyase (P450c17 or Cyp17) and P450 
aromatase (P450arom), and the hydroxysteroid dehydrogenases such as 3-
hydroxysteroid dehydrogenase (3-HSD) and 17-hydroxysteroid dehydrogenases 
(17-HSD).            
Cholesterol is converted to pregnenolone by P450scc, which is located in the inner 
mitochondrial membrane. Thereafter, pregnenolone diffuses through the 
mitochondrial membrane to the smooth endoplasmic reticulum for further conversion 
into different hormones. Pregnenolone can be metabolized to 17-
hydroxypregnenolone by cytochrome P450c17 or it may be converted by 3β-HSD to 
the first biologically significant hormone: progesterone.          
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Figure 2: Steroidogenesis in testis.                                                                          
Steroidogenesis is initiated in the Leydig cells after stimulation of the LH-receptor by LH, 
which stimulates the synthesis of cAMP from ATP.  cAMP induces the activity of protein 
kinase A (PKA), which initiates cholesterol biosynthesis and cholesterol transport protein 
synthesis for the transfer of intracellular cholesterol to the OMM and from OMM to the IMM. 
StAR interacts with a multi-protein complex for transferring cholesterol to IMM, where the 
P450scc enzyme converts cholesterol into pregnenolone. Thereafter, pregnenolone is 
transferred to the sER, where next enzymatic reactions take place. 2. reaction: 3β-HSD: 3β- 
hydroxysteroid dehydrogenase, 3. reaction: CYP17 17-20 lyase: cytochrome P450 17α-
hydroxylase; 4. reaction: 17β-HSD: family of 17β-hydroxysteroid dehydrogenase 5. reaction: 
aromatase: cytochrome P450 aromatase, 6. reaction: 5α-reductase, DHT 
(dihydrotestosterone).  Modified from (Haider 2004; Stocco 1999b). 
 
Thus, the steroidogenic pathway bifurcates into a ∆5-hydroxysteroid pathway starting 
with pregnenolone and a ∆4-ketosteroid pathway starting with progesterone. 3β-HSD 
converts the ∆5-hydroxysteroid pathway substrates into their respective ∆4-
ketosteroids, thus pregnenolone to progesterone, 17-hydroxypregnenolone to 17-
hydroxyprogesterone (17-OHP), dehydroepiandrosterone (DHEA) to 
androstenedione, androstenediole to testosterone (Lorence, et al. 1990; Miller 2008). 
P450c17 has both 17-hydroxylase as well as 17,20 -lyase activity and catalyzes the 
conversion of pregnenolone to 17-hydroxypregnenolone, which is then converted to 
DHEA for the ∆5-hydroxysteroid pathway. Likewise, for the ∆4-ketosteroids, P450c17 
converts progesterone to 17OHP, which is then converted to androstenedione (Fan, 
et al. 1992; Zuber, et al. 1986). 
17β-HSDs catalyze the last step in steroidogenesis, participating in the formation 
and inactivation of steroid hormones by modulating biological potency of estrogens 
and androgens by conversion at position 17.  There have been up to 12 types of 
17β-HSD described of which 10 are also found in humans. The most important 
enzyme for the testosterone synthesis from androstenedione is 17β-hydroxysteroid 
dehydrogenase 3 (17β-HSD3) (Geissler, et al. 1994), which is expressed in both 
human and rodent Leydig cells (Andersson 1995; Sha, et al. 1997). It was 
documented, that androstenediol is converted from DHEA by 17β-HSD1 and 5 and 
 
19 
the reverse reaction is catalyzed by 17β-HSD2 and 4 (Adamski, et al. 1995; Labrie, 
et al. 2000; Peltoketo, et al. 1999). 
As mentioned above the biological potency of estrogens is regulated by 17β-HSDs, 
where estrone is converted to the biological active estradiol by 17β-HSD1, 5 and 7, 
whereas the reverse reaction of estradiol inactivation is performed by 17β-
HSD2,4,8,10 (Adamski et al. 1995; Fomitcheva, et al. 1998; Peltoketo et al. 1999). 
Leydig cells contain a high level of 17β-HSD4 also known as peroxisomal 
multifunctional protein 2 (MFP-2) (Carstensen, et al. 1996; Normand, et al. 1995). 
The localization of the 17β-HSD4 is exceptional since it is the only 17β-HSD found in 
peroxisomes (Markus, et al. 1995). MFP-2 is involved in the peroxisomal β-oxidation 
of branched fatty acids like pristanic acid, C27-bile acid intermediates, very long 
chain fatty acids, and in the synthesis of certain polyunsaturated fatty acids (PUFA) 
(Novikov, et al. 1997). Other 17β-HSDs are localized either in cytosol, mitochondria 
or associated with the endoplasmic reticulum (Adamski and Jakob 2001; Peltoketo et 
al. 1999). 
In the testis androgens are irreversibly converted into estrogens by P450 arom 
(Simpson, et al. 1994). It converts androstenedione and testosterone to the estrone 
and estradiol, respectively. P450 aromatase is located in the smooth endoplasmatic 
reticulum and its activity is stimulated by LH. In mice the aromatase is expressed in 
Leydig cells and in seminiferous tubules, especially in spermatids (Carreau, et al. 
1999).  P450arom is also present in Sertoli cells and it was reported that during the 
early stages of testicular development the estrogen production is dominant in these 
cells in rats. However, mature Leydig cells secrete more estrogen, whereas Sertoli 
cells continue to express aromatase, but at a lower rate (Hess 2003; O'Donnell, et al. 
2001). It was shown, that human spermatozoa produce estrogens and that 
aromatase is expressed, possibly playing role in sperm mortality (Lambard, et al. 
2003). 
Estrogens act through estrogen receptors (ER and ER), which are expressed in 
most of the testicular cells (Carreau, et al. 2002a; Carreau, et al. 2002b). Different 
studies showed that estrogens have an important role in the regulation of sperm 
production and fertility (O'Donnell et al. 2001). Physiological level of estrogens is 
also necessary for the survival of germ cells (Pentikainen, et al. 2000).  
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1.1.5. Function of testosterone 
The primary role of Leydig cells is to produce testosterone, which in turn is crucial for 
spermatogenesis and fertility. This action of testosterone is mediated by the Sertoli 
cells which nourish and support the developing spermatozoa and their function is 
critically dependent on normal Leydig cell function. Testosterone effects on 
spermatogenesis via androgen receptors (ARs) that are localized in the Sertoli cells 
(Silva, et al. 2002). Testosterone is also essential for the testicular formation and 
differentiation. Testosterone diffuses from Leydig cells to seminiferous tubules and 
together with FSH induces the Sertoli cells to produce local factors that are required 
for the normal spermatogenesis. Testosterone acts on the Sertoli cells to increase its 
response to FSH resulting in increased production of androgen-binding protein 
(ABP), which binds specifically to testosterone, dihydrotestosterone and 17-beta-
estradiol. It serves them to be less lipophilic and concentrated within the luminal fluid 
of the seminiferous tubules, making the androgens available to bind the intracellular 
androgen receptor thus exerting the trophic effects on spermatogenesis. 
Testosterone action is crucial and in an absolute requirement for adult 
spermatogenesis and the main targets of its action are completion of meiosis and 
spermatogenesis (Cameron, et al. 1993; Marathe, et al. 1995; McLachlan, et al. 
2002a). Moreover, different studies indicate that testosterone is involved in Sertoli 
cell differentiation in early postnatal life (Buzzard, et al. 2003; Sharpe, et al. 2003). 
The role of testosterone in germ cell development and for spermatogonial 
development during the first wave of spermatogenesis is still not clear. It has been 
also reported that testosterone inhibits germ cell apoptosis (Singh, et al. 1995). 
Furthermore, Sertoli cell-sepcific AR knockout mice exhibit an arrest at late 
spermatocytes and beyond, suggesting that androgen action is crucial for the 
completion of meiosis and spermatogenesis in the first wave (Chang, et al. 2004; De 
Gendt, et al. 2004). Thus, spermatogonial development, meiosis and spermiation are 
the three main processes, where the action of gonadotrophins and testosterone is 
critical (Matthiesson, et al. 2006; McLachlan, et al. 2002).   
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1.2. Peroxisomes 
Peroxisomes (originally called microbodies) are organelles found in all eukaryotic 
cells. Peroxisomes were first identified by J. Rhodin in 1954 (Rhodin, et al. 1954), 
using electron microscopy in a mouse kidney and were identified as spherical 
organelles of 0.3-1.0µm with a single limiting membrane.  Thereafter, peroxisomes 
as distinct organelles have been described by Christian de Duve in the 1960th (De 
Duve and Baudhuin 1966). They found that catalase, urate- and D-amino acid 
oxidases are localized in special particles which differ from microsomes or 
mitochondria. The term of peroxisome was given by de Duve and Baudhin, as they 
own both hydrogen peroxide (H2O2) producing oxidases and catalase degrading 
H2O2. They contain a fine granular matrix and occasionally a paracrystaline core. 
Peroxisomes exhibit remarkable morphological as well as metabolic plasticity and 
they are able to move throughout the cell along microtubule. Their number, size, 
biochemical function and protein composition differs significantly among various 
species and tissues (Baumgart 1997; Subramani 1993; Wanders and Tager 1998). 
Peroxisomes have been identified in every tissue so far with the exception of mature 
red blood cells and spermatozoa in the testis (Luers, et al. 2006).  
Peroxisomes and mitochondria share similarity in size, and both organelles are very 
dynamic. They are able to adapt their shape and number depending on the cells 
requirements (Bonekamp, et al. 2013; Polyakov, et al. 2003; Schrader, et al. 2012). 
Peroxisomes differ from mitochondria by their homogenous matrix, single 
membrane, an electron dense core as well as by absence of cristae. Lysosomes can 
be differentiated from peroxisomes by their heterogeneous matrix and staining for 
acid phosphatase (Baumgart, et al. 1989; Fujiki, et al. 1982). 
 
1.2.1. Peroxisome biogenesis 
More than 30 PEX genes encoding proteins (peroxins) were discovered, which are 
divided into the following groups required for peroxisomal biogenesis (Distel, et al. 
1996): for formation of the peroxisomal membrane (PEX3, PEX16, PEX19), for 
transport in the cytoplasm (PEX5, PEX7, PEX19), for docking (PEX13, PEX14, 
PEX17), import of proteins into the peroxisomal matrix (PEX10, PEX12), proliferation 
of the organelles (PEX11) and for organelle degradation (PEX4) (Baumgart et al. 
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1989). In contrast to mitochondria, peroxisomes do not contain DNA. Thus, 
peroxisomal matrix and membrane proteins are synthesized on free polyribosomes 
in cytoplasm and imported later into peroxisomes (Lazarow and Fujiki 1985). 
Peroxisomal matrix proteins contain peroxisomal targeting signals (PTS) either at the 
C terminus (PTS1) or at their N terminus (PTS2). They are recognized by the 
peroxisomal targeting sequence soluble receptors (PTS1 by Pex5p, PTS2 by Pex 
7p) and the receptor-cargo complexes then dock at the peroxisomal membrane with 
the docking proteins (Pex13p, Pex14p and Pex17p) (Subramani 1993). Thus, PEX13 
plays a significant role in importing proteins into the peroxisome via PTS1 and PTS2.  
Deletion of Pex13 leads to a loss of both PTS1 and PTS2 protein import, and it was 
shown that Pex13 functions as a docking protein for the predominantly PTS1 
receptor (Gould 1996).  Pex13 gene defect leads to the peroxisomal protein import 
disruption and peroxisomal metabolic dysfunction (Liu, et al. 1999; Maxwell, et al. 
2003; Shimozawa, et al. 1999).  
 
1.2.2. Metabolic functions of peroxisomes 
Peroxiosomes play a strong role in cellular metabolism, which is especially evident 
by the devastating consequences in cells in conditions of peroxisome deficiency or 
absence. Peroxisomal enzyme composition varies depending on a cell type and a 
distinct organ, as well as they respond differently to developmental and 
environmental conditions (Baumgart 1997). They proliferate easily after treatment 
with hypolipidemic drugs and are involved in lipid metabolic pathways (Baumgart 
1997).  They participate in fatty acid β-oxidation, peroxide metabolism, fatty acid α-
oxidation, biosynthesis of ether phospholipids/plasmalogens, retinoid metabolism, 
cholesterol metabolism, protein /amino acid metabolism as well as conversion and 
biosynthesis of bile acid and polyunsaturated fatty acids (PUFAs). 
 
1.2.2.1. Peroxisomal fatty acid β-oxidation 
One of the main functions of peroxisomes is the breakdown of fatty acids. Generally, 
oxidation of fatty acids occurs in three subcellular organelles: mitochondria, 
peroxisomes and the CYP4A catalyzed oxidation occurring in the endoplasmatic 
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reticulum (Mannaerts, et al. 2000; Ortiz de Montellano 1995). Mitochondrial β-
oxidation is responsible for the oxidation of the bulk of the short, medium and long 
chain fatty acids and in the process, contributes to energy generation via ATP. 
Peroxisomes are involved in the β-oxidation of lipids which cannot be oxidized by 
mitochondria (Wanders and Tager 1998). These include: very-long-chain fatty acids 
(VLCFA), notably hexacosanoic acid (C26:0), the 2-methyl branched-chain fatty 
acids (pristanic acid) long-chain dicarboxylic acids, the bile acid synthesis 
intermediates (di and trihydroxycholestanoic acid, prostaglandins, leukotriens and 
certain xenobiotics. Fatty acids are taken into the peroxisome and esterified to CoA 
by the solute carrier family member proteins ABCD1/ALDP, ABCD2/ALDRP, or 
ABCD3/PMP70. ABCD1 and ABCD3 are strongly expressed in Sertoli cells, whereas 
peroxisomes in Leydig cells show the highest expression levels of ABCD2 (Nenicu et 
al. 2007).The substrates transported by ABCD2 are ill-defined. Several studies 
indicate the role of ABCD2 in the synthesis of the poly-unsaturated fatty acid, which 
requires chain shortening by peroxisomal β-oxidation. The peroxisome β-oxidation 
pathway consists of the similar reaction steps as the mitochondrial, but the enzymes 
involved are different and also oxidation does not go to completion. In contrast to the 
mitochondria, peroxisomal β-oxidation of fatty acids does not yield ATP. Products 
formed are transported out of peroxisomes to the mitochondria for full oxidation to 
CO2 and H2O. β-oxidation of fatty acids as the main function of peroxisomes also 
leads to the formation of H2O2. Peroxisomal β-oxidation systems consist of a 
classical peroxisome proliferator-activated receptor (PPAR)-inducible pathway for 
catabolism of eicosanoids and straight-chain acyl-CoAs by fatty acyl-CoA-oxidase 
(ACOX1), multifunctional protein 1 (MFP1) and thiolase A (pTH1), and a second 
non-inducible pathway catalyzing the oxidation of the cholesterol side chain and 2-
methyl-branched fatty acyl-CoA by a branched-chain acyl-CoA oxidase in humans 
ACOX2, (ACOX3 in mice)(Baumgart, et al. 1996a; Baumgart, et al. 1996b), 
multifunctional protein 2 (MFP2) (Novikov et al. 1997), also known as (HSD17B4), 
and sterol carrier protein X (SCPX). MFP-2 is involved in the peroxisomal -oxidation 
of very-long- chain fatty acids, pristanic acid, C27-bile acid intermediates as well in 
the synthesis of PUFA (Wanders, et al. 2001b).    
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Figure 3. Model for a peroxisome 
 
1.2.2.2. The role of peroxisomes in cholesterol synthesis 
Peroxisomes are also involved in the de novo cholesterol synthesis and in 
cholesterol oxidation (Biardi, et al. 1994; Krisans 1992; Krisans, et al. 1994). 
Cholesterol synthesis begins from acetyl-CoA, which is derived mostly from an 
oxidation reaction in mitochondria. Enzymes involved in cholesterol synthesis are in 
the cytoplasm, endoplasmatic reticulum (ER) and peroxisomes. Peroxisomes contain 
acetoacetyl-CoA thiolase, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) 
reductase, HMG-CoA synthase, mevalonate kinase, and farnesyl diphosphate (FPP) 
synthase. Under the enzymatic reaction of an acetoacetyl-CoA thiolase, two acetyl-
CoA are condensed to create acetoacetyl-CoA. It has been shown, that this enzyme 
has a peroxisomal target signal 1 (Song, et al. 1994). HMGCoA reductase, which 
catalyzes the conversion of HMG-CoA into mevalonate, is the rate limiting enzyme of 
the cholesterol biosynthetic pathway. Different studies showed that this enzyme is 
located in the sER and in the peroxisomes (Engfelt, et al. 1997; Keller, et al. 1985; 
Kovacs, et al. 2001). The next steps of cholesterol biosynthesis occur exclusively in 
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peroxisomes, since the following enzymes contain peroxisomal targeting signal: 
phosphomevalonate kinase (PMvK), mevalonate diphosphate decarboxylase (MPD) 
and isopentenyl phosphase (IPP) isomerase and farnesyldiphosphate synthase 
(FPP) (Biardi and Krisans 1996). FPP is utilized further by the ER for squalene 
synthesis resulting final product cholesterol (Goldstein and Brown 1990), which 
occurs only in the sER. 
 
1.2.3. Oxidative stress in the cells 
Oxidative stress arises due to a significant increase in the concentration of reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) and/or a decrease of 
antioxidant mechanisms.  Production of free radicals is a natural and continuous 
process in the body. ROS are generated as common by-products of normal cellular 
metabolism, and in normal physiological levels they act as intracellular signaling 
molecules in different biological mechanisms: cell proliferation, cell differentiation, 
cell apoptosis, immune reactions, inflammatory processes, aging (Fialkow, et al. 
2007). ROS are highly reactive molecules, which include oxygen radicals such as 
superoxide anion (O2−), hydroxyl radical (⋅OH), nitric oxide (⋅NO), also non-radical 
species such as hydrogen peroxide (H2O2), peroxynitrite and other compounds. 
Increased, harmful levels of ROS in the cells are usually decomposed by protective 
detoxifying mechanisms, which include antioxidant enzymes, such as catalase, 
glutathione peroxidase, superoxide dismutase 2 or mitochondrial SOD2, superoxide 
dismutase 1 or SOD1, peroxiredoxins 1-6, epoxide hydrolase and antioxidant 
molecules, such as glutathione, alpha tocopherol (Vit E), ascorbic acid (Vit C). 
The major sources of ROS in cells are mainly generated as a by-product of 
mitochondrial respiration (Boveris 1984; Mammucari and Rizzuto, 2010). Other than 
mitochondrial respiration, peroxisomes are also playing an important role as in 
production as well as in scavenging of oxygen free radicals in cells, particularly 
H2O2 (Dansen and Wirtz 2001; Nordgren and Fransen 2014; Schrader and Fahimi 
2006).  
ROS lead to cell damage through different mechanisms: DNA damage, peroxidation 
of lipids, oxidation of proteins. Moreover, they mediate an increased release of pro-
inflammatory cytokines. The major interest to oxidative stress arises considering 
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their significant role in the pathogenesis of different pathologies including 
atherosclerosis, inflammation, hypertension, diabetes, cancer, ischemia, injury, 
fibrosis, aging and other conditions (Chapple 1997; Madamanchi, et al. 2005; Raha 
and Robinson 2000).   
 
1.2.3.1. Mitochondria and oxidative stress  
The mitochondrion consists of two major membranes: inner and outer mitochondrial 
membranes separated by an intermembrane space. The inner membrane surrounds 
the mitochondrial matrix, which contains its own DNA and the enzymes responsible 
for the central reactions of oxidative metabolism. 
Mitochondria are known as the powerhouses of the cell, as they are responsible for 
the energy generated from the oxidative breakdown of fatty acids and carbohydrates, 
which are converted to ATP through oxidative phosphorylation (ox-phos). Cellular 
ATP is mainly generated through mitochondrial oxidative phosphorylation, a process 
where electron transport occurs along four enzyme complexes located at the inner 
mitochondrial membrane: mitochondrial complex I (NADH dehydrogenase), complex 
II (succinate dehydrogenase), complex III (cytochrome bc1), complex IV (cytochrome 
oxidase) and complex V (ATP synthase). Electrons are generated by citric acid cycle 
in the mitochondrial matrix. During electron transport, protein complexes push 
protons from the matrix into intermembrane space, creating a proton gradient, which 
generates the mitochondrial membrane potential (ΔΨm) and pH differential (ΔpH). 
Mitochondrial membrane potential is essential for the physiological function of the 
respiratory chain to generate ATP, including the powering the ATP synthase. 
Mitochondrial respiration with energetic processes is not without dangers. It 
consumes 85-90% of the oxygen necessary inside the cells, making them a major 
producer and the greatest potential source of ROS in the cells. Mitochondrial 
electron transport chain with molecular oxygen directly generates primarily the 
superoxide radical and via SOD2 hydrogen peroxide (Chance, et al. 1979; Hansford, 
et al. 1997). The two major respiratory chain regions responsible for ROS production 
are complex I and complex III (Baumgart, et al. 2001; Cross and Jones 1991; 
Shimomura, et al. 1985).  
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1.2.3.2. Peroxisomes and oxidative stress 
Oxygen is necessary for many metabolic reactions in different cellular locations with 
mitochondria, endoplasmic reticulum (ER) and peroxisomes being the major sites. 
Respiratory pathway in peroxisomes and the role of this organelle in the metabolism 
of ROS have been already described by early investigators (De Duve and Baudhuin 
1966; Oshino, et al. 1973; Sies 1974). β-oxidation of fatty acids is the most important 
metabolic process in peroxisomes contributing to the formation of hydrogen peroxide 
by fatty acyl-CoA oxidases. There are also other oxidases in peroxisomes such as 
urate oxidase, D-amino acid oxidase, D-aspartate oxidase, xanthine oxidase, 
pipecolic acide oxidase, polyamine oxydase and nitric oxide synthase. To maintain 
the balance between production and scavenging of ROS, peroxisomes house a 
variety of other antioxidant enzymes for the cell rescue from the damaging effects of 
ROS. Catalase is one of the most important antioxidant enzymes, which has a 
protective function against the peroxides generated in peroxisomes, and is 
considered as a marker enzyme for peroxisomes. It has been revealed, that catalase 
is highly expressed in peroxisomes in Leydig cells (Nenicu et al. 2007). The high 
amount of catalase in peroxisomes of Leydig cells can play a protective and 
beneficial role for steroidogenesis. 
As mentioned above, there are also other antioxidant enzymes which are mainly 
localized in mitochondria and/or cytosol, but they are present in peroxisomes as well. 
Different isoenzymes of glutathione peroxidases present in all cell compartments 
including peroxisomes (Singh, et al. 1994), and their role is to reduce lipid 
hydroperoxides as well as hydrogen peroxide. SOD1, which is mainly present in the 
cytoplasm and SOD2, primarily localized in mitochondria, was reported to be 
localized in peroxisomes as well (Dhaunsi, et al. 1992; Keller, et al. 1991; Singh 
1996). Recently in our laboratory was shown that mammalian SOD2 is exclusively 
located in mitochondria, but not in peroxiosmes (Karnati, et al. 2013). Both enzymes 
protect cells against superoxide anions by converting them into H2O2. The production 
of hydrogen peroxide, superoxide anion, hydroxyl radicals, as well as the discovery 
of different antioxidant enzymes in these organelles has supported the notion, that 
peroxisomes play a key role in both the generation of ROS with grave consequences 
for the cell fate, and scavenging of ROS in a cell, in particular hydrogen peroxide 
(Schrader and Fahimi 2006). Peroxiredoxin I (PRDX1) is also playing an important 
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role in oxdative cell protection. It was reported to be present in rat liver peroxisomes 
as well as in cytoplasm, mitochondria and nucleus (Immenschuh, et al. 2003). It has 
been reported, that increased levels of hydrogen peroxide can inhibit 
steroidogenesis via blockage of the mitochondrial P450scc, StAR protein expression 
(Tsai, et al. 2003) and also 3β-HSD (Stocco, et al. 1993). 
 
1.2.4. Peroxisomal disorders 
There are more than 20 human peroxisomal disorders with severe clinical 
manifestation, which reveal the relevance of the peroxisome for proper functioning of 
the cell and for human health. Severe inherited peroxisomal diseases can lead to 
death at early age and are usually characterized by an accumulation of VLCFAs, 
BCFAs or bile acid intermediates and also other components in the plasma. The 
peroxisomal disorders are divided into two classes: peroxisome biogenesis disorders 
and the single peroxisomal enzyme deficiencies (Fujiki 2016). 
 
1.2.4.1. Peroxisome biogenesis disorders  
Peroxisome biogenesis disorders (PBDs) include Zellweger syndrome (ZS), neonatal 
adrenoleukodystrophy (NALD), infantile Refsum disease (IRD)(Wanders, et al. 
2001a), which are collectively called the Zellweger spectrum disorders (ZSDs) as 
well as rhizomelic chondrodysplasia punctata (RCDP) type 1 (Goldfischer, et al. 
1973; Govaerts, et al. 1982; Steinberg, et al. 2006; Wanders and Waterham 2005).  
The molecular defects of these diseases are deletions or mutations of PEX genes, 
which are responsible for peroxisome biogenesis. PBDs are autosomal recessive 
disorders, in which functional peroxisomes are absent. The Zellweger syndrome 
(cerebrohepatorenal syndrome) is considered to be the most severe form of 
peroxisomal biogenesis disorders leading to early death of the children. Patients 
demonstrate developmental brain disorders, malformation in the central nervous 
system, skeletal dysmorphisms, liver dysfunction, adrenal insufficiency and 
retinopathy. In these patients very long chain fatty acids and branched chain fatty 
acids, such as phytanic acid are accumulated in plasma as well as in other cell 
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types. In addition, plasmalogens and ether-phospholipids levels are deficient, which 
is necessary for normal brain and lung function. 
 
1.2.4.2. Single Peroxisomal enzyme deficiencies 
Several diseases resulting from single peroxisomal enzyme deficiencies exist, where 
one of the peroxisomal metabolic pathways is affected. It can be enzyme defect in 
(1) peroxisomal -oxidation, (2) ether phospholipid synthesis, (3) peroxisomal -
oxidation, (4) glyoxylate detoxification or (5) H2O2-metabolism (Wanders 2004; 
Wanders and Waterham 2006). 
One of the single peroxisomal enzyme disorders is X-linked adrenoleukodystrophy 
(X-ALD) primarily occuring in males, which is classified in two most frequent 
phenotypes: childhood cerebral ALD (CCALD) and adrenomyeloneuropathy (AMN) 
(Powers 1985). Also, adolescence cerebral ALD exists, where symptoms manifest in 
adolescence. In these diseases an ABCD1 gene defect was described, an ABC-
transporter on the peroxisomal membrane, leading to the dysfunction of  the 
transport of very long-chain fatty acids into the peroxisomal matrix (Kemp and 
Wanders 2007) thus leading to the disruption of transport and subsequent 
breakdown of VLCFAs. The biochemical hallmark of X-ALD is the accumulation of 
VLCFAs in plasma as well as in different cell types. The accumulation of VLCFAs is 
mainly toxic to the adrenal cortex and myelin. CCALD usually manifests between 3 
and 10 years of age with progressive behavioral and neurologic deterioration, 
whereas AMN starts at a later age of onset between 28-35 years.    
Patients with a MFP-2 deficiency mostly die in their first years of life, exhibiting 
severe hypotonia, developmental abnormalities, neuronal migration defects and 
convulsions in the neonatal period. Clinically they are strongly similar to patients with 
Zellweger syndrome or cerebrohepatorenal syndrome (Gould, et al. 1996; Wanders 
et al. 2001b). 
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1.2.5. Peroxisomes and testis  
In the testis, peroxisomes were discovered first in interstitial Leydig cells via routine 
electron microscopy and through positive peroxidase staining for the localization of 
the peroxidatic activity of peroxisomal catalase (Reddy and Svoboda 1972; Reddy 
and Svoboda 1972a). Catalase is generally used as peroxisomal marker, because it 
is the most abundant peroxisomal protein found in other organs and tissues.  They 
were the first to speculate that Leydig cell peroxisomes play a role in cholesterol and 
steroid biosynthesis and/or catabolism. Through the analysis of the expression of 
catalase mRNA in male reproductive tract, peroxisomal marker protein was detected 
in peritubular and interstitial Leydig cells (Zini and Schlegel 1996). Later it has 
confirmed by in situ hybridization that catalase expression is restricted to Leydig cells 
(Baumgart, et al. 1997). The localization of peroxisomes only in Leydig cells as well 
as in epididymis was also shown by Western and Northern blotting (Reisse, et al. 
2001). However, later through visualization of different peroxisomal proteins, it was 
shown that peroxisomes are present in most cell types in the testis, except for 
mature spermatozoa (Luers, et al. 2003; Luers et al. 2006; Nenicu et al. 2007). 
These studies show the difference of peroxisomal protein composition dependent of 
specific cell type. Leydig cells express high level of catalase and peroxisomal lipid 
transporter ABCD2, whereas ABCD1, ABCD3 as well as the acyl-CoA oxidase 2 
(ACOX2) were found mostly in Sertoli cells (Nenicu et al. 2007). 
 
1.2.6. Peroxisomal dysfunction and testicular impairment 
Peroxisomes play a significant role in human testis development and function. This is 
stressed by gonadal impairment such as impaired spermatogenesis, primary 
hypogonadism and infertility in patients with peroxisomal dysfunction. Male patients 
with X-ALD demonstrate an adreno-testiculo-leukomyeloneuropathic-complex of 
symptoms with central and peripheral nerve disturbance, as well as impairment of 
endocrine system such as adrenal cortex and the gonads (Brennemann, et al. 1997; 
Powers 1985; Powers and Schaumburg 1981). Histological findings of testicular 
tissue of adult patients show hypocellularity and vacuolation of seminiferous tubules, 
germinal cell arrest and disturbed maturation of spermatogenesis. In some patients, 
the decrease in the number of Leydig cells was detected. Light microscopy of the 
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testis tissue revealed striations in Leydig cells, suggesting an accumulation of 
VLCFA in the cytoplasm in these cells (Powers and Schaumburg 1981). Sixty three 
percent of the AMN patients exhibit elevated serum LH and low levels of 
testosterone, confirming an impairment of the Leydig cells. Additionally, they 
possess increased serum FSH, which is the result of impaired Sertoli cell function 
consequently of deficient spermatogenesis (Brennemann et al. 1997). ALD-patients 
suffer from infertility, which can develop within one year (Aversa, et al. 1998). Poor 
response of hCG treatment was also demonstrated in many patients. Assies et al 
1998 demonstrated that some X-ALD patients exhibit reduced levels of DHEA 
(Assies, et al. 1998). 
Due to early postnatal death of patients with peroxisomal biogenesis disorders, very 
sparse information is known about the role of peroxisomes for male fertility and 
testicular function. However, Zellweger spectrum patients, surviving to adolescence 
also show testicular abnormalities with vacuolated Sertoli cells, a complete 
degeneration of Leydig cells and an arrest of spermatogenesis. Patients with a 
severe form of peroxisomal biogenesis disorders show cryptorchidism (Dimmick 
1997). It was suggested that cryptorchidism could be a result of androgen 
insufficiency or disturbed androgen signaling pathways in patients with peroxisomal 
disorders (Foresta, et al. 2008). Moreover, several studies with mouse models 
associated with peroxisome dysfunction show impaired testicular function. Testicular 
impairment was demonstrated in different mouse models with single peroxisomal 
enzymes deficiencies i.e. acyl CoA oxidase (Fan, et al. 1996a, b), MFP-2 (Huyghe, 
et al. 2006a), and dihydroxyacetonephosphate acyltransferase (DAPAT) (Rodemer, 
et al. 2003) knockout mice and mouse model with peroxisome biogenesis 
disturbance i.e Sertoli cell specific Pex 5 knockout mice (Huyghe et al. 2006a).   
In ACOX1 deficient mice with defects in peroxisomal β-oxidation, testes were smaller 
compared to wild-type controls. A strong decrease in Leydig cell population, and 
reduction of spermatogenesis, but no changes in Sertoli cells were seen in the testis 
of ACOX −/− mice (Fan et al. 1996b). 
DAPAT is a key enzyme in plasmalogen biosynthesis. Studies revealed that male 
adult DAPAT knockout mice were infertile and showed an arrest in spermatogenesis 
with a complete absence of elongated spermatids and spermatozoa. Moreover, 
partial arrest and apoptosis of spermatocytes was detected. Proliferation of 
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interstitial Leydig cells in clusters was noted in knockout mice compared to controls 
(Rodemer et al. 2003). 
MFP-2- knockout mice partly mimicked the human diseases. In contrast to human 
disease they did not show severe neurodevelopmental problems and the survival 
into adulthood permitted to observe a significance of this enzyme in several organs, 
including testis. Knocking out of MFP-2 leads to an inactivation of peroxisomal β-
oxidation. It causes severe male infertility, exhibiting a strong accumulation of neutral 
lipids in Sertoli cells in the prepubertal stages. Studies show that germ cells 
gradually disappeared from the tubulus seminiferous, spermatogenesis was already 
severely impaired by the age of 5 weeks.  At the age of 5 months, the testes 
demonstrated a complete fatty degeneration and obliteration of the seminiferous 
tubules till complete testicular atrophy. Biochemical analyses showed that 
peroxisomal β-oxidation substrates, such as VLCFA and pristanic acids were 
elevated in the testis. According these studies interstitial Leydig cells were normal 
until the age of 12 weeks, thereafter the number of Leydig cells was difficult to 
estimate due to disintegrating seminiferous epithelium. The basal and hCG-
stimulated testosterone levels were not changed in knockout mice whereas 
quantitative PCR results of the Leydig cell-specific gene expression, 3β-HSD, P450 
cholesterol side chain cleavage enzyme and P450c17 were lower with no statistical 
significance. Interestingly female MFP-2 knockouts exhibited only a reduced fertility 
(Huyghe et al. 2006a).  In this study, also shortly Sertoli cell-specific Pex5 knockout 
mice were described, where they show severe affected spermatogenesis, testicular 
atrophy and infertility similar to MFP-2 knockout mice. 
Different mouse models with generalized inactivation of Pex genes involved in PTS1- 
and PTS2-dependant matrix protein import (Pex2-, Pex5- and Pex13-knockouts) 
have been developed to investigate the underlying pathogenesis of the most severe 
peroxisomal biogenesis disorder, Zelweger syndrome (Baes, et al. 1997; Faust and 
Hatten 1997; Liu et al. 1999). All knockout models demonstrated different organ 
impairments typical for ZS, including disturbed neocortex neuronal migration and 
development as well as hypotonia.  Due to their early postnatal mortality, it was not 
possible to investigate the role of peroxisomes in adult tissues in Pex-knockout mice, 
losing their usefulness as models for postnatal disease pathogenesis. Particularly, 
these Pex-KO mice were not suitable to study testicular pathologies observed in 
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patients with Zellweger syndrome. Later, through advanced Cre-loxP technology was 
possible conditionally inactivate genes in specific cell type. Conditional knockout of 
Pex13 and Pex5 specifically in Sertoli cells were generated to study the functional 
importance of peroxisomes in these cells. Both knockouts showed severe impaired 
spermatogenesis, with lipid accumulation in Sertoli cells leading to arrest of 
spermatogenesis (Huyghe, et al. 2006b; Nenicu et al. 2007). In Pex13-KO mice the 
proliferation of Leydig cells with hormonal alterations was observed, which is 
considered to be a compensatory alteration in response to the loss of Sertoli cells. 
The morphological and biochemical phenotyping on the protein level of the Sertoli-
cell-specific Pex13-knockout mouse has been largely done in our lab (Nenicu 2010). 
To clarify the role of peroxisomal function in Leydig cells, we were able to establish a 
conditional knockdown of Pex13 in Leydig cells. Pex13 gene encodes a protein that 
is essential for PTS1 and PTS2 protein import into the peroxisome. Pex13p is the 
putative docking protein which interacts not only with the PTS1-receptor Pex5p, but 
also with PTS2-receptor Pex7p (Stein, et al. 2002). Deletion of Pex13 leads to a loss 
of both PTS1 and PTS2 protein import. If the import of matrix proteins is defective, 
this results to a complete disruption of peroxismal metabolism (Gould et al. 1996). 
In the Pex13-/- mouse, morphologically detectable peroxisomes were absent in the 
liver and peroxisomal ghosts in cultured fibroblast were detected with peroxisomal 
metabolic deficiency (Maxwell et al. 2003).  
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2. Materials and Methods 
2.1. Materials 
2.1.1. Laboratory Instruments 
Table 1. All laboratory instruments used for experiments in this thesis are 
summarized with appropriate supplier. 
Instruments Manufacturer 
AGFA Horizon Ultra Color Scanner  AGFA, Mortsel, Belgium  
Biocell A10 water system  Milli Q-Millipore, Schwalbach, Germany  
Biofuge Fresco  Heraeus, Hanau, Germany  
Biofuge Pico  Heraeus, Hanau, Germany  
Dish washing machine (G 78 83 CD)  Miele, Gütersloh, Germany  
Gel-Doc 2000 gel documentation 
system  
Bio-Rad, Heidelberg, Germany  
Hera cell 240 incubators  Heraeus, Hanau, Germany  
Hera safe, clean bench KS-12  Heraeus, Hanau, Germany  
Ice machine, Scotsman AF-100  Scotsman Ice Systems, Vernon Hills, IL, USA  
I Cycler PCR machine MiQ2 optical 
module  
Bio-Rad, Heidelberg, Germany  
Leica DMRD fluorescence microscope  Leica, Bensheim, Germany  
Leica DC 480 camera  Leica, Bensheim, Germany  
Leica TCS SP2 confocal laser 
scanning microscope  
Leica, Nussloch, Germany  
Microwave oven MB-392445  LG, Willich, Germany  
Mini-Protean 3 cell gel chamber  Bio-Rad, Heidelberg, Germany  
Multifuge 3 SR centrifuge  Heraeus, Hanau, Germany  
pH meter E163649  IKA, Weilheim, Germany  
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Pipettes  Eppendorf, Hamburg, Germany  
Pipette-type electroporator 
Microporator MP-100 
PeQLab, Digital Bio Technology,  
Power supply - 200, 300 and 3000 Xi  Bio-Rad, Heidelberg, Germany  
Pressure/Vacuum Autoclave FVA/3  Fedegari, Albuzzano, Italy  
Sorvall Evolution RC centrifuge  Kendro, NC, USA  
SmartspecTM 3000 spectrophotometer  Bio-Rad, Heidelberg, Germany  
Thermo plate HBT 130  Medax, Kiel, Germany  
Thermo mixer HBT 130  HLC, BioTech, Bovenden, Germany  
Trans-Blot SD semi dry transfer cell  Bio-Rad, Heidelberg, Germany  
TRIO-thermoblock  Biometra, Göttingen, Germany  
Ultra-balance LA120 S  Sartorius, Göttingen, Germany  
Vortex M10  VWR International, Darmstadt, Germany  
Water bath shaker GFL 1083  GFL, Burgwedel, Germany  
 
2.1.2. General materials, culture media, buffers and solutions 
Table 2. Details for culture media, buffers and solutions used in this thesis.  
Cell Culture Media 
 
MLTC-1 medium 
RPMI-1640 containing 25mM HEPES and 
supplemented with 10% fetal calf serum (FCS), 
2Mm L-glutamine 
 
MA-10 medium 
Waymouth’s complete medium MB752/1 
supplemented with heat inactivated horse serum, 
penicillin G (100 units/ml), and streptomycin 
(100ug/ml) 
 
Mouse primary Leydig cell culture 
DMEM/F12 supplemented with 15% horse serum, 
2.2µg/l sodium bicarbonate, 10mm HEPES, 
1mg/ml BSA, 500ng/ml insulin, 100IU/ml penicillin, 
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medium (first day) 100µg/ml streptomycin 
 
Mouse primary Leydig cell culture 
medium  
DMEM/F12 supplemented with 2.2µg/l sodium 
bicarbonate, 10mm HEPES, 1mg/ml BSA, 
500ng/ml insulin, 100IU/ml penicillin, 100µg/ml 
streptomycin 
 
Testis enzymatic digestion medium 
for isolation of primary cells 
DMEM/F12 supplemented with 10 mM HEPES (pH 
7.4), collagenase A (1 mg/ml), hyaluronidase (1 
mg/ml), 0,07% BSA 
 
Stock Solution Percoll (90%) 
Percoll +10 X Earle’s balanced salt containing 
0,7% BSA and 250 mM HEPES 
 
Percoll gradient  
Percoll solution (21, 26, 34, 40 and 60%) in 
isotonic Earle’s salt buffer containing 0.07% BSA 
 
Solutions for Molecular Biology and Western Blotting 
Cell lysis buffer 
50mM Tris, 400mM NaCl, 100mM EDTA, 0.5% 
SDS 
Loading dye (10 ml) 
16μl saturated aqueous bromophenol Blue, 80μl 
500mM EDTA, pH 8.0, 720μl 37% formalin stock 
solution, 4ml 10X gel buffer fill up to 10 ml ddH2O 
1X Formaldehyde gel 
100 ml 10x RNA transfer buffer 10x, formaldehyde, 
880ml ddH2O2 
Agarose gel 2%, 120 ml 2,4g of agarose, 120 ml of 1x TAE, Stain G 4,5µl 
10X RNA transfer buffer 
200nM MOPS, 50 mM sodium acetate, 10 mM 
EDTA, pH 7.0 
LB medium 
0.17M sodium chloride + 1% Trypton + 0.5% Yeast 
extract, pH 7.0 
LB-Agar LB medium + 1g/50ml Agar + 100 µg/ml Ampicillin 
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Solutions for Immunofluorescence 
 
Fixative solution 
4% depolymerized paraformaldehyde, containing 
2% sucrose in 1X PBS (150mM NaCl, 13.1 mM 
K2HPO4, 5mM K2HPO4, pH 7.4 
 
Citrate buffer 
Buffer A: 1 mM C6H8O7 H2O; Buffer B: 50 mM 
C6H5Na3O7 2H2O; Citrate buffer: 0.15 mM buffer 
A, 8.5 mM buffer B, pH 6.0 
 
Homogenization buffer 
50Mm Tris + 150mM NaCl+1% Triton-X-100 (pH 
7.4), before using add 10% protease inhibitor 
 
Resolving gel (12%) for SDS-PAGE 
gels 
6.7 ml ddH2O, 8ml of 30% acrylamide, 5 ml 1.5 M 
Tris buffer (pH 8.8), 200µl SDS (10%), 120 μl 10% 
APS, 10 μl TEMED 
 
Stacking gel for SDS-PAGE gels 
6.0 ml ddH2O, 1300µl of 30% acrylamide, 2,5 ml 
0.5 M Trispuffer (pH 6.8), 100µl SDS (10%), 60 μl 
10% APS, 10 μl TEMED 
10 X Electrophoresis buffer 2 M glycin +250 mM Tris + 1% SDS 
 
10X Sample Buffer 
3.55 ml ddH2O +1.25 ml 0.5 M Tris-HCl (pH 6.8), + 
2.5 ml 50% glycerol +2 ml 
10% SDS, a tip of 0.05% bromophenol blue.  Prior 
to use add 50 μl b-Mercaptoethanol 
20 X Transfer Buffer 
NuPAGE transfer buffer (Invitrogen), Heidelberg 
Germany 
10 X TBS  0.15 M NaCl, 0.1 M Tris, 0.05% Tween 20, pH 8.0 
1 X TBST (washing buffer) 
1ml (for 100ml) of 10X TBS + 0.05% Tween 20, pH 
8.0 
10% Blocking Buffer 10 g fat free milk powder in 100 ml 1X TBST C                               
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Glycine (1%) 1g Glycine in 100 ml of 1X PBS buffer 
Glycine (1%) + Triton X-100 (0.3%) 
1g Glycine in 100 ml of 1X PBS buffer + 0.3 ml 
Triton X-100 
 
IF Blocking buffer 
4% bovine serum albumin (BSA) in Tris-buffered 
saline containing 0.05% Tween 20 (TBST) 
 
Buffer for diluting antibody 
1% TBST (150 mM NaCl,50 mM Tris, 0.05% 
Tween 20, pH 7.4) 
 
Mowiol 488 solution 
Overnight stirring of 16.7% Mowiol 488, 80 ml 1x 
PBS; add 40 ml glycerol stir again overnight; 
centrifuge at 15,000 g for 1h and store supernatant 
at -20ºC 
Anti-fading agent (2.5%) 
2.5g N-propyl-gallate in 50 ml of 1 x PBS +50 ml of 
glycerol 
Mounting medium  
1 part anti-fading agent, 3 parts Mowiol 488 
solution 
PBS 10X 
1.5 M NaCl, 131 mM K2HPO4, 50 mM KH2PO4, 
pH 7.4 
TBS 10X 0.5 M Tris, 1.5 M NaCl, fill up to 1l ddH2O2, pH 7.4 
Trypsin (0.01%) 0,01g trypsin in 100 ml PBS buffer 
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2.1.3. Chemicals 
Table 3. List of reagents and media ingredients used in this study. 
 
Reagent Company name 
Abiraterone Acetate Cayman Chemical, Michigan, USA 
Acrylamide Roth, Karlsruhe, Germany 
Agarose LE Roche, Grenzach Wyhlen, Germany 
Ampicillin Difco, MI, USA 
Bradford reagent Sigma, Steinheim, Germany  
Btomophenol blue Riedel-de-Haen, Germany 
BSA Sigma, Steinheim, Germany  
Catalase assay kit Cayman Chemical, Germany 
Collagenase Type I Sigma, Steinheim, Germany  
Deoxyribonuclease I, Amplification 
Grade  
Invitrogen, Heidelberg, Germany 
Diethyl ether Sigma-Aldrich, Germany 
Dihydroethidium Molecular Probe, Oregon, USA 
Dimethyl Sulfoxide (DMSO) Sigma, Steinheim, Germany 
Dithiotreitol (DTT) Sigma, Steinheim, Germany 
DMEM/F12 GIBCO, New York, USA 
dNTPs Promega GmbH, Madison, USA 
Dulbecco`sModified Eagle´s 
Medium/Ham`s F-12 
GIBCO, New York, USA 
Dnase Sigma, Steinheim, Germany 
Earle´s balanced salt solution 10x Sigma, Steinheim, Germany 
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Earle´s balanced salt solution  Sigma, Steinheim, Germany 
Ethanol Riedel-de-Haen, Germany 
Ethylenediaminetetraacetic acid 
(EDTA) 
Fluka, Biochemik, Steinhaeim, Germany 
Fetal calf serum PAA, Pasching, Austria 
Formaline Sigma, Steinheim, Germany 
FuGENE HD Transfection Reagent Promega, Madison, USA 
Gentamycin Sigma, Steinheim, Germany 
GSH-Glo™ Glutathione Assay Promega, Madison, USA 
Glycine Roth, Karlsruhe, Germany 
Glycerol Sigma, Steinheim, Germany 
HEPES Biochrom, Berlin, Germany 
Horse serum PAA, Pasching, Austria 
Hyaluronidase Sigma, Steinheim, Germany  
22(R)-Hydroxycholesterol Santa Cruz Biotech, Heidelberg, Germany 
Immun-StarTM AP Bio-Rad, Heidelberg, Germany 
Insulin Sigma, Steinheim, Germany 
INTERFERin Transfection Reagent Polyplus-transfection Inc, New York, USA 
Interleukin-1 beta (IL-1 beta) Biomol, Hamburg, Germany 
Interleukin-6 (IL-6) Biomol, Hamburg, Germany 
Isopropanol Sigma, Steinheim, Germany 
Isotonic Earle’s salt buffer Sigma, Steinheim, Germany 
Lipofectamin RNAiMAX Invitrogen, Heidelberg, Germany 
Mowiol 4-88 Polysciences, Eppelheim, Germany 
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N-Propyl-gallate Sigma, Steinheim, Germany 
Oil O Red Fluka, Steinheim, Germany 
OPTI-MEM GIBCO, New York, USA 
Paraffin (Paraplast) Sigma, Steinheim, Germany 
Paraformaldehyde (PFA) Sigma-Aldrich, Germany 
Penicillin/Streptomycin Sigma, Steinheim, Germany 
Percoll Sigma, Steinheim, Germany 
Potassium carbonate Sigma-Aldrich, Germany 
Protease inhibitor mix M Serva, Heidelberg, Germany 
Protease K Sigma, Steinheim, Germany 
PCR kit QIAGEN, Hilden, Germany 
PVDF membranes Bio-Rad, Heidelberg, Germany 
QIAGEN Plasmid midi kit Qiagen, Hilden, Germany 
RNeasy kit QIAGEN, Hilden, Germany 
RNAzol Sigma-Aldrich, Germany 
RPMI-1640 GIBCO, NY, USA 
RT-PCR kit Invitrogen, Karlsruhe, Germany 
ScreenFect A Transfection Reagent InCella GmbH, Mannheim, Germany 
Sodium bicarbonate Sigma, Steinheim, Germany 
Sodium chloride (NaCl) Sigma, Steinheim, Germany 
Sodium dodecyl sulfate (SDS) Sigma, Steinheim, Germany 
Sucrose Merck, Darmstadt, Germany 
Taq polymerase Promega GmbH, Madison, USA 
Tetramethylenediamine (TEMED) Roth, Karlsruhe, Germany 
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2.1.4. Antibodies 
Table 4. List of primary and secondary antibodies, which were used for 
immunofluorescence and for Western blots. 
 
 
Host 
 
Primary antibodies 
 
Methods and 
dilution 
Supplier 
 
rabbit 
 
Mouse Catalase polyclonal antibody  
 
IF 1:2.000                                                
WB 1: 40.000 
Gift from Denis I 
Crane Biomol.Biomed. 
Sci., Griffith Univ., 
Nathan, Brisbane, Qid 
4111, Australia 
 
rabbit 
Mouse Cytochrome P450 side chain 
cleavage enzyme (P450scc) 
 
IF 1:1.000                               WB                                      
Chemicon 
International CA, 
TransIT-LT1 Transfection Reagent Mirus, Madison, USA 
Trilostane Sigma-Aldrich 
Trishydroxymethylaminomethane 
(Tris) 
Merck, Darmstadt, Germany 
Tris-HCL Sigma, Steinheim, Germany 
Triton X-100 Sigma, Steinheim, Germany 
Trypan blue Sigma, Steinheim, Germany 
Trypsin Sigma, Steinheim, Germany 
Tween 20 Merck, Darmstadt, Germany 
ViafectTM Transfection reagent Promega, Madison, USA 
Viromer Blue, Green Transfection 
Reagent 
Lipocalyx, Halle, Germany 
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polyclonal antibody 1: 5.000 Temecula, 92590 CA, 
USA Cat. No. AB12 
44 
 
rabbit 
 
 
Mouse Glutathione Reductase 
polyclonal antibody 
 
WB 1:2.000 
Biozol, Diagnostica 
Vertrieb GmbH; D-
85380 Eching        
Cat. No: ab 16801 
 
 
mouse 
 
Mouse Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 
monoclonal antibody 
 
WB 1:10.000 
 
HyTest Ltd, 20520 
Turku, Finland Cat. 
No: 5G4 
 
 
mouse 
Mouse Oxidative Phosphorylation 
Complex III (OxPhos III) polyclonal 
antibody 
 
IF 1:2.000 
WB 1:500  
Molecular 
Probes/Invitrogen, 
Carlsbad, CA 92008, 
USA  
Cat. No: A 11143 
 
rabbit 
 
Mouse Peroxin13 (PEX13) 
polyclonal antibody 
 
IF  1:1.000               
WB  1: 6.000 
 
Gift from Denis I. 
Crane                 
(address see above) 
 
rabbit 
 
Mouse Peroxin14 (PEX14) 
polyclonal antibody 
 
IF  1: 2.000               
WB  1: 30.000 
 
Gift from Denis I. 
Crane                  
 
rabbit 
 
Mouse Steroidogenic acute 
regulatory protein (StAR), 
monoclonal antibody 
 
IF 1:100                                
WB 1:1.000 
 
Cell Signaling 
Technology     Cat. 
No: 8449P 
 
rabbit 
 
Mouse Steroidogenic Acute 
Regulatory protein (StAR) polyclonal 
antibody 
 
IF    1:100                   
WB 1:1.000 
 
Abcam, Cakmbridge, 
CB4 0FW, UK, Cat. 
No. (ab3343) 
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rabbit 
 
Mouse Superoxide dismutase 1 
(SOD1) (Cu/Zn SOD) polyclonal 
antibody 
 
WB 1: 1.500 
 
Fitzgerald Industries 
International, Inc. 
Concord, USA 
Cat. No: RDI-
RTSODabR 
 
rabbit 
 
Mouse Superoxide dismutase 2 
(SOD2) (Mn-SOD) polyclonal 
antibody 
 
WB 1:4.000 
 
RDI, Research 
Diagnostics, Inc, 
Flanders, NJ 07836 
 
rabbit 
 
Mouse Tubulin (alpha) polyclonal 
antibody 
 
WB 1:4.000 
 
SIGMA, Saint Louis, 
Missouri 63103 USA, 
Cat. No: T 3526 
 
 
Host 
 
Secondary antibodies 
 
Methods and 
dilution 
 
Supplier 
 
donkey 
 
Anti-Mouse IgG TexasRed, Kit 
 
IF 1:300 
 
VECTOR, Burlingame, 
CA,  
USA, Cat. No: Ti-2000 
 
donkey 
 
Anti-Rabbit IgG AlexaFluor488 
 
IF 1:300 
Molecular 
Probes/Invitrogen, 
Carlsbad, CA, USA, 
Cat. No: A21206 
 
 
goat 
 
 
Anti-Rabbit IgG alkaline 
 
 
WB 1:20.000 
 
Molecular 
Probes/Invitrogen, 
Carlsbad, CA, USA, 
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phosphatase conjugate Cat. No: A0545 
 
goat 
 
Anti-Mouse IgG alkaline 
phosphatase conjugate 
 
WB 1:20.000 
 
Molecular 
Probes/Invitrogen, 
Carlsbad, CA, USA, 
Cat. No: A3562 
 
donkey 
 
Anti-Rabbit IgG horseradish 
peroxidase conjugate 
 
WB 1:10.000 
 
Jackson Immuno 
Research Cat. No: 
715035152 
 
donkey 
 
Anti-Mouse IgG horseradish 
peroxidase conjugate 
 
WB 1:10.000 
 
Jackson Immuno 
Research Cat. No: 
715035150 
 
Counterstaining of nuclei  Supplier 
Hoechst 1:500   
TOTO-3 nucleic acid staining 1:1,000 IF 1:1.000 
Molecular 
Probes/Invitrogen, 
Carlsbad, CA, USA 
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2.1.5. Primers 
Table 5. List of primers 
Gene Accession 
no. 
Forward/reverse primers leng
th  
Ann 
temp 
in °C 
28 S ribosomal RNA 
(28S rna) 
 
NR_003279 
For CCTTCGATGTCGGCTCTTCCTAT 
Rev GGCGTTCAGTCATAATCCCACAG 
 
254 
 
65 
Acyl-Coenzyme A 
oxidase 1, palmitoyl 
(Acox1) 
 
NM_015729 
For CTGAACAAGACAGAGGTCCACGAA 
Rev TGTAAGGGCCACACACTCACATCT 
 
565 
 
60 
Acyl-Coenzyme A 
oxidase 2, branched 
chain (Acox2) 
 
NM_053115 
For CTCTTGCACGTATGAGGGTGAGAA 
Rev CTGAGTATTGGCTGGGGACTTCTG 
 
688 
 
58 
Acyl-Coenzyme A 
oxidase 3, pristanoyl 
(Acox3) 
 
NM_030721 
For GCCAAAGCTGATGGTGAGCTCTAT 
Rev AGGGGTGGCATCTATGTCTTTCAG 
 
813 
 
55 
ATP-binding cassette, 
subfamily D, member1 
(ABCD1) or (ALDP) 
 
NM_007435 
For GAGGGAGGTTGGGAGGCAGT 
Rev GGTGGGAGCTGGGGATAAGG 
 
440 
 
63 
ATP-binding cassette, 
subfamily D, member 2 
(ABCD2) or (ALDPR) 
 
AK134763 
For TGCAAAATTCTGGGGAAGA 
Rev TGACATCAGTCCTCCTGGTG 
 
405 
 
58 
ATP-binding cassette, 
subfamily D, member 3 
(ABCD3) or (PMP70) 
 
NM_008991 
For CTGGGCGTGAAATGACTAGATTGG 
Rev GGGATAAGGTCCCCAGTCAAGTG 
 
523 
 
65 
ATP-binding cassette, 
subfamily D, member 4 
(ABCD4) or (PMP70R) 
 
BC050102 
For TGAAAGGCTCAGTGCAGATG 
Rev GGCTGCAGGTAGAAGAGACG 
 
304 
 
62 
 
Catalase (Cat) 
 
NM_009804 
For ATGGTCTGGGACTTCTGGAGTCTTC 
Rev GTTTCCTCTCCTCCTCGTTCAACAC 
 
312 
 
65 
Cytochrome P450, 
family 11, subfamily a 
polypeptide 1, (P450 
scc) or (Cyp11a1) 
 
NM_019779 
For GCTGGAAGGTGTAGCTCAGG 
Rev TTCTTGAAGGGCAGCTTGTT 
 
432 
 
58 
 
47 
 
Cytochrome P450, 
family 17, subfamily a, 
polypeptide 1, 
(P450c17) or 
(Cyp17a1) 
 
 
 
NM_007809 
 
 
For ACCAGCCAGATCGGTTTATG 
Rev AGGGCAGCTGTTTGTCATCT 
 
 
204 
 
 
58 
Cytochrome P450, 
family 19, subfamily a, 
polypeptide 1 (P450 
arom) or (Cyp19a1) 
 
NM_007810 
 
For GACACATCATGCTGGACACC                          
Rev CAAAGCCAAAAGGCTGAAAG 
 
722
 
58 
Enoyl-coenzyme A 
hydratase/3-
hydroxyacyl coenzyme 
dehydrogenase 
(multifunctional protein 
1) (Ehhadh) or (MFP1) 
 
NM_023737 
 
For ATGGCCAGATTTCAGGAATG 
Rev TGCCACTTTTGTTGATTTGC 
 
211 
 
56 
Follicle stimulating 
hormone receptor 
(Fshr) 
 
NM_013523 
For CCAGCCTTACCTACCCCAGT 
Rev CTGTGGTGTTCCCAGTGATG 
 
345 
 
58 
Glutathione 
peroxidase1 (Gpx1) 
 
BC086649 
For GGGACTACACCGAGATGAACGA 
Rev ACCATTCACTTCGCACTTCTCA 
 
430 
 
55 
Glutathione S-
transferase 1 (Gsta1) 
 
BC132572 
For 
GCAGACCAGAGCCATTCTCAACTAC 
Rev CTGCCAGGCTGTAGGAACTTCTTC 
 
480 
 
55 
β(3b-HSD III) or 
(Hsd3b3) 
 
NM_001012
306 
For TCAATGTGAAAGGTACCC 
Rev ATCATAGCTTTGGTGAGG 
 
499 
 
55 
17b-Hydroxysteroid 
dehydrogenase 4 
(multifunctional protein 
2) (MFP2) or 
(Hsd17b4) 
 
NM_008292 
For GAGCAGGATGGATTGGAAAA 
Rev TGACTGGTACGGTTTGGTGA 
 
223 
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3-Hydroxy-3-
methylglutaryl-
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Coenzyme A reductase 
(Hmgcr) or (HMG-
CoAR) 
NM_008255 For CCCACGAGCAAACATTGTC                                       
Rev TGAGCCCCACACTGATCAACC 
741 55 
 
3-Hydroxy-3-
methylglutaryl-
Coenzyme A synthase 
1 (Hmgcs1) or 
(MGC36662) 
 
NM_145944 
 
For CTTTGCCTGACTGTGGTTCA 
Rev GACCACAGGGTACTCGGAGA 
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62,7 
 
Isopentenyl-
diphosphate isomerase 
(Idi1) or (MGC8139) 
 
NM_145360 
 
For GGGCTGACACCAAGAAAAAC 
Rev ACTGGCTGCCTTCTTCAAAA 
 
 
470 
 
 
62,7 
Luteinizing 
hormone/choriogonadot
ropin receptor (LH-R) 
 
NM_013582 
For 
ATGGATCCCTCTCACCTATCTCCCTGT 
RevAGTCTAGATCTTTCTTCGGCAAATT
CCTG 
 
702 
 
58 
Peroxiredoxin 1 (Prdx1) 
or (PAG) 
 
NM_011034 
For TCTCTTTCAGGGGCCTTTTT 
Rev CCAAAACACAGCTCAGACCA 
 
396 
 
35 
Peroxiredoxin 5 (Prdx5) 
or (Pmp20) 
 
NM_012021 
For GAAAGAAGCAGGTTGGGAGTGT 
Rer CCCAGGGACTCCAAACAAAA 
 
182 
 
35 
Peroxisome biogenesis 
factor 13 (Pex13) 
 
NM_023651 
ForGACCACGTAGTTGCAAGAGCAGAGT 
RevCTGAGGCAGCTTGTGTGTTCTACTG 
 
717 
 
65 
Peroxisome biogenesis 
factor 14 (Pex14) 
 
NM_019781 
For CACCTCACTCCGCAGCCATA 
RevCTGACAGGGGAGTGTCACTGCT 
 
298 
 
56 
Steroidogenic acute 
regulatory protein 
(StAR) or (Star) 
 
NM_011485 
For GTTCCTCGCTACGTTCAAGC 
Rev TTCCTTCTTCCAGCCTTCCT 
 
292 
 
58 
Sterol-carrier protein X 
(ScpX) or (SCPX) 
 
M91458 
For GGCCTTCTTTCAAGGGAAAC 
Rev ACCACAGCCCAATTAGCAAC 
 
230 
 
56 
3-Ketoacyl-CoA 
thiolase (Thiolase A) or 
(pTH1) 
 
AY273811 
For TCAGGTGAGTGATGGAGCAG 
Rev CACACAGTAGACGGCCTGAC 
 
241 
 
60 
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2.2. Cell Culture 
2.2.1 Mouse Leydig Tumor cells (MLTC-1 and MA-10 cells) 
MA-10 and MLTC-1cells which are by far the most widely used and the best 
characterized tumor cell lines of mouse Leydig cells (Ascoli 1981a; Rebois 1982) 
were used in this study.  They were established from the M548O transplantable 
Leydig cell tumor carried in C57BL/6 mouse. Two variants of the M5480 tumor were 
later identified: M5480A (MA-10) and M5480P (MLTC-1).  
 
2.2.1.1. Culture of MLTC-1 cells 
The MLTC-1 cell line was bought from the American Type Culture Collection 
(ATCC), ATCC number CRL-2065 TM.  The base medium for this cell line is ATCC-
formulated RPMI-1640 Medium, Catalog No. 30-2001 (see Table 2). 
MLTC-1 cells were cultured in RPMI-1640 containing 25mM HEPES and 
supplemented with 10% fetal calf serum (FCS), without antibiotic, pH 7.3 at 37°C 
under a humidified atmosphere of 95% air and 5% CO2. Cells were cultured at a 
density 1 x 106 in 10cm Petri dishes. At 60% confluence, the cells were 
disaggregated with trypsin-EDTA (0.05%) for 3 min. and dissolved in growth 
medium. During splitting the viability of the cells was determined with 0.4% trypan 
blue (w/v) exclusion. Cells were sub-cultured at 1.5 x 105 in per well 6 well plates, 
7.5 x 104 in per well 12 well plates, 3,8 x 104 in per well 24 well plates for different 
experiments and grown for 3 days prior to their use in experiments.  
 
2.2.1.2. Culture of MA-10 cells 
MA-10 cells were a gift from Prof. Dr. Ralf Middendorff (JLU-Giessen), a colleaque in 
our institute. MA-10 cells were cultured in RPMI 1640 containing 10% of heat 
inactivated horse serum, penicillin G (100 units/ml), and streptomycin (100ug/ml). 
Cells were incubated at 37°C in 5% CO2 in a humidified incubator. Cells were sub-
cultured at a density of 1 x 106 in 10cm Petri dishes, 1,5 x 105 in per well 6 well 
plates, 7.5 x 104 in 12 well plate for different experiments and grown for 3 days prior 
to their use in experiments.  
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2.2.2. Isolation and primary culture of mouse Leydig cells 
Primary mouse Leydig cells were isolated according to the method of Schumacher 
and colleges (Schumacher, et al. 1978)  with some modifications using a procedure 
involving enzymatic dissociation and Percoll-gradient centrifugation. For each 
experiment 6 -12 adult mice (3-4 months of age) were sacrificed by cervical 
dislocation. Testes were removed aseptically under asterile hood and collected into 
chilled Dulbecco's Modified Eagle Medium/ Ham´s F-12 (DMEM/F12; 1:1, v/v) with 
gentamycin.  All following steps were performed under sterile conditions. Testes 
were transferred in a new sterile medium and the tunica albuginea was carefully 
removed from the testes. De-capsulated testes were put into a 50ml tube containing 
10ml (for 2 testes 2 ml medium) medium DMEM/F12 with collagenase 1.0 mg/ml, 10 
mM HEPES, 0.07% BSA, hyaluronidase 1.0 mg/ml, pH 7.4. The incubation was 
carried out for 15 min at 34°C in a water bath shaker. After collagenase digestion, 
tubules and the suspension of cells were left for sedimentation on ice for 2-3 min. 
The suspension obtained was filtered through 70µm Nylon gauze (BD Falcon) and 
the crude interstitial cells were collected by centrifugation at 300 x g for 10 min. Cells 
were washed twice with DMEM/F12 by centrifuging at 200 x g for 8 min to remove 
the collagenase. Finally, collagenase-dispersed cells were re-suspended in 6ml (for 
6 mice) of Leydig cell medium (DMEM/F12 supplemented with 10mM HEPES (pH 
7.4), 1mg/ml BSA, 500ng/ml insulin, 100 units/ml penicillin, 100µg/ml streptomycin). 
Three ml was loaded (3ml for each Percoll tube) on top of a discontinuous Percoll 
gradient and centrifuged for 30 min at 800 x g. In order to prepare a gradient, the 
osmolality of Percoll (undiluted) had to be first adjusted with saline or cell culture 
medium to make the Percoll isotonic with physiological salt solutions. Adding 9 parts 
(v/v) of Percoll to 1 part (v/v) 10 x concentrated cell culture medium was the way of 
preparing a Stock Isotonic Percoll (SIP) solution. Nine parts Percoll were mixed with 
1 part 10 x Earle`s balanced salt solution containing 0.7% serum albumin and 
250mM HEPES, pH 7.4 to prepare a 90% stock solution Percoll. Discontinuous 
Percoll gradient (25, 35, 50 and 60%) were prepared by diluting the 90% Percoll 
stock solution with isotonic Earle`s salt buffer containing 0.07% BSA.  Following 
centrifugation, 4 visible bands were detected and the highly purified Leydig cells 
were found in the third band. Leydig cells formed a distinct band close to the 
interphase between 50 % and 60% of Percoll. This band was isolated and added to 
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3 volumes of serum free medium DMEM/F12 with 10mm HEPES and the isolated 
Leydig cells were washed twice by centrifuging at 100 x g for 10 min. The purified 
Leydig cells were plated on day 1 in DMEM/F12 medium containing 15% horse 
serum and supplemented with 10mm HEPES, 1mg/ml BSA, 500ng/ml insulin, 
100IU/ml penicillin, 100µg/ml streptomycin at a density of 1 x 105 cells/cm2 in 24 
well plate and incubated in a humidified atmosphere of 95% air-5%CO2 at 34°C. On 
the following day cells were changed to serum free but supplemented with 10mm 
HEPES, 1mg/ml BSA, 500ng/ml insulin, 100IU/ml penicillin, 100µg/ml streptomycin, 
DMEM/F12 medium and they were maintained under this culture condition for 
additional 3 days with daily medium change. Cells were treated on day 4 with 
100ng/ml hCG for 6h. After treatment, the medium from each well was removed and 
stored at -20°C for assay of progesterone, testosterone by radioimmunoassay and 
by ELISA. The percentage and purity of Leydig cells in the identified fraction was 
determined by staining with an antibody against the mitochondrial P450scc, as a 
further Leydig cell marker. Primary mouse Leydig cells were stained immediately 
after isolation according to cytospin protocol (Cytospin Centrifuge, Hettich Lab 
Technology). 200ul of each cell suspension (with a concentration of approximately 
5x105 cells/ml) was added to a slide chamber and spined at 800 rpm for 5 minutes. 
Slides were carefully removed from cytocentrifuge and allowed to air dry prior to 
staining. Additionally, cells were plated in 24 well plates with collagen coated 
coverslips. Following 4 days of culture cells were stained with P450scc. The 
percentage of Leydig cells in this fraction varied between 80 and 90% of all 
nucleated cells. 
 
2.3. Transformation of E.coli and preparation of plasmid DNA 
The tube containing the competent E.coli cells was removed from -80°C storage and 
bacteria were thawed on ice. One hundred ng plasmid DNA was pipetted into a 50µl 
competent cells and mixed gently tapping the side of the tubes. Immediately the tube 
was incubated on ice for 20 min, which allows bacteria to take up plasmid DNA 
through the cell membrane. The cells in the tube were subjected to a heat shock for 
exactly 90 seconds at 42°C and the tube was returned quickly to the ice for 2 
minutes in order to stop the heat shock. 200µl of LB medium without antibiotics was 
added to the tube and the cells were incubated for 30 min at 37°C in a water bath. 
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Using a sterile glass spreader 50-200µl of transformation mixture was spread all over 
the plates (Ampicillin-LB-Agar plates, pre-warmed at RT). After the soaking of the 
fluid into the agar, plates were inverted and incubated overnight, at 37°C. 
 
2.3.1. Endotoxin-free, midi preparation of plasmid DNA 
The next morning, a single colony was picked from the agar plate and inoculated into 
3-5ml of LB medium. Culture was grown overnight at 37°C and 300 rpm for 8-12h. 
Thereafter 700 µl of culture bacteria were mixed with 300 µl of 50% glycerol and 
stored at -80oC as frozen stock. The plasmid DNA purification was done with Nucleo 
Bond columns according to the protocol of Macherey-Nagel.  1 ml of the bacterial 
suspension was centrifuged at 6,000 x g for 10min at 4°C and the supernatant was 
discarded completely. The pellet was re-suspended in 8ml of Resuspension Buffer 
RES-EF and RNase A by pipetting the cells up and down. Eight ml of Lysis Buffer 
LYS-EF was added to the suspension and was mixed gently by inverting the tube 5 
times after which the mixture was incubated at RT for 5 min. NucleoBondR Xtra 
Column together with the inserted column filter was equilibrated with 15ml of 
Equilibration Buffer (EQU-EF). Eight ml of Neutralization Buffer NEU-EF was added 
to the suspension and was mixed immediately gently by inverting the tube 15 times 
after which was incubated on ice for 5 min.  The lysate was loaded onto the column 
and was allowed the column to empty by gravity flow. Thereafter, the column filter 
was washed with the 5ml Equilibration Buffer EQU. NucleoBondR Xtra Column Filter 
was discarded by turning the column upside down and the NucleoBondR Xtra 
Column was washed with 8ml of Wash Buffer. Plasmid DNA was eluted with 5ml of 
Elution Buffer ELU and the eluate was collected in a 50ml centrifuge tube. 3.5 ml of 
room-temperature isopropanol was added to precipitate the eluted plasmid DNA and 
was centrifuged at 15,000 x g for 30 min at 4°C. The supernatant was removed 
carefully and discarded whereas the pellet was washed with 2ml of room-
temperature 70% ethanol and centrifuged at 15,000 x g for 5min at RT. The ethanol 
was removed carefully with a pipette tip and the pellet was left to air dry at RT for 5-
10 min. The plasmid DNA pellet was dissolved in an appropriate volume of buffer TE 
or sterile H2O. 
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2.4. Transfection 
2.4.1. Transfection via microporation with Pex13 shRNA in MLTC-1 cells  
For the analysis of the effects of peroxisomal deficiency in Leydig cells, we used 
specific shRNA plasmid to knock down Pex13 in MLTC-1 cells via microporation. 
Microporation is a unique electroporation technology developed by NanoEnTek. It 
uses a pipette Tip as an electroporation space. Through microporation the 
transfection efficiency and cell survival rate are high. In our laboratory, we used the 
Pipette-type electroporator Microporator MP-100 (peQLab, Biotechnologie GmbH), 
Digital Bio. 
We established a transfected Pex13 shRNA knockdown model using microporation 
to study the consequences of peroxisomal deficiency in MLTC1 cells.  shRNA 
plasmid enable efficient gene knockdown using short-hairpin RNA 
. shRNA plasmids were purchased from Qiagen (Catalog no.: 336311 KM37506G), 
where 5 plasmids were provided for each gene: four Pex13 gene-specific shRNA 
plasmids and one negative control plasmid. Each plasmid carries an shRNA under 
the control U1 promoter and a green fluorescent protein (GFP) reporter gene to 
detect transfected cells by fluorescence microscopy.   
Table 6. Pex13 specific shRNA plasmids (1-4) and NC (scr-shRNA). 
 
Clone ID Insert Sequence 
1 (Pex13 shRNA) agacctgcttacagttcattt 
2 (Pex13 shRNA) acaggacttatacctgcaaat 
3 (Pex13 shRNA) tgccgtgtctgatgaagaaat 
4 (Pex13 shRNA) tgatttgggccctactttatt 
NC ggaatctcattcgatgcatac 
 
The above mentioned Pex13 specific shRNA plasmids were used to transfect MLTC-
1 cells and in our hands clone 3 with insert sequence (tgccgtgtctgatgaagaaat) gave 
the most efficient knockdown (Table 6). One scrambled shRNA (scr-shRNA) plasmid 
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vector was used as a negative control. The scr-shRNA has no significant sequence 
homology to mouse, rat or human gene sequences.  
Materials: Cell, DNA, culture medium (+FBS without antibiotics), 24 well plate, 1.5 ml 
tube Kit components: Gold-Tip, Microporation Tube (MPT-100) BufferR 
(resuspension buffer), Buffer E (electrolytic buffer). 
Transfection was done according to the manufacturer’s manual instruction. Briefly, 
MLTC-1 cells were cultured at density 1 x 106 in 10cm Petri dish in RPMI-1640 
containing 25mM HEPES and supplemented with 10% fetal calf serum (FCS), pH 
7.3 at 37°C under a humidified atmosphere of 95% air and 5% CO2. At 60% 
confluence, the cells were rinsed using 1 X PBS and disaggregated with trypsin-
EDTA (0.05%) for 3 min. Trypsin was neutralized by adding medium containing 
serum and cells were dissolved in growth medium. They were centrifuge at 1000 rpm 
for 3 min at room temperature. Media was aspirated and pellets were rinsed using 
culture media (+FBS, antibiotic). One aliquot of cell culture was taken and the cells 
were counted to determine the cell number and calculate the volume to be used for 
seeding. Cells were centrifuged at 1000 rpm for 2 min at room temperature. 500µl of 
culture medium containing serum (with supplements, but without antibiotics) was 
added in each well of 24 well plates and pre-incubate plates at 37°C in 5% CO2 in a 
humidified incubator. To avoid cell from damage, it was necessary to transfer the 
cells directly into pre-warmed medium (37°C). Cell pellets were re-suspended the in 
R-buffer.  1 x 105 MLTC-cells per 10µl of R-buffer was used for transfection. Re-
suspended cells were transferred to a 1.5 ml tube. Plasmid DNA was added into re-
suspended cells. The concentration of DNA is dependent on the cell type. A DNA 
amount of 0,5µg/10µl was used for the beginning.  For MLTC-1 cells the optimal 
DNA amount for transfection was 1µg/10µl concentration. The quality of plasmid 
DNA strongly influences the results of transfection experiments. Therefore, care has 
been taken to isolate high quality plasmid and to adjust to the optimal concentrations 
to obtain the highest transfection efficiency.  Three ml Buffer E was added in 
Microporation Tube (MPT-100). The cells and DNA was mixed by pipetting. The 
microporator pipette was inserted into the pipette station. The cells were immediately 
plated after microporation into the media in the culture well plate. Desired pulse 
conditions for microporation were set on the microporator MP-100 (peQLab). 
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To obtain the highest transfection efficiency via microporation for MLTC-1 cells 
several different conditions were tested (Table 7). Optimal conditions were found for 
MLTC-1 cells with 90% transfection efficiency as controlled via GFP fluorescence by 
using condition 3, which was applied thereafter for all shRNA plasmid experients 
(1350 Pulse Voltage, 20 Pulse Width, 2 Pulse Number). Following 72 h of 
transfection, cells were used for different experiments. Treatment with hCG to 
stimulate the steroid production was done after 72h of transfection. 
Table 7. Microporation parameters for transfection with shRNA plasmids in MLTC-1 
cells. 
Conditions 1  2  3  4  5  6 
Pulse 
Voltage 
1050   1275 1350 1400 1400 1700 
Pulse Width  30  40  20  10  20  20 
Pulse 
Number 
 2   1  2  1  2 1 
Transfection 
efficiency %  
 5%  25% 85% 10% 70% 20% 
 
 
2.4.2. Transfection of MLTC-1 cells via lipofection using shRNA 
Since the widely used lipofection method of transfection is more cost-effective, we 
tried to compare the transfection efficiency of a few transfection reagents available in 
the market with microporation. Transfections of MLTC-1 cells via lipofection using 
shRNA have been done according to the protocols given by the manufacturers with 
the following compounds tested: 1. ViaFect (ViaFect(TM) Transfection Protocol), 2. 
Attractene (Attractene-QIAGEN Supplementary Protocol), 3. InCella (Davidson), 4. 
Fugene (Corporation), 5. TransIT®-LT1 (TransIT_LT1_Transfection Protocol). 
After several experiments a relatively high transfection rate of 70% could be obtained 
with ViaFect(TM) (results not shown). However, microporation was chosen to be the 
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desired transfection procedure for this study owing to the higher transfection 
efficiency and reproducibility 
Table 8. Conditions for lipofection of MLTC-1 cells with shRNA using different 
transfection reagents. 
Compounds Viafect TM Attractene InCella FuGENEHD TransIT®-LT1 
Transfection 
Reagent 
3µl 1.5µl 2µl 1.5µl 1,5µl 
shRNA (µg) 1µg 1µg 1µg 1µg 2.5µg 
Cell number  
per well 
30.000 cells 30.000 cells 30.000 cells 30.000 cells 30.000 cells 
Final 
volume 
per well 
500 µl  500µl 500µl 500µl 500µl 
Transfection 
efficiency 
70% 50% 30% 10% 5% 
 
  
2.4.3. Pex13 or Mfp2 (Hsd17b4) silencing by RNA interference technology 
(RNAi) in MLTC-1 and in primary Leydig cells 
As an althernative approach to microporation and shRNA mediated knockdown, 
MLTC-1 cells and primary Leydig cells were also transfected by a  small interfering 
RNA approach for the mouse Pex13 gene or Mfp2 (Hsd17b4) gene. The mouse 
Pex13 siRNA (siRNA ID# 176738) or Mfp2 siRNA (siRNA ID#: s67849) was 
purchased from Ambion (Austin,TX). Sequence: Length: 21 
 
 Pex13:          Sense: 5' GCUAUAGCCCUUAUAGUUAdTdT                                                                                   
                        Antisense: 5' UAACUAUAAGGGCUAUAGCdTdT 3' 
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 Mfp2:               Sense: CAUUAGUCAUUGUUAACGAtt 
                         Antisense: UCGUUAACAAUGACUAAUGct 
 
One scrambled siRNA (scr-siRNA) was used as a negative control. This control 
siRNA did not possess any significant sequence homology to mouse, rat or human 
gene sequences. 
Different transfection reagents were tried according to the protocols given by 
manufacturers 1. InCella (Davidson), 2. Viromer Green (Weber), 3. INTERFERin 
(INTERFERin Transfection Protocol), 4.Lipofectamin RNAiMAX (Technologies). 
Different concentrations of siRNA (15, 30 or 40 nM) and different volumes of 
transfection reagents were used in order to obtain high transfection efficiency. 
Conditions used for transfection of MLTC-1 cells are presented in table 9. 
Table 9. Conditions for transfection of MLTC-1 cells with siRNA using different 
transfection reagents in 24 well plate. 
Compound InCella 
Screenfect 
INTERFERin Viromer 
green 
Viromer 
blue 
RNAimax 
Transfection 
Reagent 
used 
amount of 
1.7µl 1.7µl 
 
 
1.7µl 
 
2µl 1,5µl 
siRNA (nM) 40nM 40nM 40nM 40nM 40nM 
Cell number 
per well 
30.000 cells 30.000 cells 30.000 cells 30.000 cells 30.000 cells 
Final 
volume 
per well 
500 µl  500µl 500µl 500µl 500µl 
Transfection 
efficiency 
65% 50% 20% 10% 10% 
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The best transfection efficiency with low toxicity and reproducibility was achieved 
using InCella (Davidson) (Table 9). 
Similarly, primary Leydig cells were also transfected using Incella ScreenFect. 
Briefly, purified primary Leydig cells were plated at a density of 2 x 105 in 24 well 
plates and cultured for 24h in the aforementioned medium. The following day, Leydig 
cells were transfected with Pex13 or Mfp2 siRNA (40nM) and control scr-siRNA (40 
nM) using the ScreenFect transfection reagent (InCella). Transfection complex 
(ScreenFect A and siRNA) were first mixed with an appropriate volume of serum free 
DMEM/F12 medium with the aforementioned supplements and added to adherent 
cells. The medium was replaced with fresh medium after 24 h. After 48 h of 
transfection, cells transfected were treated with hCG (100ng/ml) for 6h. At the end of 
the experiment, the medium from each well was collected and stored at -80°C for 
assay of hormones and the cells were processed for total protein isolation. The 
optimal conditions for the amount of transfection reagent (ScreenFect A), the dilution 
of the siRNA and the number of cells are presented in table 10. 
 
Table 10. Optimal conditions for the transfection of primary Leydig cells using Pex13- 
and Mfp2- siRNA.  
ScreenFect A 2µl in 40µl of supplied Dilution Buffer 
Pex13-, Mfp2 or scr-siRNA 40nM in 40µl of supplied Dilution Buffer 
Combined complex volume 80µl 
Cell number per well 1.5-2 x 105 
Cells/media 420µl 
Final volume 500µl 
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2.5. RNA expression analysis by semi-quantitative RT-PCR 
RNA isolation 
Total RNA isolation from cells was performed using the RNeasy kit (cat. No 74101 
Qiagen, Hilden, Germany) as well as RNAzol RT(RNAzol RT, Sigma-Aldrich Co).  
Homogenization of cells in RLT buffer was carried out through a QIAschredder spin 
column placed in a 2-ml collection tube, and centrifuged for 2 min at 15.000g speed. 
RNA extraction was performed with the RNeasy Mini Kit from Qiagen according to 
the manufacturer´s protocol.  
Homogenization of cells in RNAzol RT (1ml per cm2) was done directly on the culture 
dish. To form a homogenous lysate, the cell lysate was passed several times 
through a pipette. RNA extraction was performed according to the manufacturer´s 
protocol (RNAzol RT (Sigma-Aldrich Co) (Catalog no.: FRT4533). 
Dnase I digestion  
Prior to reverse transcription, a DNase I digestion step was carried out for RNA 
samples to remove residual genomic DNA. The DNase digestion mixture was 
prepared and incubated for 15 min at RT 25°C after which the DNase was 
inactivated by the addition of 1µl of 25Mm EDTA to the mixture and heated for 10 
min at 65°C (Table 11). 
Table 11. Conditions for Dnase I digestion. 
RNA sample 1µg 
10X DNase I reaction 
buffer 
1µl 
DNase I, Amp Grade, 
1U/ul 
1µl 
DEPC-treated water to 10µl 
 
First-strand cDNA was synthesized from total RNA (0.5-1µg) with oligo (dT) 12-18 
primers using the Superscript II reverse transcriptase (#18064-022, Invitrogen, 
Germany).   
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The polymerase chain reaction (PCR) was set up in a final volume of 25 µl using 1µl 
cDNA. PCR conditions and all primers were optimized with gradient PCRs on a 
BioRad iCycler. 28S rRNA was used as a control to normalize the levels of cDNA 
(Table 12).   
Table 12. Protocol for the polymerase chain reaction (PCR).   
Template 1.0 µl 
10x PCR buffer 2.5 µl 
10mM dNTPs 0.2 µl 
Forward primer 1.0 µl 
Reverse primer 1.0 µl 
Taq DNA polymerase 0.2 µl 
Sterile H20 19.1 µl 
Total volume 25.0 µl 
 
 
2.6. Western Blot analysis 
Isolation of the whole cell lysates 
Cells were washed twice with 1 X PBS and 50-150µl of cell lysis buffer was added to 
each well of 24 well plates. Using a rubber policeman, cells were scraped thoroughly 
and placed to Eppendorff tubes. Tubes were transferred on ice for 30 min and were 
vortexed at intervals every 10 min. Afterwards tubes were centrifuged for 10 min at 
1,000 x g at 4°C, thereafter the supernatants were collected and stored at -20°C. 
Preparation of Western Blots 
The protein samples (15µg-30µg) were separated on 12% SDS polyacrylamide gels 
and transferred onto polyvinylidene fluoride (PVDF) membranes (Catalog no.: 162-
0218, BioRad, Munich, Germany) by electrotransfer with a BioRad blotter. To block 
nonspecific protein-binding sites, membranes were incubated with Tris-buffered 
saline (TBS) containing 10% nonfat milk powder and 0.05% Tween-20 for 1h at RT. 
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The membranes were incubated with the primary antibody for 1 h, at RT or overnight 
at 4°C. Thereafter, the blots were washed 3 times for 10 min with TBST buffer and 
then incubated with alkaline phosphatase-conjugated secondary antibodies for 1h at 
RT. The concentrations of the antibodies used for WB are given in Table 4. Alkaline 
phosphatase activity was detected using Immun-StarTMAP (No.: 170-5018) substrate 
from BioRad (Munich, Germany). Blots were exposed to Kodak Biomax MR films 
and the bands on films were quantified with ImageJ. All Western Blot analyses were 
done and analyzed with different membranes at least three times. 
 
2.7. Immunofluorescence for MLTC-1 and mouse primary Leydig cells 
Cells were plated on coverslips and allowed to grow for 3-4 days. The cells were 
washed with warm (37°C) 1x PBS (pH 7.4) and fixed with 4% paraformaldehyde 
(PFA) +2% saccharose in PBS for 20 min at RT. Then the coverslips containing the 
cells were washed three times with 1x PBS for 10 min. Thereafter, the cells were 
incubated in PBS containing 1% glycine for 10 min at RT and additionally with PBS 
containing 1% glycine and 0.1% Triton for 25 min at RT. Cells were incubated for 45 
min in PBS containing 1% BSA and 0.05% Tween to block nonspecific protein 
binding sites. After blocking, cells were incubated with primary antibodies in a moist 
chamber overnight at 4°C. The next day cells were washed three times with 1X PBS 
for 5 min and incubated with secondary antibodies for 1h at RT.  Thereafter, cells 
were washed once with 1X PBS and nuclei were counter-stained with Hoechst 
22358 and TOTO-3 iodide (Molecular Probes/ Invitrogen, Carlsbad, USA) for 10 min 
at RT. Samples were inspected with a LEICA fluorescence microscope or with a 
LEICA TCS SP2 confocal laser scanning microscopy (CLSM).  
 
2.8. ROS detection by staining with dihydroethidium (DHE) 
Dihydroethidium, (DHE), also called hydroethidine, which is a cell permeable reagent 
was used to evaluate reactive oxygen species (ROS) production. DHE upon reaction 
with superoxide anions forms the red fluorescent product which intercalates with 
DNA. MLTC-1 cells were treated with dihydroethidium (D-23107, Invitrogen) after 72 
h of transfection. 5µmol of DHE was added to 1 ml (24 well plate) of normal MLTC-1 
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medium and incubated at 37°C for 30 min. Thereafter, cells were washed three times 
for 5 min with 1 X PBS and incubated with 4% PFA for 20 min at RT for fixation. The 
cells were washed three times for 10 min with 1X PBS and nuclei were counter-
stained with Hoechst 22358 for 10 min at RT. The samples were inspected with a 
LEICA fluorescence microscope or with a LEICA TCS SP2 confocal laser scanning 
microscopy (CLSM).  
 
2.9. Detection of glutathione using GSH-Glo™ Glutathione Assay 
The GSH-Glo™ Glutathione Assay was used to detect and quantify the reduced 
glutathione (GSH) level in cells. Reduced glutathione is an important antioxidant, the 
level of which in the cells is an indicator of oxidative stress. Reduced form of 
glutathione is able to donate an electron donor to other reactive oxygen species. 
Thereby, GSH is changed to the oxidized form becoming itself reactive, oxidized 
form, which readily reacts with another reactive glutathione to form the glutathione 
disulfide (GSSG).   
The GSH-Glo™ Glutathione Assay is a luminescence-based assay, which was done 
according to the manufacturer´s  protocol (GSH-Glo Glutathione Assay, Promega). 
The signal is a result of two chemical reactions and based on the conversion of a 
luciferin derivative into luciferin in the presence of GSH, which is catalyzed by a 
glutathione S-transferase (GST) enzyme supplied in the kit. Generated luciferase is 
proportional to the amount of reduced glutathione present in the sample.  
After 72 h of transfection, the medium from the transfected MLTC-1 cells were. 
removed and GSH-Glo™ Reagent was added. The Luciferin Detection Reagent was 
added to the plate after 30 min of incubation. Following a 15min incubation, the plate 
was read in a luminometer.  
 
2.10. Determination of catalase activity 
Catalase (CAT) activity measurements were performed using Cayman’s Catalase 
Assay Kit assay, which uses the peroxidase function of catalase to determine the 
enzyme activity, based on the reaction of CAT with methanol in the presence of 
hydrogen peroxide (H2O2). 
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Briefly, MLTC-1 cells were transfected with Pex13shRNA and control shRNA via 
microporation in 12 well plates. After 72 h of transfection, cells were collected using 
a rubber policeman and centrifuged at 2.000 x g for 10 min at 4°C. The cell pellet 
was homogenized on ice in 1 ml of cold buffer (50 mM potassium phosphate 
containing 1mM EDTA, pH 7.0) and centrifuged at 10,000 x g for 15 min at 4°C. 
Thereafter, the supernatant was removed and stored on ice for the Catalase (CAT) 
activity assay, done according to the manufacturer’s protocol (Catalase Assay Kit). 
Formaldehyde standard wells, positive control wells and sample wells were prepared 
by adding 100µl of diluted assay buffer, 30µl of methanol and 20µl of standard or 
diluted catalase or sample respectively. Reaction was initiated by adding 20µl of 
H2O2, after which plate was covered and incubated on a shaker for 20 min at RT. 
Thereafter, 30µl of diluted potassium hydroxide and 30 µl of Catalase Purpald 
(Chromogen) were added to each well and incubated for 10 min on the shaker at RT. 
After adding 10µl of Catalase Potassium Periodate and incubating on a shaker for 5 
min at RT, the absorbance was red at 540 nm using a plate reader. 
 
2.11. Detection of the Mitochondrial Membrane Potential (∆Ψm)   
The DePsipher™ Kit (TREVIGEN, Catalog# 6300-100-K) was used for the detection 
of the mitochondrial membrane potential (∆Ψm) in MLTC-1 cells transfected with 
Pex13 siRNA and control siRNA. The experiment was done according to the protocol 
provided with the DePsipher™ Kit. 1X Reaction buffer was prepared from 10X 
Reaction Buffer by diluting with distilled water. 1 µl of DePsipher™ solution was 
added to 1 ml of 1X Reaction Buffer and were vortexed to homogenize the solution. 
After 72 h of transfection, the medium was collected and MLTC-1 cells were covered 
with diluted DePsipher™ solution. Cells were incubated at 37˚C in a 5% CO2 
incubator for 15-20 minutes. Thereafter, the cells were washed with 1 X Reaction 
Buffer with stabilizer solution and observed immediately under the microscope using 
a fluorescein long-pass filter. A lipophilic cation, a unique cationic dye (5, 5’, 6, 6’, 
tetrachloro-1, 1’, 3, 3’- tetraethylbenzimidazolyl carbocyanin iodide) was used to 
detect the loss of the mitochondrial potential. It enters cells forming a red fluorescent 
compound within healthy mitochondria. If the mitochondrial potential is disturbed, the 
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dye cannot accumulate within the mitochondria, remains in cytoplasm showing 
primarily green fluorescence.  
2.12. Enzyme-linked immunosorbent assays (ELISA) and radioimmunoassay’s 
(RIAs) 
Measurement of different steroid hormone production in MLTC-1 and in primary 
mouse Leydig cells was done by enzyme-linked immunoassays (ELISA) (DRG 
Instruments GmbH, Germany). The principle of the test is based on typical 
competitive binding scenarios. The wells in the microplate are coated with an 
antibody directed towards an antigenic site of the hormone molecule.  
The hormone (antigen) in the sample competes with a hormone-horseradish 
peroxidase conjugate for binding to the antibodies coated on the microtiter wells. The 
amount of bound peroxidase conjugate is inversely proportional to the concentration 
of hormone in the sample. Following the incubation, the unbound conjugate was 
washed off and the enzyme substrate was added.  After addition of the substrate 
solution, the intensity of color (blue) formed is inversely proportional to the 
concentration of hormone in the sample.  The enzymatic reaction was stopped by 
adding stop solution (H2SO4) in each well, where a blue color changes into yellow. 
The absorbance of each well was determined at 450±10nm with a microtiter plate 
reader.  
Pregnenolone, progesterone, testosterone, dehydroepiandrosterone (DHEA), 
estrone and estradiol production in MLTC-1 as well as in primary Leydig cells was 
measured according to the protocols given by the manufacturers (ELISA kit) (DRG 
Instruments GmbH, Marburg, Germany).  For progesterone measurement, the 
samples from MLTC-1 cells were diluted 1/80 and samples from primary Leydig cells 
were diluted1/15. For pregnenolone measurement samples from MLTC-1 and 
primary Leydig cells were diluted 1/45. Dilution factor was taken into account for the 
calculation of the hormone concentrations. 
A set of standards was used to plot a standard curve from which the hormone 
concentration in the samples and controls was calculated. 
Radioimmunological measurements of testosterone and progesterone 
Measurements of testosterone and progesterone from MLTC-1 cells and primary 
Leydig cells by RIA were performed in the laboratory of the Clinic for Obstetrics, 
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Gynecology and Andrology of Animals, Justus Liebig University, Giessen (Prof. Dr. 
Gerhard Schuler). Radioimmunological measurements in the lab were set up as 
competitive assays as previously described by (Hoffmann, et al. 1973). 
 
2.13. Experiments with different treatments of MLTC-1 cells and primary 
Leydig cells 
2.13.1. Treatment with human chorionic gonadotropin (hCG) 
Human chorionic gonadotropin (hCG) is a glycoprotein hormone normally 
synthesized by trophoblastic cells of the placenta after embryo implantation during 
pregnancy. hCG is a vital hormone during early pregnancy to support the production 
of progesterone by the corpus luteum (Fritz and Speroff 2011; Mesiano 2009).  hCG 
consists of α and β subunits, where the alpha-subunit is identical to other three 
hormones such as luteinizing hormone (LH), follicle-stimulating hormone (FSH), and 
thyroid-stimulating hormone (TSH) and is coded by a single gene. However, the β 
subunits are unique and define their biological specificity. In conclusion, LH and hCG 
have similar structure and function to bind and activate a common receptor, the 
LH/choriogonadotropin receptor (LHCGR), also known as the LH or lutropin receptor 
(Lhr) (Ascoli et al. 2002; Puett, et al. 2007).To determine if MLTC-1 cells produce 
steroids in response to hCG, MLTC-1 cells were seeded at a density 1,5 x 105 per 
well in 6 well plates and cells were allowed to grow for 3 days.  On the day preceding 
an experiment, cells were washed and replaced with serum-free RPMI 1640 
medium. hCG (Predalon 5000 IU) at 100ng/ml or 1,49 IU/ml was constituted fresh, 
diluted in serum-free RPMI1640 medium and applied to MLTC-1 cells. Cells were 
incubated in 800µl (per well) of serum free medium with 100ng/ml hCG for 6 and 24 
h. After the incubation, the medium from each well was removed, the supernatants 
were collected, centrifuged at 670 x g for 10 min, at 4°C) and the final supernatant 
was stored at -20°C for assay of progesterone, testosterone by radioimmunoassay 
and by ELISA. Cells were processed for total RNA or protein isolation. Steroid 
production was normalized as mass per µg of total protein.  
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2.13.2. Treatment with 22 (R)-Hydroxycholesterol 
22(R)-Hydroxycholesterol (22R-HC) is a cholesterol substrate derivative and 
hydrosoluble form of cholesterol that readily passes through cell and orhanelle 
membranes. 22R-HC is a membrane-permeable substrate for CYP11A1 in the 
mitochondria and enters the inner mitochondrial membrane without the help of StAR, 
which is a limiting factor in the steroidogenesis and is responsible for the transfer of 
cholesterol from the outer mitochondrial membrane to the inner mitochondrial 
membrane.  
MLTC-1 cells were transfected with Pex13 shRNA and control shRNA as mentioned 
in chapter (transfection via microporation) and seeded at 1x105 per well in 24 well 
plates. After 72 h of transfection cells were treated with 40µM 22R-HC in serum free 
medium for 6h. 
Mouse primary Leydig cells after isolation were plated at density 1,5 x105 /per well in 
24 well plates. On the following day cells were transfected with Pex13siRNA and 
control siRNA. Following 48h of transfection cells were treated with 40µM 22R-HC 
for 6h. All treatments were performed in serum-free media. Final concentrations of 
ethanol used as chemical solvents were less than 0.4% and included in controls. At 
the end of all experiments, medium samples were taken and stored at -20℃ for the 
hormone measurements by ELISA. 
2.13.3. Treatment of MLTC-1 cells with trilostan and abiraterone acetate 
MLTC-1 cells were transfected with Pex13 shRNA and control shRNA as mentioned 
above. After 72 h of transfection, cells were pre-incubated for 30 min with trilostane 
(5µM) and abiraterone acetate (17nM). At the end of preincubation cells were 
washed and incubated with hCG (100 ng/ml) and 22R-HC (40 µM) in serum free 
media for another 6h.  Trilostan was used as an inhibitor of 3β-hydroxysteroid 
dehydrogenase to block the formation of progesterone. Abiraterone acetate blocks 
CYP17A1 by potently inhibiting both the 17α-hydroxylase and the 17, 20-lyase 
activities thus inhibiting further conversion of pregnenolone to DHEA. After 
incubation, cells were processed for total protein isolation. Medium from each well 
was removed and stored at -20°C for assay of pregnenolone by ELISA. Steroid 
production was normalized as mass per µg of total protein. 
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 2.13.4. Treatment of MLTC-1 cells with antimycin A  
Antimycin A is known to bind the Qi site of cytochrome c reductase in the 
mitochondrial complex III to inhibit the mitochondrial electron transfer between 
cytochrome b and c. The disruption of electron transport causes a collapse of the 
proton gradient across the mitochondrial inner membrane, leading to the loss of the 
mitochondrial membrane potential (ΔΨm) and a reduction in the cellular levels of 
ATP (Balaban, et al. 2005; Campo, et al. 1992; Pham, et al. 2000). MLTC-1 cells 
were cultured at a density 5x104/per well in 24 well plates for 3 days in RPMI-1640 
medium supplemented with 10% fetal serum.  On the 3rd day cells were pre-
incubated with antimycin A (5µM) for 30 min. Thereafter, cells were stimulated during 
4h with hCG (100ng/ml) or 22R-HC (40 µM) in the serum free RPMI 1640 medium in 
the presence or absence of antimycin A (1µM). Progesterone production in the 
incubation media was measured by ELISA. 
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3. Aims of the study 
Prior to this dissertation, no study in the international literature was providing direct 
evidence for the involvement of peroxisomes in steroid synthesis in Leydig cells. At 
the very beginning, Reddy and Svoboda in 1972 hypothesized on the involvement of 
peroxisomes in cholesterol and steroid metabolism. Thereafter, Mendis-Hadagama 
and colleagues showed that the number of peroxisomes and peroxisomal volume in 
Leydig cells as well as testosterone production were increased upon LH treatment, 
whereas LH deprivation resulted in a strong reduction in the number of these 
organelles and testosterone secretion, suggesting that the peroxisomal compartment 
is involved in steroid synthesis (Mendis-Handagama 1997; Mendis-Handagama, et 
al. 1992; Mendis-Handagama, et al. 1990a).  Moreover, patients with peroxisomal 
disorders demonstrated testicular pathologies, which indicated that peroxisomal 
metabolism is crucial for normal testicular function. Nevertheless, till now the role of 
peroxisomes in steroid metabolism in Leydig cells and its influence on male fertility is 
not completely understood. Therefore, the aim of this study was to investigate the 
role of peroxisomes in steroid synthesis in Leydig cells.     
The major aims of this study were: 
1. To establish a good cell culture model for functional studies with mouse Leydig 
tumor cell lines (MLTC-1 and MA-10 cells). 
2. To analyze and compare the expression of steroidogenic enzymes in MLTC-1 and 
MA-10 cells. 
3. To analyze the steroid synthesis of MLTC-1 cells stimulated by hCG. 
4. To establish optimal mouse Leydig cells isolation and primary culture to study the 
functional aspects in primary Leydig cells. 
5. To investigate the expression, abundance and relevance of peroxisomes in Leydig 
cells. 
6. To analyze the effects of peroxisome deficiency in Leydig cells on steroid 
metabolism by generating a knock down of Pex13 gene. 
7. To analyze the consequences of Pex13 knockdown on redox state and 
mitochondrial function in Leydig cells. 
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8. To investigate the biological potency of androgens and estrogens in Leydig cells 
with MFP2 (17-HSD4) knockdown. 
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4. Results  
4.1. Comparison of genes involved in steroidogenesis in MA-10 and MLTC-1 
cells 
Exploring different aspects of Leydig cell physiology using primary Leydig cell 
cultures in vitro is particularly difficult due to their low abundance in the testis and 
methods to isolate them are quite laborious. Moreover, primary Leydig cells in 
culture lose their ability to respond to LH treatment after a few days, resulting in 
decrease steroid production. Internationally, the mouse Leydig tumor cell lines 
MLTC-1 and MA-10 are therefore widely used as in vitro models to study Leydig cell 
physiology and to investigate the regulation of steroidogenesis.  
The first aim of this thesis work was to characterize MA-10 and MLTC-1 cells for the 
expression of enzymes involved in steroidogenesis and to analyze if they are 
suitable models to study the involvement of peroxisomes in steroidogenesis. 
Using semi-quantitative RT-PCR, the steady state levels for the mRNAs encoding 
different steroidogenic enzymes, carrier proteins and receptors were determined in 
total RNA of the two murine tumor Leydig cell lines, MA-10 and MLTC-1 cells in 
comparison to each other. 
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Figure 4. Semiquantitative RT-PCR analyses on cDNAs prepared from total RNA of 
MLTC-1 and MA-10 cells. The RT-PCR products of Lh-r: Luteinizing hormone/chorion 
gonadotropin receptor; Fsh-r: follicle stimulating hormone receptor; Star: steroidogenic acute 
regulatory protein; P450scc: mitochondrial cytochrome P450 side chain cleavage enzyme; 
Cyp17: cytochrome P450c17; 3β-Hsd: 3β-hydroxysteroid dehydrogenase; Cyp19: 
cytochrome; P450aromatase; MFP2: peroxisomal 17β-hydroxysteroid dehydrogenase 4; 
Scpx: sterol carrier protein x, 28S rRNA: 28 S ribosomal RNA as internal control in MA-10 
and in MLTC-1 cells without treatment with hCG. To calculate the differences in mRNA 
expression levels, the RT-PCR band intensities of steroidogenesis-related genes were 
normalized for the band intensity of the house keeping gene 28S rRNA of the same cDNA 
samples.  
 
Semi-quantitative RT-PCR analysis revealed that MA-10 and MLTC-1 cells 
differentially express the genes involved in steroidogenesis. In strong contrast to 
MLTC-1 cells, the expression of the aromatase gene was absent in MA-10 cells. 
MLTC-1 cells exhibited a higher steady state expression levels of LHr, P450scc and 
3β-HSD genes, whereas, other proteins or enzymes involved in steroidogenesis 
such as Star, Cyp17 and MFP2 were expressed in a similar fashion between MLTC-
1 and MA-10 cells. Both MA-10 and MLTC-1 cells did not express the FSH receptor, 
a typical Sertoli cell gonadotropin receptor (Fig. 4). 
Interestingly, it was observed during cell culture that MA-10 cells in culture were 
loosely attached to culture flash bottom and formed clusters. Moreover, in 
comparison to MLTC-1 cells, MA-10 cells showed a decreased rate of proliferation 
(results not shown).  
Considering these factors, mouse Leydig tumor cell line (MLTC-1) was chosen as a 
better model in comparison to MA-10 cells to study steroidogenesis. 
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4.2. MLTC-1 cells respond to human chorionic gonadotropin (hCG) treatment 
Next, MLTC-1 cells were stimulated with hCG to test their ability to produce steroids. 
1.5 x 105 MLTC-1 cells were grown for 3 days in 6-well-plates after which cells were 
treated with hCG (100ng/ml) in serum-free medium for 6h and 24h. Semi-quantitative 
RT-PCR was done for determination of StAR, P450scc and LHr mRNA expressions. 
 
Figure 5. Semiquantitative RT-PCR analyses on cDNAs prepared from total RNA of 
MLTC-1. 28S rRNA (28S ribosomal RNA) as internal control, StAR (Steroidogenic acute 
regulatory protein), P450scc (mitochondrial cytochrome P450 side chain cleavage enzyme), 
Lhr (Luteinizing hormone/chorion gonadotropin receptor), in MLTC-1 cells after exposure to 
hCG (100ng/ml) for 6 h and 24 h. 
 
Stimulation of MLTC-1 cells with hCG resulted in an induction of StAR mRNA 
expression. hCG-induced StAR mRNA expression was found to be significant at 6h 
in comparison to 24h (Fig. 5), wherefore mainly 6h treatment with hCG was used for 
all following analyses. 
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It was previously shown, that the stimulation with hCG down-regulate the mRNA 
levels of Lhr (Menon, K M J et al. 2004). This feature was also noted in MLTC-1 
cells, which also served as an indirect confirmation, that these cells respond to hCG 
treatment (Fig. 5). 
At the protein level, stimulation with hCG caused a strong increase in the induction of 
StAR especially that of the 30kDa cleaved form of StAR, which is responsible for 
cholesterol transport from outer mitochondrial membrane into the inner mitochondrial 
membrane for further pregnenolone synthesis. Moreover, also a slight increase of 
the 37kDa precursor form of StAR was noted. Similarly, the mitochondrial cholesterol 
side-chain cleavage enzyme, P450scc was also up-regulated after hCG stimulation 
(Fig. 6).  
 
Figure 6. Western blot analysis for 
steroidogenic acute regulatory protein 
(StAR) and mitochondrial cytochrome 
P450 side-chain cleavage enzyme 
(P450scc) of the whole the cell lysate 
from MLTC-1 cells without and with 6h 
hCG stimulation. Cells were lysed and 
20µg of proteins were loaded in each lane 
on 12.5% SDS gels. The same blots were 
stripped and re-probed several times with 
specific antibodies. StAR - steroidogenic 
acute regulatory protein, P450scc–
cytochrome P450 side chain cleavage enzyme, alpha Tubulin- as an internal control.  
 
Collectively, these results indicate that MLTC-1 cells respond to hCG treatment and 
are a good cell culture model to study steroidogenesis. 
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4.2.1. Hormone production in MLTC-1 cells. 
Next, we were interested to check the ability of MLTC-1 cells to produce hormones. 
Therefore, progesterone and testosterone secretion by MLTC-1 cells with hCG 
stimulation were determined by RIA, the most sensitive method for analysis also of 
smaller steroid amounts. 
 
Figure 7. Progesterone and testosterone production by MLTC-1 cells per well in 
response to 6h hCG (100ng/ml) treatment measured by RIA. MLTC-1 cells were grown in 
culture to 60% confluency and after 3 days of culture cells were treated with hCG (100ng/ml) 
for 6h. Media were collected and subjected to measurement of progesterone and 
testosterone by RIA. Hormones concentrations were normalized according to each sample 
cell pellet protein concentration. Basal progesterone (1,6ng/ml), hCG-mediated progesterone 
(428 ng/ml), basal testosterone (1,15 ng/ml),  hCG-mediated testosterone (7,25ng/ml). 
 
RIA results revealed that MLTC-1 cells produce high levels of progesterone as 
reported in many different studies. Interestingly, we found that there is significant 
production of testosterone by MLTC-1 cells after culturing those for 3 days and 
treating for 6 h with hCG (100ng/ml).  
 
 
basal + hCG
0
100
200
300
400
500
MLTC-1 cells
n
g
/m
l
Progesterone
«««
RIA
Testosterone
basal +hCG
0
2
4
6
8
10
n
g
/m
l
MLTC-1 cells
RIA
«
 
75 
Similar results were also obtained by measuring progesterone and free testosterone 
concentration produced by MLTC-1 via ELISA (Fig. 8). 
 
 
Figure 8. Progesterone and testosterone production by MLTC-1 cells per well in 
response to hCG (100ng/ml) treatment measured by ELISA. MLTC-1 cells were grown in 
culture to 60% confluency. After 3 days of culture they were treated with hCG (100ng/ml) for 
6h. Media were collected and subjected to measurement by ELISA. Hormones 
concentrations were normalized according to each sample cell pellet protein concentration. 
 
Furthermore, ELISA revealed that MLTC-1 cells can also produce DHEA, estradiol 
and estrone (Fig. 9).  
 
Figure 9. Estradiol, estrone and DHEA production 
by MLTC-1 cells per well in response to hCG 
(100ng/ml) treatment measured by ELISA. MLTC-
1 cells were grown in culture to 60% confluency and 
after 72 h of culture cells were treated with hCG 
(100ng/ml) for 6h. Media were collected and 
subjected to measurement by ELISA. Hormones 
concentrations were normalized according to each 
sample cell pellet protein concentration. 
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4.3. Peroxisomal genes and proteins are differently expressed in MLTC-1  cells 
Having confirmed the ability of MLTC-1 cells to produce steroids, we next profiled 
these cells for the expression of peroxisomal genes. Semi-quantitative RT-PCR 
analyses revealed that majority of peroxisomal genes are well expressed in MLTC-1 
cells (Fig. 10). The antioxidant enzyme catalase was found to be highly expressed in 
MLTC-1 cells at the RNA level. 
 
 
 
Figure 10. Semiquantitative RT-PCR analysis on cDNAs prepared from total RNA of 
MLTC-1 cells. Peroxisomal biogenesis genes Pex13, Pex14.  Peroxisomal ABCD-
transporters Abcd1-3.  Enzymes of the β-oxidation pathway 1, Acox1: acyl-CoA oxidase 1, 
Ehhadh multifunctional protein 1 (MFP1), Thiolase A: peroxisome 3-ketoacyl-CoA thiolase; 
Enzymes of the β-oxidation pathway 2, Acox2 and Acox 3: acyl-CoA oxidase 2 and 3, 
Hsd17β4: Multifunctional protein 2 (Mfp2); ScpX: sterol carrier protein X.  Antioxidants in 
peroxisomes, Cat: catalase, Prdx1: peroxiredoxin-1, Prdx5: peroxiredoxin-5, Sod1: 
superoxide dismutase 1. Enzymes for cholesterol synthesis, Idi 1:  isopentenyl-diphosphate 
delta isomerase 1, Hmgcr: 3-hydroxy-3-methylglutaryl-CoA reductase, Hmgcs1: 3-hydroxy-
3-methylglutaryl-CoA synthase 1. 
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Moreover, a high abundance of peroxisomes in MLTC-1 cells as shown by 
immunofluorescence analysis with the peroxisomal marker protein catalase and 
peroxisomal biogenesis proteins PEX13 and PEX14 corroborated the high 
expression of mRNAs for peroxisomal biogenesis genes and catalase in MLTC-1 
cells. 
 
Figure 11. Immunofluorescence detection of peroxisomal proteins in MLTC-1 cells            
MLTC-1 cells were stained for the peroxisomal biogenesis proteins: A. Peroxin 13 (PEX13); 
B. Peroxin 14 (PEX14) and for the localization of peroxisomal antioxidant enzyme                             
C. Catalase. Bars represent in A-C 20µm, in D-F 10µm (D magnification from A,                          
E magnification from B, F magnification from C). Pictures were taken by confocal laser 
scanning microscopy (CLSM). Representative pictures were obtained from 3 different 
experiments. 
 
As described previously (Nenicu et al 2007), peroxisomes are abundant in Leydig 
cells, which is also the case in MLTC-1 cells. Similar to Leydig cells in testis 
sections, peroxisomes are surrounding lipid droplets. In addition, 
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immunofluorescence staining confirmed the high abundance of the catalase protein, 
exhibiting a similar distribution pattern as PEX13 and PEX14.  
To summarize, these findings indicate that MLTC-1 cells are abundant in 
peroxisomes and serve as a good model to study the influence of peroxisomes on 
steroidogenesis. 
 
4.4. shRNA mediated knock-down of Pex13 in MLTC-1 cells 
To investigate the specific role of peroxisomes in Leydig cells, we were interested to 
establish a cell culture model with peroxisome deficiency. As mentioned above, the 
Pex13 gene encodes a protein that is essential for the biogenesis of peroxisomes. 
Pex13 is responsible for the import of matrix proteins into the peroxisomes. 
Therefore, if the import of matrix proteins is defective, it will lead to a complete 
disruption of peroxisomal metabolism. To achieve this, we were first interested to 
obtain an efficient transfection protocol with minimal toxicity and high transfection 
rate in MLTC-1 cells. 
As mentioned in Materials and Methods (chapter 2.4.1., table 7) different conditions 
for microporation were used to check the transfection efficiency using a control 
shRNA plasmid also expressing the green fluorescent protein (GFP). Detection of 
GFP after microporation via fluorescence microscopy was done to check the 
transfection efficiency in MLTC-1 cells.  After trying different conditions for 
microporation, we found that MLTC-1 cells were highly transfectable with an 
efficiency of 85% using the following microporation parameters: voltage-1350, pulse 
width- 2, pulse number-2. Viability and the proliferation rate of the transfected cells 
were normal indicating no toxicity after control shRNA transfection. 
 
4.4.1. Establishing the Pex13 knockdown in MLTC1 cells 
Next, MLTC-1 cells were transfected with a shRNA plasmid for Pex13 and a control 
non-targeting shRNA as described under Materials and Methods (chapter 2.4.1). 
After 72 h of transfection, cells were processed for total RNA and protein isolation.    
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Figure 12. Semi-quantitative RT-PCR analysis of Pex13 from total RNA of MLTC-1 cells 
transfected with Pex13 shRNA- and control shRNA-palsmids (A). Pex13: Peroxisomal 
biogenesis gene 13; 28S rRNA: 28S ribosomal RNA as internal control. B. Model of a 
peroxisome. 
 
Semi-quantitative RT-PCR analyses revealed that the Pex13 mRNA was significantly 
reduced in MLTC-1 cells transfected with the Pex13 shRNA plasmid in comparison 
to cells transfected with control shRNA (Fig. 12).  
Similarly, Western blot analysis showed that PEX13 protein level in MLTC-1 cells 
transfected with the Pex13 shRNA plasmid was reduced approximately by 80% in 
comparison to control shRNA plasmid transfected MLTC-1 cells (Fig. 13). 
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Figure 13. Western blot analysis for the peroxisomal biogenesis protein PEX13 in 
MLTC-1 cells transfected with the Pex13 shRNA plasmid.  After 72h of transfection cells 
were lysed and subjected to Western blot analysis. Twenty micrograms of total proteins were 
loaded in each lane on 12.5% SDS gels. First the membrane was incubated with antibody 
against PEX13: peroxin13. The same blot was stripped and reprobed for the α tubulin as an 
internal control. Chemiluminescent signals were visualized and quantified through ImageJ. 
Data are representatives of similar results obtained from three independent experiments            
(* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3). 
 
4.4.2. shRNA mediated knock-down of Pex13 leads to mistargeting of catalase 
into the cytoplasm in MLTC-1 cells 
Loss of functional peroxisomes results in the mistargeting of peroxisomal proteins to 
the cytoplasm. Previous studies have reported that the highly abundant catalase 
protein is mistargeted into the cytoplasm in peroxisomal knockout cells (Baes et al. 
1997). Moreover, this is also observed in the cells of patients with peroxisomal 
biogenesis disorders (Sheikh, et al. 1998). 
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Figure 14. Double-fluorescence of green fluorescent protein (GFP) and catalase 
immunolocalisation in MLTC-1 cells transfected with the Pex13 shRNA plasmid also 
expressing GFP. MLTC-1 cells were transfected with the control shRNA and with Pex13 
shRNA plasmids. Immunostaining for the peroxisomal matrix protein catalase was done 
following 72 h of transfection. Pictures were taken by confocal laser scanning microscopy 
(CLSM). The immunofluorescence staining revealed that the catalase is localized in 
peroxisomes in the cells transfected with the control shRNA (A,B,C,). In contrast, in the 
MLTC-1 cells transfected with the Pex13 shRNA, the catalase protein was mistargeted to the 
cytoplasm (D,E,F). Bars A-F represent: 50µm. Similar pictures were obtained in 3 different 
experiments. 
 
To understand if the knockdown of Pex13 in MLTC-1 cells would lead to the loss of 
functional peroxisomes we performed immunofluorescence studies for staining the 
peroxisomal matrix protein catalase in Pex13 shRNA transfected MLTC-1 cells. 
Immunofluorescence staining revealed that the catalase staining was clearly present 
in peroxisomes in the cells transfected with the control shRNA.  In contrast, the 
catalase protein was mistargeted to the cytoplasm in the cells transfected with the 
Pex13 shRNA plasmid, demonstrating the loss of matrix protein import due to Pex13 
deficiency. In summary, the Pex13 knockdown in MLTC-1 cells leads to an impaired 
import of matrix proteins, such as catalase, into peroxisomes (Fig. 14). 
 
4.5. hCG-induced up-regulation of StAR is strongly inhibited in MLTC-1 cells 
with Pex13 knockdown  
Next, to understand the influence of peroxisomes on steroidogenesis we decided to 
analyze and compare hCG-stimulated control and Pex13 shRNA-transfected                   
MLTC-1 cells. At first, we examined the effects of hCG stimulation on StAR protein 
which regulates the rate-limiting step in steroid biosynthesis. The cholesterol 
transport from the outer to the inner mitochondrial membrane is mediated by StAR. 
StAR is rapidly synthesized in cytoplasm in response to cAMP, which is translated as 
a 37kDa precursor. After phosphorylation by PKA-A, it is cleaved within the 
mitochondria to generate the intramitochondrial 30kDa form. 
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Figure 15. Western blot analysis for StAR abundance in response to hCG treatment 
after Pex13 knockdown in MLTC-1 cells.  MLTC-1 cells were transfected with Pex13 
shRNA and control shRNA plasmids. Following 72h of transfection cells without and with 
treatment (100ng/ml hCG for 6h) were lysed and subjected to Western blot analysis. Twenty 
micrograms of proteins were loaded in each lane on 12.5% SDS gels. First the membrane 
was incubated with anti-StAR antibody (StAR- Steroidogenic acute regulatory protein). The 
same blot was stripped and reprobed for the localization of α tubulin as an internal control. 
Chemiluminescent signals were visualized and quantified through ImageJ. Data are 
representative of similar results obtained from three independent experiments                                   
(* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3). 
 
As expected hCG stimulation in control shRNA plasmid transfected cells induced the 
protein levels of StAR with specific induction of the intramitochondrial cleaved form 
of 30kDa StAR (Fig. 15). Interestingly, hCG stimulation in Pex13 shRNA transfected 
MLTC-1 cells resulted in a reduced up-regulation of StAR (approximately to 56%) 
protein in comparison to control shRNA transfected cells. More specifically, this 
impaired induction of StAR protein was clearly seen for the mature 30kDa form of 
StAR after hCG stimulation. Basal 37kDa StAR protein level is reduced in Pex13 
kcockdown MLTC-1 cells in the represented picture, but in different other 
experiments we did not notice the significant difference between 37kDa StAR protein 
levels in Pex13 shRNA and control shRNA transfected MLTC-1cells without hCG 
stimulation. In short, peroxisomal knockdown leads to a decrease in the hCG-
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induced up-regulation of the intramitochondrial form of 30 kDa StAR protein (Fig. 
15). 
 
4.6. Mouse primary Leydig cell isolation, culture and treatment with hCG 
To confirm the importance of peroxisomes for steroid synthesis in Leydig cells, and 
to rule out the possibility that the observed findings in MLTC-1 cells are a cell-line 
specific phenomenon, it was important to induce a Pex13 gene knockdown in murine 
primary Leydig cells. Moreover, isolated primary Leydig cells are ideal for direct 
biochemical and acute functional studies on steroidogenesis and they are often 
better suited than intact animals.  
To study the relevance of peroxisomal metabolism and effects of peroxisomal 
deficiency on different steps of steroid synthesis, the establishment of the primary 
mouse Leydig cell isolation and Leydig cell culture model was crucial.  
 
4.6.1. Isolation of primary Leydig cells 
Leydig cells were isolated using enzymatic dissociation and Percoll density gradient 
centrifugation as described in Materials and Methods (Chapter 2.2.2.). When the cell 
suspension was loaded on top of a discontinuous Percoll gradient and centrifuged 
for 30 min, separation into 4 visible bands was obtained. The upper band consisted 
mainly of damaged cells whereas the second band consisted of mainly of germ cells 
and single Leydig cells. The fraction of most intact Leydig cells formed a third distinct 
band at the interphase between 50% and 60% of Percoll. A purity of isolated Leydig 
cells was reached of ca. 90% depending on the experiment as tested by 
immunofluorescence staining for cytochrome P450 side-chain cleavage enzyme 
(P450scc), a marker specific for this cell type (Fig. 16). The fourth band in the 
gradient predominantly contained erythrocytes. 
Immediately after isolation most of Leydig cells were round in shape and some of 
them were single in the suspension and some of them appeared in clusters. Leydig 
cells required an initial 24h culture period to attach to the culture plates. After 4 day 
of culture, Leydig cells were elongated in spindle, triangular or polygonal shapes. 
They grew in aggregation and some cells grew individually (Fig. 16).  
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Figure 16. Immunofluorescence staining of primary mouse Leydig cell cultures (LC) 
stained for the mitochondrial cytochrome P450 side-chain cleavage enzyme 
(P450scc), a marker specific for this cell type.  
Cells were stained in suspension immediately after isolation. (A,B,C).  
Staining of four-day-old cultures of Leydig cells (D,E,F,G,H,I). Cells were plated in  24 well 
plates with collagen coated coverslips. After 4 days of culture cells were stained for 
P450scc. Nuclei were counterstained with TOTO-3 iodide (blue). Bars represent in A-F 30 
µm, in G-I 400µm. Representative pictures were similar in 3 different experiments. 
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4.6.2. Treament of primary Leydig cells with hCG. 
Isolated Leydig cells in culture are known to lose their responsiveness with time to 
gonadotropin treatment, due to the down regulation of their LH/hCG receptors 
(Chen, et al. 2002; Hsueh 1980; Janszen, et al. 1976; Klinefelter, et al. 1987). 
Therefore, primary cultures of mouse Leydig cells were maintained as described in 
Materials and Methods (chapter 2.2.2) and tested for their ability to respond to hCG 
treatment.  
                                                                                                                        
 
 
 
 
 
 
 
Figure 17. Western blot analysis for the steroidogenic acute regulatory protein (StAR) 
of the whole the cell lysate from primary mouse Leydig cells without and with hCG 
stimulation. Primary mouse Leydig cells were grown in culture and treated with hCG for 6 h 
on the 4th day after isolation. Cells were lysed and subjected to Western blot analysis to 
assess the level of StAR. Twenty-five microgram of proteins was loaded in each lane on 
12.5% SDS gels. First the membrane was incubated with anti-StAR antibody: StAR- 
Steroidogenic acute regulatory protein. The same blot was stripped and reprobed for the 
localization of α tubulin as an internal control. 
 
As shown in figure15 stimulation with hCG induced the protein levels of StAR             
(37kDa and 30kDa) and confirmed the ability of the primary Leydig cell model to 
respond to hCG stimulation.  
 
 
Primary Leydig cells 
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4.6.3. Hormone production in primary mouse Leydig cells and comparison with 
hormone secretion in MLTC-1 cells. 
The functional relevance of hCG induced StAR protein expression in MLTC-1 cells 
was also confirmed in isolated mouse primary Leydig cells by quantifying their ability 
to produce hormones upon stimulation. For a comparison, the culture supernatants 
from hCG-stimulated MLTC-1 cells were also used for analysis to understand the 
differences (if any) in the steroid synthesis capacity between these two models. 
ELISA and RIA revealed that primary Leydig cells produce significantly higher levels 
of testosterone than MLTC-1 cells which corresponds to data in the existing literature 
(Mellon 1986) that MLTC-1 cells express low or undetectable levels of 17β-HSD. 
Similarly, DHEA measurements showed that MLTC-1 cells produce significantly 
higher amounts in comparison to primary Leydig cells owing to the lack of 17β-HSD 
activity in MLTC-1 cells. Moreover, progesterone, pregnenolone and estrone but not 
estradiol levels were found to be higher in MLTC-1 cells. 
In summary, we were able to obtain primary Leydig cell cultures with high purity and 
these cells in culture respond to hCG-treatment. Moreover, there exist significant 
differences in the steroid synthesis capacity between MLTC-1 cell line and murine 
primary Leydig cells with MLTC-1 cells exhibiting more precursor forms and less end 
products (testosterone and estradiol).  
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Figure 18. Steroid hormone production by primary mouse Leydig cells and MLTC-1 
cells stimulated with hCG (100ng/ml) as measured by RIA and/or ELISA. Primary 
Leydig cells (pLC) were isolated and grown in culture as described in materials and 
methods. On the 4th day after isolation cells were treated with 100 ng/ml hCG for 6h.             
MLTC-1 cells were grown in culture to 60% confluence and after 72 h of culture cells were 
treated with hCG (100ng/ml) for 6h. Media were collected and subjected to measurement by 
RIA or/and ELISA.  Steroid hormone concentrations were normalized to protein 
concentrations for each sample and the graphs represent results from three independent 
experiments (n=3).   A. Progesterone concentrations in pLC and MLTC-1 by ELISA (A) and 
RIA (A´). B. Testosterone concentrations in pLC and MLTC-1 by ELISA (B) and RIA. (B´) C. 
DHEA concentrations in pLC and MLTC-1 by ELISA. D. Pregnenolone concentrations in pLC 
and MLTC-1 by ELISA E. Estradiol concentrations in pLC and MLTC-1 by ELISA. F. Estrone 
concentrations in LC and MLTC-1 by ELISA. (* p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.001). (N=3)  
 
4.6.4. Establishing a Pex13 knockdown in mouse primary Leydig cells via a 
siRNA approach 
To verify and confirm the results obtained after Pex13 knockdown in MLTC-1 cells it 
was important to establish the knockdown also in isolated primary Leydig cells. 
4.6.4.1. Establishment of a siRNA-mediated RNAi–analysis of the functionality 
of different Pex13 siRNAs for the knockdown of the Pex13 gene in MLTC-1 
cells and establishing a Pex13 knockdown in mouse primary Leydig cells via 
siRNA approach in primary Leydig cells 
At first, we transfeced primary Leydig cell with Pex13 shRNA and control shRNA 
plasmids via microporation. After transfection, the number of primary Leydig cells 
was extremely low in culture due to the high stress and toxicity caused by 
microporation (results not shown). Hence we decided to obtain a siRNA mediated 
knockdown of Pex13 in primary Leydig cells. To establish the best siRNA conditions 
and to choose the most efficient Pex13si RNA, we first tested the efficiency of the 
siRNA in MLTC-1 cells and used different lipofection reagents to obtain minimal 
toxicity and an efficient knockdown as described in Materials and Methods (Chapter 
2.4.3., Table 9) (results not shown). Our results showed that the transfection reagent 
Screenfect (Incella) was the best suited among the ones tested.  
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Figure 19. Western blot analysis for the peroxisomal biogenesis protein PEX13 in 
MLTC-1 cells transfected with Pex13 siRNA. Twenty micrograms of proteins were loaded 
in each lane on 12.5% SDS gels. First the membrane was incubated with anti-PEX13 
antibody. The same blot was stripped and reprobed for the GAPDH as an internal control. 
Chemiluminescent signals were visualized and quantified through ImageJ. Data are 
representatives of similar results obtained from three independent experiments. (* p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.001) (N=3). 
 
Western blot analysis revealed that transfection with Pex13 siRNA significantly 
reduced the expression of PEX13 protein in MLTC-1 cells in comparison to cells 
transfected with control siRNA (Fig.19). 
Moreover, as observed in case of shRNA-mediated knockdown also Pex13-siRNA 
transfected MLTC-1 cells showed an impaired hCG-mediated StAR up-regulation 
(approximately to 62%) (Fig.20).  
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Figure 20. Western blot analysis for StAR abundance in response to hCG treatment in 
MLTC-1 cells transfected with Pex13 siRNA. Twenty micrograms of proteins were loaded 
in each lane on 12.5% SDS gels. First the membrane was incubated with anti-StAR 
antibody: StAR- Steroidogenic acute regulatory protein. The same blot was stripped and 
reprobed for the localization of α tubulin as an internal control. Chemiluminescent signals 
were visualized and quantified through ImageJ. Data are representative of similar results 
obtained from three independent experiments. (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3). 
A down regulation of Pex13 in primary Leydig cells was also observed using RNAi approach 
(Fig. 21). After several experiments the optimal conditions for the amount of transfection 
reagent Screenfect (Incella), number of cells, the dilution of the siRNA was found and are 
presented in Materials and Methods (Chapter 2.4.3., Table 10). 
 
                                                            
Figure 21: Western blot analysis for the 
peroxisomal biogenesis protein PEX13 
in mouse primary Leydig cells 
transfected with Pex13 siRNA. Total 
protein (20µg) from primary Leydig cells 
were loaded in each lane on 12.5% SDS 
gels. First the membrane was incubated 
with antibody against PEX13. The same 
blot was stripped and reprobed for the 
localization of α tubulin as an internal 
control. Chemiluminescent signals were 
visualized and quantified through ImageJ. 
Data are representative of results obtained 
from three independent experiments. (* p 
≤0.05, ** p ≤ 0.01, **** p ≤0.001) (N=3). 
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Similarly, primary Leydig cells transfected with Pex13 siRNA showed significantly 
reduced amount of PEX13 approximately by 60% in comparison to control siRNA 
transfected cells (Fig. 21). 
 
4.6.5. hCG-induced up-regulation of StAR is inhibited in primary Leydig cells 
with Pex13 knockdown   
After demonstration of a strong decrease of hCG-stimulated StAR protein expression 
in MLTC-1 cells transfected with Pex13shRNA, we were interested to check hCG-
stimulated StAR protein expression in primary Leydig cells after Pex13 knockdown. 
Primary Leydig cells were treated with hCG after 48 h of transfection with 
Pex13siRNA. Followed the treatment, cells were processed for total protein isolation 
and the media were collected for steroid hormones assay by radioimmunoassay and 
by ELISA.  
 
 
 
 
 
 
 
 
Figure 22. Western blot analysis for StAR abundance in response to hCG treatment 
after Pex13 knockdown in mouse primary Leydig cells. Total protein (20µg) from primary 
Leydig cells were loaded in each lane on 12.5% SDS gels. First the membrane was 
incubated with antibody against StAR. The same blot was stripped and reprobed for the 
localization of αTubulin as an internal control. Chemiluminescent signals were visualized and 
quantified through ImageJ. Values represent the fold reduction of StAR normalized to 
αTubulin from three independent experiments (* p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.001) (N=3).  
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Indeed, also the Pex13-RNAi technology in primary Leydig cells induced 
peroxisomal deficiency in primary Leydig cells leading to a decrease of hCG-
mediated induction of 30 kDa intramitochondrial form of StAR (Fig. 22). 
 
4.7. Pex13 knockdown reduces progesterone secretion in response to hCG 
treatment in MLTC-1 and in primary Leydig cells 
Next the cell culture supernatant from Leydig cells with Pex13 knockdown were 
collected for steroid hormones assay by radioimmunoassay and by ELISA. After 
transport of cholesterol via StAR into the inner mitochondrial membrane, cholesterol 
is converted to pregnenolone by mitochondrial P450scc. Subsequently, 
pregnenolone is processed to progesterone by 3β-HSD. Since knock down of Pex13 
in MLTC-1 cells and in primary Leydig cells leads to a significant decrease of hCG-
mediated StAR protein expression, we hypothesized that downstream progesterone 
production would be also impaired in peroxisome deficient Leydig cells.  
 
 
 
 
 
 
 
 
 
 
Figure 23. RIA for detection of progesterone in MLTC-1 cells and primary Leydig cells 
with Pex13 knockdown. Media were collected from MLTC-1 cells transfected with the 
indicated shRNA for 72 hours followed by treatment with hCG (100 ng/ml) for 6 h. (B) Media 
were collected from primary Leydig cells transfected indicated siRNA for 48 hours followed 
by treatment with hCG (100 ng/ml) for 6 h for steroid hormones assay by RIA. After 
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treatment, media were collected and subjected to a progesterone production measurement 
via RIA. Hormone concentration was normalized to protein concentration for each sample. 
Data are representative of similar results obtained from three independent experiments. 
 
 
 
 
 
 
 
 
  
 
Figure: 24. ELISA for detection of progesterone in MLTC-1 cells and primary Leydig 
cells with Pex13 knock-down after treatment with hCG. Media were collected from 
MLTC-1 and primary Leydig cells with Pex13 knockdown after treatment with hCG (100 
ng/ml) for 6 h for steroid hormones assay by ELISA. Hormones concentrations were 
normalized to each sample cell pellet protein concentration. Data are representative of 
similar results obtained from three independent experiments. (* p ≤ 0.05, ** p ≤ 0.01, ****       
p ≤ 0.001). (N=3)  
Accordingly, RIA as well as ELISA revealed that knockdown of Pex13 in MLTC-1 
cells as well as in primary Leydig cells partially inhibited the hCG-stimulated 
production of progesterone in comparison to the respective controls (Fig. 23 and Fig 
24), whereas basal level of progesterone was not changed (results not shown). 
 
4.7.1. Effects of peroxisome deficiency on the activity of P450scc in Leydig 
cells. 
To understand if the decrease in progesterone levels are solely due to the impaired 
StAR regulation and to test the StAR-independent effects of peroxisome disruption 
on steroid synthesis we stimulated MLTC-1 cells with 22(R)-hydroxycholesterol 
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(22R-HC) instead of hCG and the pregnenolone levels were measured. Cholesterol 
once transported to the mitochondria is converted to pregnenolone by the 
mitochondrial enzyme P450scc. 22R-HC freely diffuses through the inner 
mitochondrial membrane without the help of StAR, thereby bypassing the need of 
StAR function in steroidogenesis. To avoid downstream processing of pregnenolone 
once it is produced we used the inhibitor of 3β-HSD (Trilostane), which blocks the 
conversion of pregnenolone to progesterone. We also pretreated MLTC-1 cells with 
abiraterone acetate, the inhibitor of P450c17 to inhibit the further conversion of 
pregnenolone to androgens (Fig. 25).                         
                              
Figure 25. Activity of P450scc in 
MLTC-1 cells with peroxisome 
deficiency. MLTC-1 cells were 
transfected with Pex13 shRNA and 
control shRNA. After 72 h of 
transfection cells were pre-
incubated for 30 min with trilostane 
(5µM) and abiraterone acetate 
(17nM), prior to incubation with hCG 
(100 ng/ml) and 22R-HC (40 µM) in 
serum free media for another 6h. As 
shown above further conversion of 
pregnenolone was significantly 
inhibited in the presence of 
trilostane and abiraterone. Each 
sample was collected and subjected 
to a progesterone production measurement via ELISA. Hormones concentrations were 
normalized to each sample cell pellet protein concentration. Results shown are from three 
independent experiments (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3). 
 
ELISA measurements revealed that in the presence of trilostane and abiraterone 
acetate, the pregnenolone production was decreased in Pex13 shRNA transfected 
cells stimulated with hCG but not with 22R-HC indicating that the peroxisome knock 
down in Leydig cells does not influence the activity of P450scc (Fig. 25). 
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4.7.2. Effects of peroxisomal deficiency on 22R-HC-stimulated progesterone 
synthesis  
To test the effect of peroxisomal disturbance on the activity of 3β-HSD which acts 
downstream of P450scc we treated MLTC-1 and primary Leydig cells with 
peroxisome deficiency with 22R-HC. After treatment, the product of 3β-HSD activity, 
progesterone was measured by ELISA.  
 
 
 
Figure 26. Effects of peroxisomal deficiency on 22R-HC-stimulated progesterone 
synthesis. MLTC-1 cells after transfection with Pex13 and control shRNA were cultured in 
24 well plates and after 72 hours were treated with 100 ng/ml hCG and 40M 22R-HC for 6 
hours. Similarly, primary Leydig cells after transfection with Pex13 siRNA were treated with 
above mentioned substances. Following treatment, media were collected and subjected to 
progesterone production measurements via ELISA. Hormone concentration was normalized 
to protein concentration for each sample. Data are representative of similar results obtained 
from three independent experiments (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3).  
 
As expected, ELISA measurements revealed that in Pex13-knockdown cells the 
amount hCG-induced progesterone was reduced. Surprisingly, the 22R-HC-induced 
production of progesterone was also significantly reduced although not as strong as 
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in the case of hCG-mediated progesterone levels in both MLTC-1 cells and primary 
Leydig cells with Pex13 knockdown in comparison to the respective control cells      
(Fig. 26). This finding indicates that peroxisome deficiency in Leydig cells affects 3β-
HSD enzyme activity in both MLTC-1 and in primary Leydig cells independent of 
StAR. 
 
4.8. Pex13 knockdown leads to inhibition of testosterone synthesis in                 
MLTC-1 cells and in primary Leydig cells 
Since the 22RHC-induced progesterone synthesis was affected in Pex13 knockdown 
cells we hypothesized that the downstream steroidogenesis pathways might also be 
impaired in these Leydig cells. To test this, we measured the final product of 
steroidogenesis which is testosterone in MLTC-1 cells and primary Leydig cells by 
RIA as well as by ELISA. 
A                                                                            B 
 
Figure 27. Radioimmunoassay (RIA) for detection of hCG-stimulated testosterone 
production in MLTC-1 cells and primary Leydig cells with peroxisome deficiency.            
(A) Media were collected from MLTC-1 cells transfected with the for 72 hours followed by 
treatment with hCG (100 ng/ml) for 6 h. (B) Media were collected from primary Leydig cells 
transfected with Pex13 siRNA and control siRNA for 48 hours followed by treatment with 
hCG (100 ng/ml) for 6 h. The collected medium samples were subjected to testosterone 
production measurements via RIA. Testosterone concentrations were normalized to protein 
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concentration for each sample. Data are representatives from three independent 
experiments (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3).  
           C                                                                      D 
 
Figure 28. ELISA for detection of testosterone in MLTC-1 cells and primary Leydig 
cells with Pex13 knock-down after treatment with hCG as mentioned above. C. 
Testosterone production in MLTC-1 cells transfected with the Pex13 shRNA and control 
shRNA. D. Testosterone production in primary Leydig cells transfected with the Pex13 
siRNA and control siRNA. 
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Figure 29. Effects of peroxisome deficiency on 22R-HC-stimulated testosterone 
secretion. MLTC-1 cells were transfected with Pex13 shRNA and control shRNA and after 
72 h of transfection cells were treated with 100 ng/ml hCG and 40µm 22R-HC for 6 hours 
(E). Similarly, primary Leydig cells after transfection with Pex13 siRNA were treated with 
above mentioned substances (F). Following treatment, media were collected and subjected 
to testosterone level measurements via ELISA. Hormone concentrations were normalized to 
protein concentration for each sample. Data are representative of similar results obtained 
from three independent experiments (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3).  
As hypothesized treatment with hCG in Pex13 knockdown in MLTC-1 cells and in 
primary mouse Leydig cells led to the inhibition of hCG-stimulated testosterone 
secretion in comparison to cells transfected with control shRNA (Fig 27 and Fig. 28). 
Similarly, the 22R-HC-stimulated testosterone secretion was also impaired by the 
knockdown of Pex13 in both MLTC-1 and primary Leydig cells (Fig. 29). These 
results suggest that the Pex13 knock down in Leydig cells affects steroidogenesis 
downstream of StAR activity (3-HSD, P450c17 and 17-HSD) in Leydig cells.  
 
4.9. A down regulation of Pex13 leads to an inhibition of DHEA production in 
Leydig cells 
Similarly, as described in previous paragraphs, we measured also the level of DHEA 
in Pex13 knockdown MLTC-1 and in primary Leydig cell after treatment with hCG 
and 22R-HC.  
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Figure 30: Effects of Pex13 knockdown on hCG and 22R-HC-stimulated DHEA 
secretion in Leydig cells. MLTC-1 cells were transfected with Pex13 shRNA and control 
shRNA. After 72 h of transfection cells were treated with 100ng/l hCG and 40M 22R-HC for 
6 hours. Similarly, primary Leydig cells after transfection with Pex13 siRNA were treated with 
the above mentioned substances. Following treatment, media were collected and subjected 
to estradiol level measurements via ELISA. Hormone concentrations were normalized to 
protein concentrations for each sample. Data are representative of similar results obtained 
from three independent experiments (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (N=3). 
 
Results show, that Pex13 knock down in Leydig cells leads to lower levels of hCG- 
as well as 22R-HC stimulated DHEA production (Fig. 30).  
 
4.10. Detection of reactive oxygen species in MLTC-1 cells 
To elucidate the underlying mechanisms by which steroidogenesis is affected by 
peroxisomal disturbances we analyzed the production of ROS after Pex13 
knockdown in MLTC-1 cells. It is well known that peroxisomes play an important role 
in both the generation and scavenging of ROS in the cell and increased oxidative 
stress has been linked to disrupted steroidogenesis in different studies (Diemer, et 
al. 2003; Zhou, et al. 2013).  
 
4.10.1. Decrease of reduced glutathione levels in MLTC-1 cells with Pex13 
knock down  
At first we measured cellular glutathione levels in control shRNA and Pex13 shRNA 
transfected MLTC-1 cells. Glutathione (GSH) is an important endogenous 
antioxidant produced by the cells, which participates directly in the neutralization of 
free radicals and prevents damage to cells caused by reactive oxygen species. 
Glutathione exists mostly in the reduced state, which usually donates an electron to 
a reactive oxygen species to minimize or reduce them. After losing an electron 
glutathione is converted to its oxidized form, glutathione disulfide (GSSG). So, a 
decreased amount of reduced glutathione levels would indicate increased cellular 
ROS levels. 
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Figure 31. GSH-GloTM Glutathione 
Assay in MLTC-1 cells with Pex13 
knockdown.  
MLTC-1 cells transfected with Pex13 
shRNA and control shRNA were 
cultured in a 96-well plate. After 72 h 
of transfection, culture medium was 
removed from the plate and prepared 
GSH-GloTM Reagent was added. 
Following 30min incubation 
reconstituted Luciferin Detection Reagent was added to the plate. After a 15min incubation, 
the plate was read in a luminometer for quantitative determination of reduced GSH levels in 
cells. 
 
As shown in figure 31 the amount of reduced GSH was significantly reduced in 
Pex13 shRNA transfected cells indicating increased oxidative stress in these cells. 
 
4.10.2. Detection of increased ROS production by DHE staining in                
MLTC-1 cells with Pex13 knockdown 
As an alternative approach increased ROS production was also determined by 
staining MLTC-1 cells with the fluorescent-dye, DHE as described in Materials and 
Methods (Chapter 2.8.). DHE is used in different studies to evaluate ROS 
production, particularly superoxide production in viable cells (Ahlemeyer, et al. 
2012). DHE is dehydrogenated to ethidium upon reaction with superoxide anions 
and stains the nucleus. 
Results show that the Pex13 knockdown in MLTC-1 cells led to an increase in the 
staining intensity of DHE in the cytoplasm as well as in the nuclear region of some 
cells (Fig. 32). Especially the nucleus was brighter in Pex13 shRNA transfected cells 
in comparison with MLTC-1 cells transfected with control shRNA. In short, this 
finding confirms the increased presence of ROS (mainly O2−), in MLTC-1 cells 
transfected with Pex13 shRNA. 
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Figure 32.  ROS detection by staining with DHE in MLTC-1 cells with Pex13 
knockdown.                                                                                                                                    
MLTC-1 cells were transfected with Pex13 shRNA and control shRNA. Following the shRNA 
transfection, the cells were stained with DHE for 30 min. Pictures were taken by confocal 
laser scanning microscopy (CLSM). Bars represent in A-D: 50µm. Representative pictures 
were obtained from 3 different experiments. 
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4.11. Pex13 knockdown leads to alterations in antioxidative enzymes levels as 
well as catalase activity in MLTC-1 cells 
Next, we hypothesized that the increased presence of ROS would alter the expression of 
antioxidative enzymes in Pex13 shRNA transfected cells. To test this, we first analyzed the 
protein abundance of catalase, which is one of the most potent cellular antioxidative 
enzymes and is localized in the peroxisomes under normal conditions. Interestingly, the 
expression of catalase was drastically decreased in cells transfected with Pex13 shRNA in 
comparison to control cells revealed by WB analysis (Fig. 33). 
 
 
 
 
Figure 33.  Western blot analysis for catalase in transfected MLTC-1 cells with Pex13 
shRNA and control shRNA. MLTC-1 cells were transfected with Pex13-shRNA and control 
shRNA. After 72 h of transfection, cells were lysed and twenty micrograms of proteins were 
loaded in each lane on 12.5% SDS gel. Data are representatives of similar results obtained 
from three independent experiments. 
 
Next, to determine whether the observed protein reduction of catalase could reflect 
the enzymatic capacity we performed catalase activity assays.  
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Figure 34. Catalase activity assay 
MLTC-1 cells after 72 h of transfection with 
Pex13 and control shRNA were centrifuged 
at 2, 000 x for 10 min at 4 °C. Thereafter, 
cell pellet was homogenized on ice in 2 ml 
cold buffer containing 50 mM potassium 
phosphate, pH 7.0, containing 1 mM EDTA 
and then centrifuged at 10,000 x g for 15 
minutes at 4°C. Supernatant was removed 
and stroed on ice for assay as described in 
Materials and Methods (Chapter 2.9.). 
Catalase activity was measured according to the protocol (Catalase Assay Kit) using a plate 
reader with a 540 nm filter. In three independent experiments catalase activity was found to 
be reduced. 
 
Results indicate that catalase activity was reduced in MLTC-1 cells with Pex13 
knockdown in comparison to control cells (Fig 34).   
Finally, we also compared the expression of a series of other antioxidative enzymes 
such as cytoplasmic SOD-1, mitochondrial SOD-2 and the glutathione reductase, 
which were up-regulated in cells transfected with Pex13 shRNA (Fig. 35).  
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B                                                                              
Figure 35. Western blot analyses 
for antioxidative enzymes in 
MLTC-1 cells transfected with 
Pex13 shRNA and control shRNA.  
MLTC-1 cells were transfected with 
Pex13-shRNA and control shRNA.   
After 72 h of transfection cells were 
lysed and twenty micrograms of 
proteins were loaded in each lane 
on 12.5% SDS gels. A. glutathione 
reductase; superoxide dismutase 1(SOD1); superoxide dismutase 2 (SOD2).                                  
B. Quantification of the blots calculated from three independent experiments (ImageJ). 
To summarize, the knockdown of Pex13 in MLTC-1 cells leads to oxidative stress 
and causes an altered expression of antioxidative enzymes in Pex13 shRNA 
transfected MLTC-1 cells. 
 
4.12. Knockdown of Pex13 induces mitochondrial dysfunction in MLTC-1 cells 
Peroxisomes and mitochondria are closely linked organelles in several different 
metabolic pathways particularly in β-oxidation of specific fatty acids. It has been 
shown that peroxisomal knockouts often suffer from mitochondrial dysfunction 
(Baumgart et al. 2001). To test if Pex13 knockdown leads to mitochondrial 
dysfunction in MLTC-1 cells, we performed assays to determine the mitochondrial 
membrane potential using the DePsipher™ Kit. This Kit uses a special cationic dye 
to detect the loss of the mitochondrial membrane potential. It can readily enter cells 
and form an orange-red fluorescent compound within healthy mitochondria. If the 
mitochondrial membrane potential is disturbed, the dye cannot reach the 
transmembrane space and remains in cytoplasm. Healthy mitochondria show red 
fluorescence, whereas when the mitochondrial membrane potential is disturbed the 
dye remains primarily green in its monomeric form. 
G
R
SO
D
1
SO
D
2
0
100
200
300
400
500
Antioxidative enzymes
MLTC-1  cells
Control shRNA
Pex13 shRNA
««
«
«
 
105 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Mitochondrial membrane potential assay. A,E: Control MLTC-1 cells, B,F: 
MLTC-1 cells treated with Antimycin A. C,G: MLTC-1 cells transfected with control siRNA, 
D,H:  MLTC-1 cells transfected with Pex13 siRNA. Cells were incubated with medium 
containing DePsipher (25 μg/ml) for 30 min at 37 °C. Green fluorescence represents 
mitochondria with disturbed membrane potential. Bars represent in A-H: 50µm. 
Representative pictures were obtained from 3 different experiments. 
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The mitochondria of both control and Pex13 knockdown MLTC-1 cells exhibited 
different patterns of red fluorescence signals. Untreated and unstimulated MLTC-1 
cells taken as a control group showed a similar mitochondrial pattern as MLTC-1 
cells transfected with control siRNA, indicating an intact mitochondrial potential in 
those cells (Fig 36 A,C,E,G). In contrast, cells with peroxisome deficiency due to the 
transfection with Pex13 siRNA and cells treated with antimycin A exhibited an 
unspecific pattern, indicating the disturbance of mitochondrial membrane potential 
(Fig. 36 B,D,F,G). Antimycin A, a complex III inhibitor of the mitochondrial respiratory 
chain was used as a positive control to show the disturbed mitochondrial membrane 
potential. Moreover, an accumulation of green fluorescence signals was also noted 
in MLTC-1 cells with the Pex13 knockdown and in cells treated with antimycin A 
indicating the increased presence of the monomeric form of the dye. In contrast, the 
untreated control group of MLTC-1 cells as well as MLTC-1 cells transfected with 
control shRNA showed only very weak green fluorescent signals (Fig. 36). This 
finding indicates that the mitochondrial membrane potential was reduced in MLTC-1 
cells with peroxisome deficiency.  
 
 
 
 
 
 
Figure 37. Western blot analysis for mitochondrial complex III of the respiratory chain 
in MLTC-1 cells transfected with Pex13 shRNA and control shRNA.  
Complex III: mitochondrial complex III of the respiratory chain. Cells were lysed and twenty 
micrograms of proteins were loaded in each lane on 12.5% SDS gels. Data are 
representative of similar results obtained from three independent experiments. 
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Further, we performed Western blot analyses for complex III of the mitochondrial 
respiratory chain and as shown in figure 37 the protein abundance of complex III was 
significantly reduced in MLTC-1 cells transfected with Pex13 shRNA in comparison 
to cells transfected with control shRNA. To summarize, these results indicate the 
presence of mitochondrial dysfunction in Pex13 shRNA transfected cells. 
 
4.13. Mitochondrial dysfunction impairs hCG-induced as well as 22R-HC–
mediated steroid synthesis in MLTC-1 cells. 
Next, to test if mitochondrial dysfunction can lead to impaired steroid synthesis in 
Leydig cells we pretreated MLTC-1 cells with the complex III inhibitor antimycin A 
before stimulating with hCG and 22R-HC.  
                                                                          Figure 38. Effect of antimycin A in 
steroid synthesis in MLTC-1 cells after 
treatment with hCG and 22R-HC. 
MLTC-1 cells were stimulated with hCG 
and 22R-HC in the presence and in the 
absence of the inhibitor antimycin A 
(5µM) for 1h. After 3h of stimulation 
progesterone production in the incubation 
medium was measured by ELISA and 
data are shown as progesterone 
concentration (ng/ml). The results are 
obtained from three independent 
experiments.  *P ≤0.05; **P ≤0.01;  
 
 
Progesterone measurements by ELISA revealed that hCG as well as 22R-HC-
mediated mediatedy progesterone production was decreased after antimycin-A 
treatment in MLTC-1 cells (Fig. 38). To summarize, these findings indicate that 
mitochondrial dysfunction in MLTC-1 cells may lead to disturbed steroid synthesis.   
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4.14. Mfp2 siRNA transfection in primary Leydig cells 
Different 17β-HSDs participate in the process of steroid synthesis as well as 
inactivation, modulating the biological potency of estrogens and androgens by 
conversion at position 17. It has been shown earlier that the 17β-HSD4 also known 
as peroxisomal multifunctional protein 2 (Mfp-2) is the only 17β-HSD found in 
peroxisomes (Carstensen et al. 1996; Normand et al. 1995; Novikov et al. 1997). To 
further investigate the role of Mfp2 in steroidogenesis, we were interested to 
knockdown the expression of the Mfp2 gene in primary Leydig cells. Therefore, 
primary Leydig cells were transfected with Mfp2 siRNA and control siRNA as 
described in Materials and Methods (2.4.3., Fig. 10). 
 
 
 
 
 
 
 
 
Figure 39. Western blot analysis for peroxisomal multifunctional protein 2 (MFP2) in 
mouse primary Leydig cells transfected with Mfp2 siRNA. Primary Leydig cells were 
transfected with Mfpsi siRNA and control siRNA. After 48 h of transfection total protein 
(15µg) from primary Leydig cells was subjected to subjected and loaded in each lane on 
12.5% SDS gels. First the membrane was incubated with antibody against MFP2. The same 
blot was stripped and reprobed for GAPDH the as an internal control. Chemiluminescent 
signals were visualized and quantified through ImageJ. Data are representative of similar 
results obtained from three independent experiments. (* p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.001) 
(N=3). 
Western blot results show, that transfection with MFP2 siRNA significantly reduced 
the expression of MFP2 in primary Leydig cells in comparison to control siRNA 
transfected cells.  The strongest knockdown of MFP2 protein expression was found 
after 48 h of transfection (Fig. 39). 
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4.14.1. Mfp2 knock down in Leydig cells leads to an inhibition of DHEA   
production. 
The role of 17β-HSD4 in different steps of steroidogenesis remains controversial. It 
has been shown earlier that isolated 17β-HSD4 oxidized 5-androstene-3β, 17β-diol 
to DHEA in Leydig cells (Adamski et al., 2000). To evaluate the role of MFP2 in 
DHEA synthesis, primary Leydig cells were transfected with Mfpsi and control si 
RNA as described above and stimulated with hCG for 6 h. Thereafter, medium was 
subjected to DHEA level measurements via ELISA. 
  
 
                                                                       
 
 
 
 
 
 
Figure 40: Effects of Mfp2 knock down on hCG-
stimulated DHEA, estrone and estradiol 
secretion in primary Leydig cells. 
Primary Leydig cells were transfected with Mfp2si 
and control siRNA.  Following 48h of transfection 
cells were treated with hCG for 6h. After treatment, 
media were collected and subjected to DHEA, 
estron and estradiol levels measurements via 
ELISA. Hormone concentrations were normalized to 
protein concentrations for each sample. Data are 
representatives of similar results obtained from three independent experiments 
Hormone measurement showed that down regulation of MFP2 leads to the inhibition 
of DHEA secretion in Leydig cells. However, the estrone and estradiol levels were 
not affected by the Mfp2 knockdown in primary Leydig cells (Fig. 40). 
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5. Discussion 
Infertility is a global health issue, affecting approximately 10-15% of couples 
worldwide. Nature and exact proportion of the prevalent cause of the infertility is still 
controversial, however, the male partner is thought to be involved in 50% of cases. 
Even though the treatment of infertility has been largely improved, the genetic and 
molecular causes of male infertility are still elusive. The dysfunction of Leydig cells in 
testis is proposed to be a factor leading to infertility since Leydig cells are involved in 
steroid synthesis, particularly testosterone, which primary function is to maintain 
spermatogenesis. 
Interestingly, human disorders with peroxisomal deficiency show a range of testicular 
pathologies leading to male infertility; the molecular pathogenesis of which is not yet 
understood (Aversa et al. 1998; Powers 1985; Powers and Schaumburg 1981).  
Previously we have characterized the peroxisomal protein composition in distinct cell 
types of mice and human testis, and have demonstrated that peroxisomes are 
abundant in both Leydig cells and Sertoli cells (Nenicu et al. 2007). Moreover, 
different studies have demonstrated that peroxisomes are essential for Sertoli cell 
functioning (Huyghe et al. 2006a; Nenicu 2010). However, till now only sparse 
information is available on the role of peroxisomes in Leydig cells. Mendis-
Handagama and colleagues showed that LH/hCG treatment in Leydig cells 
increased the peroxisomal volume, intraperoxisomal SCP-2 content, whereas, LH 
deprivation resulted in a strong reduction in the number of these organelles (Mendis-
Handagama 2000; Mendis-Handagama et al. 1992; Mendis-Handagama, et al. 1998; 
Mendis-Handagama et al. 1990a). In this thesis work we have extended these 
findings and we report that peroxisomes play a crucial role in steroidogenesis of 
murine Leydig cells. Furthermore, we demonstrate that peroxisomal dysfunction 
leads to an impaired regulation of the cholesterol transport protein StAR in 
mitochondria and leads to decreased production of hCG-stimulated testosterone. 
 
 
 
 .  
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5.1. Mouse Leydig tumor cells (MLTC-1 cells) produce steroids, including 
testosterone 
Cell lines of various cell types are frequently used in literature for functional studies, 
and are a good research tool to perform multiple experiments. They can be 
expanded without limitation and are easy to culture. The mouse Leydig tumor cell 
lines MA-10 and MLTC-1 cells are derived from the transplantable and the 
hormonally responsive murine Leydig cell tumor designated as M5480, originating in 
a C57B1/6J mouse (Moyle and Ramachandran 1973; Neaves 1975).  Two different 
subtypes of M5480 tumor were later identified: M5480A, which synthesize 
progesterone and androgens, and M5480P, which mainly produce progesterone. 
MA-10 (Ascoli 1981a, b; Ascoli and Puett 1978) and MLTC-1 cells (Rebois 1982) 
originate from M5480P and are the best characterized Leydig tumor cell lines so far.  
Rebois et al. established the MLTC-1 cell line, where only hCG-stimulated 
progesterone production was measured. Measurements of other steroids were not 
done because of previous studies reporting minimal secretion of testosterone or 
androstenedione by M5480P cells, due to the loss of P450c17 (Cyp17) (Ascoli and 
Puett 1978; Lacroix, et al. 1979). It was also previously shown that originally M4580 
cells were able to produce high levels of progesterone and androstenedione, but a 
low level of testosterone. Later with time these tumor cells started to synthesize 
mostly progesterone (Ascoli 1981a; Lacroix et al. 1979; Moyle and Ramachandran 
1973). Later Panesar and colleagues showed that MLTC-1 cells produce 
progesterone as well as low concentration of androstenedione and testosterone 
(Panesar, et al. 2003). From the literature, it is known that both cell lines of MA-10 
and MLTC-1 cells exhibit normal Leydig cell feature, but the expression of mRNA 
and activity of Cyp17, 17-β-HSDs and aromatase are insignificant. They produce 
large amount of progesterone and very small amounts of DHEA, testosterone, 
estradiol and estrone (Mellon and Vaisse 1989).  
In our study, we demonstrated that MLTC-1 cells, purchased from ATCC (CRL-
2065), express the key enzymes and important steroidogenic carrier proteins 
involved in steroid synthesis: Star, P450scc, 3β-HSD, as well as Cyp17, 17β-HSD4 
and aromatase. 
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Previously it was reported that MA-10 cells don’t express P450c17 and produce only 
progesterone (Mellon and Vaisse 1989). But our study indicates that under adequate 
cell culture conditions MA-10 cells express almost all steroidogenic enzymes, 
including the P450c17 gene. However, in contrast to MLTC-1 cells, MA-10 cells 
lacked the expression of aromatase. Moreover, MA-10 cells in culture formed 
clusters and their proliferation rate was low. In conclusion, these findings suggest 
that although MA-10 cells express P450c17, the MLTC-1 cell line is a better model to 
study steroidogenesis.  
MLTC-1 cells have been extensively used in research to study the first steps of 
steroid synthesis because of their ability to respond to LH/hCG treatment and  
because they express the key genes of steroidogenesis: StAR, P450scc and 3β-
HSD (Manna, et al. 2004). Our findings are consistent with these reports, and state 
that MLTC-1 cells respond efficiently to hCG treatment. After hCG stimulation, the 
expression of StAR and P450scc was found to be up-regulated at the mRNA and 
protein levels. MLTC-1 cells also express high levels of LHr, which is the first target 
for LH/hCG to stimulate steroid synthesis. Our findings indicate that LHr mRNA 
expression is downregulated in response to hCG stimulation, which is in agreement 
with the previous report that the loss of steady-state levels of LHr mRNA in the hCG-
induced state was due to a post transcriptional mechanism with increased 
degradation of the LHr mRNA (Menon, et al. 2004).  
It is widely accepted that MLTC-1 cells produce mainly a high level of progesterone, 
because they do not contain the final two enzymes necessary for downstream 
steroid synthesis: P450c17 and 17β-HSDs. But the results of this thesis indicate that 
MLTC-1 cells, besides producing high levels of progesterone, also have the 
capability to synthesize low levels of testosterone. Moreover, MLTC-1 cells produce 
high levels of androstenedione, as well as DHEA, upon hCG stimulation. Hence, we 
postulate that the conversion of progesterone and pregnenolone to downstream 
hormone synthesis is due to the expression of the P450c17 enzyme in MLTC-1 cells.  
However, RIA and ELISA analysis confirmed that the amount of progesterone 
produced by MLTC-1 cells was considerably higher (approximately 250-fold more) 
than that of the testosterone. Very low expression of 17HSD3 in MLTC-1 cells 
might explain the low level of testosterone converted from androstenedione. Finally, 
for the first time in this thesis it was reported that, besides progesterone and 
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androgens, MLTC-1 cells are capable of producing estrogens, estradiol and estrone, 
also confirming the expression and activity of aromatase, as well as different 
17HSDs genes. In summary, our study suggests that the Leydig tumor cell line 
MLTC-1 is also a suitable in vitro model to study the downstream steps of 
steroidogenesis in Leydig cells.  
 
5.2. Primary Leydig cell culture 
Compared to Leydig tumor cell lines, isolated Leydig cells in primary cells culture are 
a superior model, which is closer to the in vivo situation, and more importantly are 
considered to be better and more reliable than cell lines, as they maintain normal cell 
morphology and functions seen in vivo.  In addition, experiments with primary Leydig 
cells are generally done to study the downstream steroid synthesis compared to 
Leydig tumor cell lines. Steroid synthesis in Leydig cells is regulated dominantly by 
LH/hCG produced by pituitary. Steroid synthesis can be modulated by different 
growth factors, steroids or cytokines through endocrine, autocrine and paracrine 
regulation or cell-cell interactions in the testis (Huleihel and Lunenfeld 2004; 
Matsumoto and Bremner 1989; Roser 2008; Sharpe, et al. 1990). In order to study 
the exact function of peroxisomes in Leydig cells it was necessary to establish a 
primary culture model, because in a whole body, for example in an animal model, 
such as mouse, it is difficult to observe whether the increased or decreased hormone 
production is due to the impaired steroid synthesis specifically in Leydig cells or 
because of other regulatory factors or disrupted function of other testicular cell types, 
which might have an influence on Leydig cell functioning.  
After collagenase dissociation of decapsulated testis with some modifications of the 
method of Schumacher (Schumacher et al. 1978) we were able to obtain highly 
purified (80-90%) and viable populations of Leydig cells, using percoll gradient 
centrifugation. Following centrifugation, Leydig cells were isolated from the third 
band; it was crucial to wash cells three times to avoid further degenerative effect of 
collagenase on the cells. After isolation to stimulate their proliferation Leydig cells 
were directly cultured with serum supplemented medium for 24h, considering that 
Leydig cell proliferation, besides LH, is regulated by growth factors through 
endocrine, paracrine and autocrine mechanisms. LH, together with locally produced 
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growth factors, stimulates the proliferation and differentiation of Leydig cells, 
whereas LH alone exhibits a little effect (Khan, et al. 1992). 
Thereafter, cells were incubated in special serum-free Leydig cell medium with daily 
change of the culture medium, as described in Materials and Methods (Chapter 
2.1.2). In response to LH/hCG stimulation primary Leydig cells in the culture lose 
their ability to synthesize testosterone after a few days due to reduction of 
steroidogenic enzymes and LHr receptor activity (Chen et al. 2002; Hsueh 1980; 
Janszen et al. 1976; Klinefelter et al. 1987). After 3 days, the LHr mediated response 
of primary cultures of rat Leydig cells was described to be weak (Shiraishi und Ascoli 
2007). In the present study, we were able to maintain mouse Leydig cells in primary 
culture with their ability to produce high levels of testosterone after 3d in culture 
without detecting any morphological changes. To culture primary Leydig cells for 3 
days was necessary for the future experiments with Pex13 siRNA transfection to 
observe the steroidogenesis in a condition of peroxisome deficiency. Our study 
indicates that primary mouse Leydig cells, after 3d of culture in vitro, were able to 
produce also other hormones: progesterone, DHEA, estrone and estradiol.  
 
5.3. Comparison of MLTC-1 and primary mouse Leydig cells in their ability to 
produce steroid hormones  
In this study, we have tried to draw a comparison between MLTC-1 cells and primary 
Leydig cells for their capacity to produce hormones. RIA and ELISA revealed that 
MLTC-1 cells produce two times more progesterone than primary Leydig cells. This 
observation is consistent with the current literature, that the activity of downstream 
enzymes of steroidogenesis is less in MLTC-1 cells compared to primary Leydig 
cells (Manna et al. 2006; Manna et al. 2004; Panesar et al. 2003). 
RIA analysis showed that the concentration of testosterone produced from Leydig 
cells is 15 times more than in MLTC-1 cells (percentage 100% Leydig cells, 6% 
MLTC-1 cells). Free testosterone measurements via ELISA showed the same 
difference in testosterone production by MLTC-1 and primary Leydig cells. 
Interestingly, DHEA production in MLTC-1 cells was much higher than in mouse 
primary Leydig cells. These findings indicate and confirm that MLTC-1 cells not only 
express P450c17 mRNA as mentioned above, but P450c17 is also enzymatically 
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active in these cells. These results lead to the hypothesis that the expression and 
activity of the multiple 17-HSDs in MLTC-1 cells might be different, which are 
involved in the conversion of androgen precursors to testosterone, leading to their 
accumulation in medium. 
Furthermore, ELISA-measurements showed that estrone secretion by MLTC-1 cells 
was higher in comparison to primary Leydig cells. It is known that estrone is 
synthesized through aromatase from androstenedione. This finding indicates that the 
aromatase gene is expressed and the protein is enzymatically active in MLTC-1 
cells. Moreover, through increased levels of androstenedione produced by MLTC-1 
cells, estrone conversion by aromatase is consequently elevated. 
Interestingly, estradiol production by primary Leydig cells was increased compared 
to MLTC-1 cells. In Leydig cells estradiol is generated through two different 
enzymatic pathways. It can be converted from testosterone by aromatase. 
Additionally, as mentioned earlier, through action of aromatase androstenedione 
generates estrone, which then via 17β-HSDs is converted to its active form 
(estradiol). Taking into consideration that testosterone level secreted by primary 
Leydig cells was higher in comparison to MLTC-1 cells we postulate that estradiol is 
synthesized in primary Leydig cells through two defined pathways, whereas, in 
MLTC-1 cells estradiol is produced predominantly through estrone conversion by 
17β-HSDs.  
In summary, in primary cell culture isolated mouse Leydig cells showed high 
responsiveness to hCG treatment even after 3d of culture, by producing high level of 
hormones. In our model of MLTC-1 cells, all key enzymes necessary for steroid 
synthesis are expressed and their activity seems only slightly disturbed except for 
17β-HSD3, which is the most important enzyme for the testosterone synthesis from 
androstenedione (Andersson 1995; Geissler et al. 1994; Sha et al. 1997). Thus, this 
thesis work provides an extended comparison of the steroidogenic capacity of 
MLTC-1 cells and primary Leydig cells and provides new information on the 
downstream steroidogenic activity of MLTC-1 cells.  
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5.4. Peroxisomal abundance in murine Leydig cells  
In 1972, Reddy and Svoboda by cytochemistry observed peroxisomes through 
positive peroxidase staining of peroxisomal catalase in Leydig cells (Reddy and 
Svoboda 1972a), and showed that peroxisomes are highly abundant in mouse 
Leydig cells and are often closely associated with SER segments or with lipid 
droplets (Reddy and Svoboda 1972b; Reddy and Ohno 1981). They were the first to 
speculate that peroxisomes might play a role in steroid or cholesterol synthesis. This 
observation is consistent with our findings that catalase is highly abundant in Leydig 
cells. In addition, we found that almost all peroxisomal genes involved in peroxisomal 
biogenesis and metabolic functions are well expressed in Leydig cells. As described 
previously (Nenicu et al 2007), using antibodies against proteins of peroxisomal 
biogenesis, such as the peroxins 13 and 14 (PEX13 and PEX14), we were able to 
confirm additionally, that Leydig cells contain numerous peroxisomes.   
 
5.4.1. Peroxisomal deficiency in Leydig cells and alteration of peroxisomal 
marker proteins 
Patients with peroxisomal disorders show severe pathological alterations in different 
tissues and organs including reproductive system mostly with disturbed lipid 
metabolism. However, to date the pathogenesis of these organ defects is not 
completely understood.  
Different mouse models have been developed with generalized inactivation of Pex 
genes involved in PTS1- and PTS2-dependant matrix protein import (Pex2-, Pex5- 
and Pex13-knockouts) to investigate the underlying pathogenesis of the most severe 
peroxisomal biogenesis disorder: Zellweger syndrome (Baes et al. 1997; Faust and 
Hatten 1997; Liu et al. 1999). All knockout models demonstrated different organ 
impairments typical for ZS, including disturbed neocortex neuronal migration and 
development, as well as hypotonia.  Due to their early postnatal mortality, it is not 
possible to investigate the role of peroxisomes in adult tissues of Pex-knockout mice. 
As a result, they lose their usefulness as models for investigation of postnatal 
disease pathogenesis. Particularly, these Pex-KO mice are not suitable to study 
testicular pathologies observed in patients with Zellweger syndrome, since the testis 
are not mature at birth, and in mice the spermatogenesis starts only at postnatal day 
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20. However, in the last decade, through advanced Cre-loxP technology, it became 
possible to conditionally inactivate genes in specific cell types. Conditional knockout 
of Pex13 and Pex5 specifically in Sertoli cells were generated to study the functional 
importance of peroxisomes in these cells. Both knockouts showed severely impaired 
spermatogenesis, with lipid accumulation in Sertoli cells leading to the arrest of 
spermatogenesis (Huyghe et al. 2006b; Nenicu et al. 2007). In Sertoli cell-sepcific 
Pex13-KO mice the proliferation of Leydig cells with hormonal alterations was 
observed, which is considered to be a compensatory alteration in response to the 
loss of Sertoli cells. Therefore, to achieve an in vitro model with peroxisomal 
deficiency in Leydig cells, we chose to target the peroxisomal biogenesis protein 
Pex13. The Pex13 gene encodes a protein that is localized in the membrane docking 
complex, essential for the import of PTS1- and PTS2-dependent matrix proteins into 
the peroxisome. The Pex13 protein was described to interact not only with the PTS1-
receptor Pex5p, but also with PTS2-receptor Pex7p (Stein et al. 2002). Deletion of 
Pex13 leads to a loss of import of both, PTS1 and PTS2, proteins. If the import of 
matrix proteins is defective, this results in a complete disruption of peroxisomal 
metabolism (Gould et al. 1996). In the Pex13-/- mouse, morphologically detectable 
peroxisomes were absent in the liver and peroxisomal ghosts in cultured fibroblast 
were detected with peroxisomal metabolic deficiency (Maxwell et al. 2003). Similarly, 
in our in vitro model the knockdown of Pex13 gene, as well as the reduced levels of 
PEX13 protein was verified in Leydig cells, independently by semi-quantitative RT-
PCR and Western blot analyses respectively. In addition, IF staining revealed the 
mistargeting of catalase into the cytoplasm, which is common phenomenon 
observed in pateints with peroxisomal deficiency (Baumgart, et al. 2003). For 
example, in vitro in skin fibroblasts obtained from patients with Zellweger-like clinical 
features or embryonic fibroblasts of appropriate Pex gene knockout models catalase 
was mislocalized to the cytosol (Baes et al. 1997; Sheikh et al. 1998).  
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5.5. Disturbed ROS homeostasis and disturbed mitochondrial function in 
Pex13 knockdown Leydig cells 
Reactive oxygen species are a double-edged sword; on one hand they are vital for 
cellular signaling and on the other hand they are detrimental in excess amounts, 
leading to lipid peroxidation and cell death. The fine balance or homeostasis is 
provided by multiple enzymes involved in production as well as scavenging of ROS. 
Peroxisomes contain multiple enzymes involved in different peroxisomal metabolic 
pathways that generate reactive oxygen species as metabolic by-products 
(Antonenkov, et al. 2010; Dansen and Wirtz 2001; Schrader and Fahimi 2006; Van 
Veldhoven 2010). Peroxisomes also contain various antioxidant enzymes, including 
catalase, Cu/Zn-superoxide dismutase (SOD1), glutathione peroxidase and 
peroxiredoxin1,5 (PRDX1,5) (Antonenkov et al. 2010; Immenschuh et al. 2003). It 
was shown that catalase, as a peroxisomal antioxidant, is responsible for the 
metabolism of H2O2 generated in peroxisomes and elsewhere in the human cells 
(Koepke, et al. 2007; Koepke, et al. 2008). Several studies show that the loss of 
catalase and increased peroxisomal reactive oxygen species can affect the 
peroxisomal metabolism (Sheikh et al. 1998; Titorenko and Terlecky 2011). It is well 
accepted, that peroxisomes play an important role in both the generation and 
scavenging of ROS in the cell, in particular hydrogen peroxide.  
In addition, peroxisomes and catalase activity are highly reduced in different 
pathological conditions in the body, including tumors of the liver and other organs, as 
well as after ischemia-reperfusion injury, inflammation (Canonico, et al. 1975; Khan, 
et al. 2000; Lauer, et al. 1999; Litwin, et al. 1999). Similarly, in Leydig cells, 
deficiency of functional peroxisomes induced by Pex13 knockdown leads to the 
reduction in the amount, as well as activity, of the peroxisomal antioxidant enzyme 
catalase due to the mistargeting and partial degradation of the enzyme in the 
cytoplasm (see Western blot analysis and catalase activity assay).  
Indications suggestive of a disturbed ROS homeostasis in Pex13 knockdown Leydig 
cells include increased levels of the cytoplasmic antioxidant enzyme SOD1 and 
glutathione reductase, and a decrease in the reduced-form of glutathione. 
Furthermore, the mitochondrial anti-oxidant enzyme SOD2 was found to be up-
regulated in Pex13 knockdown Leydig cells. SOD2 converts superoxide anions 
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(O2−), generated from mitochondrial electron transport chain (Chance et al. 1979; 
Hansford et al. 1997), into hydrogen peroxide (H2O2), which are usually reduced to 
H2O by mitochondrial peroxiredoxins, GPX1 or catalase. It is known that in 
conditions of oxidative stress, the mitochondria harbor increased amounts of SOD2. 
Increased oxidative stress with elevated levels of SOD2 is also observed in different 
organs including liver, heart, kidney, adrenal cortex of Pex5 knockout mice 
(Baumgart et al. 2003; Baumgart et al. 2001; Schrader and Fahimi 2004). Finally, the 
observation that in a Pex13 knockdown Leydig cell the intensity of DHE staining was 
increased, supports the conclusion that peroxisome dysfunction leads to oxidative 
stress in Leydig cells.  
The changes of antioxidant enzymes in different subcellular compartments suggest 
that in Pex13 knockdown Leydig cells there is an effect on the general redox 
balance. Even though almost all antioxidant enzymes are up-regulated, this increase 
is not sufficient to compensate the oxidative stress shown by DHE staining and 
reduced GSH levels. One of the reasons could be the observed reduction of 
mitochondrial complex III of respiratory chain in Pex13 knockdown Leydig cells 
leading to the release of mitochondrial ROS. 
 
5.6. Functional significance of peroxisomes in steroid synthesis in Leydig cells 
Importantly, patients with peroxisomal disorders surviving to adolescence exhibit 
different testicular pathologies including impaired spermatogenesis, testicular 
atrophy, degeneration of Leydig cells and hormonal dysfunction. Interestingly, in our 
study, Pex13 knockdown in Leydig cells led to a decrease in the hCG-induced up-
regulation of the intramitochondrial form of StAR protein, which is crucial for 
cholesterol transport into the mitochondria, where the first step of steroidogenesis 
takes place.   
Following hormonal (LH/hCG) stimulation, StAR is synthesized as a 37-kDa 
precursor in the cytoplasm and translocates to the outer mitochondrial membrane, 
where it gets activated via phosphorylation by PKA (Arakane 1997, Phosphorylation, 
Dyson 2008 mitochondrial A-Kinase). It is then imported and processed within the 
mitochondria to a 30 kDa intramitochondrial form by cleavage of an N-terminal 
mitochondrial import sequence (King and Stocco 1996). In our study, there was no 
 
120 
significant decrease in protein level of the 37 kDa precursor form of StaR in Pex13 
knockdown Leydig cells, indicating that the synthesis and expression of StAR protein 
is not affected. However, the cleaved 30 kDa form of StAR was remarkably down-
regulated in Pex13 knockdown Leydig cells in comparison to control shRNA or 
siRNA transfected Leydig cells. Since in our study we also observed mitochondrial 
dysfunction in Pex13-knockdown Leydig cells, it is feasible that this leads to the 
impaired StAR processing. Because of the disrupted StAR processing there was 
reduced production of the immediate downstream hormone pregnenolone, which is 
produced in the mitochondria by the enzyme P450scc. However, the observed 
reduction of hCG-stimulated pregnenolone was completely reversed when the cells 
were treated with 22R-HC instead of hCG under simultaneous inhibition of P450c17 
and 3β-HSD, suggesting that the Pex13 knockdown in Leydig cells did not inhibit the 
P450scc enzyme activity, but that the impaired cholesterol transport due to the 
defective processing of StAR led to the reduced levels of pregnenolone in hCG-
stimulated Pex13 knockdown cells. In contrast, treatment with hCG as well as 22R-
HC led to a decrease in progesterone synthesis in Leydig cells with Pex13 
knockdown, indicating that the activity of 3-HSD is affected independent of the 
StAR protein function. This finding is consistent with earlier reports, that defective 
StAR processing leads to a reduction in steroidogenesis (Allen, et al. 2006; Midzak, 
et al. 2011; Stocco 2001).  
Finally, Pex13 knockdown in Leydig cells also leads to a strong reduction of hCG-
stimulated testosterone synthesis. After treating with 22R-HC, the testosterone 
synthesis was still significantly reduced, confirming that the activity of steroidogenic 
enzymes downstream of StAR activity, such as P450c17 and 17-HSDs, might be 
altered. Noteworthy, and may be related to our findings, is the observation that 
patients with the peroxisomal disorders X-ALD/AMN exhibit testicular endocrine 
dysfunction with low testosterone and compensatory elevated LH levels in serum. 
The mean testosterone/LH ratio is strongly reduced in these patients indicating an 
impairment of the Leydig cells whereas FSH was elevated in response to impaired 
spermatogenesis (Brennemann et al. 1997).  
The hCG-stimulated production of other androgens such as DHEA was also 
decreased in Leydig cells with peroxisomal deficiency after hCG as well as 22R-HC 
stimulation. DHEA is a metabolic intermediate in the testosterone and estrogen 
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synthesis and it is considered to be a relatively weak androgen (Bazin, et al. 2007). It 
has been shown, that in X-ALD patients with a single transporter peroxisomal 
disorder, DHEA levels are low (Assies et al. 1998), which corroborates our findings.    
To summarize, the collective data indicates that Pex13 knockdown inhibits not only 
the up-regulation of intramitochondrial Star, but also 3-HSD and possibly other 
steroidogenic enzymes downstream of the mitochondria activity: such as P450c17 
and 17-HSD, whereas, P450scc enzyme activity was not affected, thus, leading to 
a strong reduction in steroid synthesis.  
 
5.7. Functional peroxisomes and mitochondria are required for 
steroidogenesis in Leydig cells 
Peroxisomes and mitochondria are functionally interconnected (Demarquoy and Le 
Borgne 2015; Lismont, et al. 2015; Schrader, et al. 2015). In Leydig cells with Pex13 
knockdown, the reduction in mitochondrial membrane potential and the decrease in 
the protein levels of complex III of the mitochondrial respiratory chain were noted. 
These findings corroborate with the existing literature that Pex5 knockout mice had 
severe mitochondrial abnormalities (Baumgart et al. 2001) in the liver and many 
other tissues or that the absence of peroxisomes caused mitochondrial alterations in 
isolated hepatocytes (Janssen, et al. 2003). Here in we speculate on two different 
possibilities for the cause of mitochondrial dysfunction. Firstly, the down-regulation of 
peroxisomal metabolism in Pex13 knockdown Leydig cells might lead to a condition 
where the lipid metabolites are solely dependent on mitochondria for metabolism. 
This can overwhelm the mitochondrial capacity and thus lead to a breakdown of 
mitochondrial functions. Alternatively, mitochondrial dysfunction could also arise from 
the increased oxidative stress derived in Pex13 knockdown Leydig cells, where 
mistargeting, reduction and dysfunction of catalase were noted. In line with this 
notion is the finding from Ivashenko et al that in catalase-deficient mammalian cells 
the loss of mitochondrial redox balance was observed (Ivashchenko, et al. 2011). 
However, the source of ROS generation needs to be identified to consider ROS as 
the reason for mitochondrial dysfunction since it can be generated in various cellular 
compartments such as by NADPH oxidases, in the plasma membrane or ER, in the 
cytoplasm or in mitochondria itself.   
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One of the key findings of this thesis work is that the knockdown of Pex13 in MLTC-1 
cells leads to the inhibition of the 30kDa StAR protein. It is plausible that the 
mitochondrial dysfunction caused by peroxisome deficiency in Leydig cells resulted 
in the inhibition of StAR transport into the mitochondria. Regardless of the 
controversial debate whether 30 or 37kDa StAR is responsible for cholesterol 
transfer and how StAR acts, it is conclusive that functional mitochondria are required 
for StAR activity and normal cholesterol transfer for steroid synthesis.  This notion is 
supported by findings that intact mitochondrial proton pump is required for proper 
StAR activity, and disturbed mitochondrial function leads to the inefficiency in 
cholesterol transport and impaired steroid synthesis (Allen, et al. 2004; Allen et al. 
2006; Diemer et al. 2003; King, et al. 1999; Midzak et al. 2011; Midzak, et al. 2007).  
 
 Scheme summarizing an alteration in Leydig cells after Pex13 knockdown 
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Figure 41. Deficiency of Pex13 gene in Leydig cells induces a peroxisome biogenesis defect 
leading to defective matrix protein import and catalase mistargeting, which is a common 
phenomenon observed in conditions of peroxisomal deficiency. Furthermore, peroxisomal 
deficiency induces mitochondrial disturbance and oxidative stress in Leydig cells. The hCG-
mediated induction of the intramitochondrial 30 kDa form of StAR protein was significantly 
reduced in Leydig cells with Pex13 knockdown. Moreover, 3-HSD and possibly also other 
steroidogenic enzymes activity downstream of the mitochondrial enzymes such as 
cytochrome P450c17 and 17-HSD may be decreased in Leydig cells with peroxisome 
deficiency. Thus, peroxisome dysfunction and secondary disturbance of mitochondria 
together in Pex13 knockdown Leydig cells lead to impaired steroidogenesis with significant 
reduction in the production of progesterone, testosterone and DHEA. 
 
The inhibition of intramitochondrial StAR was found to be partially responsible for the 
impaired steroidogenesis in this study. The reason explaining the inhibition of 
androgen synthesis through decreased activity of above mentioned steroidogenic 
enzymes in Leydig cell with peroxisomal deficiency needs to be explored further.            
It seems unlikely that the inhibition of steroidogenesis is only due to the decreased 
total cholesterol amount, because treatment with 22R-HC also resulted in the 
inhibition of steroid synthesis. However, it needs to be pointed out that in comparison 
to 22R-HC stimulation hCG-mediated steroid synthesis is reduced more in MLTC-1 
and in primary Leydig cells, which may be due to the additional step of disrupted 
cholesterol transport via reduced StAR activity.  
In conclusion, our findings indicate that peroxisomal deficiency induces mitochondrial 
disturbance in Leydig cells. These two organelles show a significant functional 
interplay involving ROS balance, oxidative metabolism of fatty acids and probably 
other not yet identified functional interactions, one of which might be steroid 
synthesis. An interesting hypothesis in this context is that some steps of steroid 
synthesis could take place in peroxisomes and therefore peroxisomal deficiency 
might result in the inhibition of androgen synthesis. However, at present we do not 
have enough evidence to support this notion. Further studies need to be done to 
address peroxisomal alterations after disturbing the mitochondrial potential by 
antimycin-A to understand if the inter-play between the organelles is uni-directional 
or bi-directional.   
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5.8. Biological potency of androgens and estrogens in Leydig cells with Mfp2 
knockdown. 
Patients with X-ALD, besides exhibiting infertility and impaired spermatogenesis also 
show hormonal dysfunction including the inhibition of DHEA synthesis (Assies et al. 
1998). Similarly, in our study the peroxisome deficiency in Leydig cells with Pex13 
knockdown leads to reduction of hCG as well as 22R-HC mediated DHEA 
production. DHEA is produced by the adrenal cortex and gonads in humans, 
whereas in laboratory animals sex steroids are secreted mostly in the gonads. It is 
also produced in adipose tissue, brain and skin. DHEA, together with its sulfate 
version (DHEAS), which is generated in liver, are the most abundant endogenous 
steroids in men and women. DHEA, an  endogenous precursor to more potent 
androgens such as testosterone and DHT, is produced in its highest amount at ages 
20-30 in human. The secretion of DHEA and DHEAS decrease profoundly with 
increasing age (Belanger, et al. 1994; Orentreich, et al. 1992; Yen and Laughlin 
1998), which has generated a great clinical interest since this decline is associated 
with impairment of health and age-related diseases including cardiovascular 
diseases, metabolic diseases, cancers, immune and neurological disorders. 
Interestingly, there are many studies revealing the importance of peroxisomal 
metabolism in aging and age-related diseases (Fransen, et al. 2013). Aging is linked 
with decreased activities of peroxisomal -oxidation enzymes and catalase in aging 
rat liver (Terlecky, et al. 2006).                                   
The peroxisomal enyzme Mfp2 also known as D-bifunctional protein or 17-HSD4 is 
involved in steroid synthesis altering the activity of androgens and estrogens. 17-
HSD4 is expressed the most in liver, followed by heart, prostate, testis and also 
other organs. Generally, 17β-HSDs are modulating the biological potency of 
androgens and estrogens by conversion at position C17. 17-HSD4 is the only 17β-
HSD found in peroxisomes  (Markus et al. 1995) and it was suggested that DHEA is 
metabolized by this enzyme (Prough, et al. 1994). According to several studies, 
androstenediol is catalyzed by 17β-HSD4 and 2 to DHEA  (Adamski et al. 1995; 
Labrie et al. 2000; Peltoketo et al. 1999) and estradiol is converted to inactive 
estrone by 17β-HSD2, 4, 8, 10 (Fomitcheva et al. 1998; Labrie et al. 2000). It has 
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been also shown, that 17-HSD4 catalyzes the oxidation of estradiol to estrone and 
oxidizes androstenediol to DHEA more efficiently than the reverse reaction. 
Patients with Mfp-2/17-HSD4 deficiency show severe developmental abnormalities 
and early postnatal death (Wanders et al. 2001b). Mfp-2-knockout mice did not 
exhibit severe developmental alterations and in contrast to human disease their 
survival into adulthood was a good possibility to investigate the role of Mfp2/17-
HSD4 in testis and other organs (Huyghe et al. 2006a). Knocking out Mfp-2 resulted 
in severe male infertility with neutral lipid accumulation in Sertoli cells and at later 
stages to complete fatty degeneration of seminiferous tubules and testis atrophy 
(Huyghe et al. 2006b). The morphology of Leydig cells was not altered until 12 
weeks after which the number of Leydig cells was difficult to estimate due to 
disintegrating seminiferous epithelium. However, in this study DHEA levels were not 
determined. Our observations indicate that after knockdown of Mfp2 in primary 
Leydig cells, the secretion of DHEA was decreased. Considering the peroxisomal 
localization of Mfp2/17HSD4, this finding suggested that peroxisomes could be 
involved in oxidation of DHEA. Testosterone production was not changed in Leydig 
cells with Mfp2 knockdown, which is in agreement with results from Mfp2 knockout 
mice (reference). Moreover, Mfp2 knock-down in primary Leydig cells also leads to 
slightly reduction in estrone synthesis.  
Collectively, this thesis work demonstrates that in Leydig cells the peroxisomal 
deficiency with Pex13 knockdown and knockdown of Mfp2 result in the inhibition of 
DHEA production, indicating that peroxisomes could play an important role in 
oxidation of steroids. Pathological effects of peroxisomal deficiency on cells can be 
mediated not only through known mechanisms such as disturbed lipid oxidation or 
redox balance but also through disturbed steroid oxidation which can lead to the 
development of pathological conditions or diseases. 
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6. Summary  
Infertility is a global health issue, affecting approximately 10-15% of couples 
worldwide. Male patients with peroxisomal diseases exhibit depending on the 
phenotype severity either cryptorchidism or a range of testicular pathologies leading 
in final consequence also to male infertility. Peroxisomes are ubiquitous organelles, 
which besides other metabolic pathways are involved in ROS-metabolism, 
cholesterol synthesis and in beta-oxidation of a variety of bioactive lipid derivatives. 
In this dissertation, the possible role of peroxisomes in Leydig cell steroid 
metabolism was investigated. 
The mouse tumor Leydig cell line MLTC-1 and mouse primary Leydig cells were 
used to knockdown the Pex13 gene by transfection using a Pex13 shRNA plasmid 
and microporation or Pex13 siRNA and lipofection. The resulting phenotype was 
characterized by immunofluorescence, Western blots, RT-PCR, 
Radioimmunoassays, ELISAs and different assays, analyzing ROS metabolism and 
mitochondrial dysfunction in cells. 
Our results show that the mouse Leydig tumor cell line MLTC-1 is a good model 
system to analyze the peroxisomal compartment and steroid synthesis. These cells 
exhibited, by using the correct cell culture conditions, a strong hCG-mediated 
increase of steroid synthesis, a typical feature for Leydig cells. We established 
Pex13 knockdown model in MLTC-1 cells and in primary Leydig cells (Pex13 KD) to 
study the consequences of peroxisomal dysfunction on steroid synthesis. Western 
blot and RT-PCR analyses revealed a strong reduction of the Pex13 gene as well as 
the PEX13 protein in more than 70% of these cells. Moreover, Pex13 KD led to 
mistargeting of catalase into the cytoplasm in Leydig cells, which is a common 
phenomenon observed in condition of peroxisomal deficiency.  
Furthermore, the hCG-mediated induction of the intramitochondrial 30 kDa form of 
StAR protein (steroidogenic acute regulatory protein) was decreased in Leydig cells 
with peroxisome deficiency. We also showed that a peroxisomal knockdown leads to 
significantly reduced levels of progesterone, testosterone and 
dehydroepiandrosterone (DHEA) synthesis in these cells after stimulation with hCG 
as well as with 22(R)-Hydroxycholesterol (22R-HC). In contrast, 22R-HC-mediated 
pregnenolone production was not changed in Leydig cells with peroxisome 
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deficiency. This data indicates that besides StAR, the Pex13 knockdown inhibits         
3-hydroxysteroid dehydrogenase (3-HSD), and possibly also other steroidogenic 
enzymes activity downstream of the mitochondrial enzymes such as cytochrome 
P450c17 (P450c17) and 17β-hydroxysteroid dehydrogenase (17-HSD), whereas, 
cytochrome P450 side-chain cleavage enzyme (P450scc) activity was not affected, 
thus, leading to a strong reduction in steroid synthesis. The molecular mechanism 
explaining the inhibition of androgen synthesis through decreased activity of the 
above mentioned enzymes in Leydig cell with peroxisome deficiency needs to be 
further explored.  
The results of this thesis indicate that peroxisomal deficiency induces mitochondrial 
disturbance and oxidative stress in Leydig cells. These two organelles exhibit an 
important functional interplay involving ROS balance, oxidative metabolism of fatty 
acids and probably other not yet identified functional interactions, one of which might 
be steroid synthesis.  
Additionally, knockdown of Mfp2/17-Hsd4 resulted in the inhibition of DHEA 
production, indicating that peroxisomes could play an important role in the 
metabolism of steroids. 
In conclusion, our observations support the conclusion that Pex13 knockdown in 
MLTC-1 cells and in primary Leydig cells inhibits steroid synthesis due to functional 
disturbance of peroxisomes and secondary dysfunction of mitochondria. 
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7. Zusammenfassung 
Unfruchtbarkeit ist ein globales Gesundheitsproblem, das etwa 10-15% der Paare 
weltweit betrifft. Männliche Patienten mit peroxisomalen Erkrankungen zeigen je 
nach Phänotypschwere entweder Kryptorchismus oder eine Reihe von 
Hodenpathologien, die in letzter Konsequenz auch zur männlichen Unfruchtbarkeit 
führen. Peroxisomen sind ubiquitäre Zellorganellen, die neben anderen 
Stoffwechselwegen am ROS-Metabolismus, der Cholesterinsynthese und bei der β-
Oxidation einer Vielzahl von bioaktiven Lipidderivaten beteiligt sind. In dieser 
Doktorarbeit wurde die mögliche Rolle von Peroxisomen im Steroid-Metabolismus 
von Leydig-Zellen untersucht. 
Die Maus-Leydig-Tumorzelllinie MLTC-1 und primäre Leydig-Zellen der Maus 
wurden verwendet, um das Pex13-Gen durch Transfektion eines Pex13 shRNA 
Plasmids mittels Mikroporation oder durch Transfektion von Pex13 siRNA mittels 
Lipofektion herunterzuregulieren (Pex13 Knockdown). Der resultierende Phänotyp 
wurde durch Immunfluoreszenz, Western-Blots, RT-PCR, 
Radioimmunoassays/ELISAs und verschiedenen Assays, die den ROS-
Metabolismus und die mitochondriale Dysfunktion in den Zellen analysierten, 
charakterisiert. 
Die Ergebnisse dieser Dissertation erbrachten, dass die MLTC-1 Zellen ein gutes 
Modellsystem darstellen, um das peroxisomale Kompartiment und die 
Steroidsynthese zu analysieren. Tatsächlich konnte in dieser Doktorarbeit gezeigt 
werden, dass die MLTC-1 Zellen unter den richtigen Zellkulturbedingungen eine 
hCG-induzierte Steigerung der Steroidsynthese aufwiesen, ein typisches Merkmal 
primären Leydig-Zellen. Daraufhin wurde ein gutes Pex13 Knockdown-Modell 
(Pex13 KD) in MLTC-1-Zellen und in primären Leydig-Zellen etabliert, um die 
Konsequenzen einer peroxisomalen Dysfunktion auf die Steroidsynthese zu 
untersuchen. Western-Blot- und RT-PCR-Analysen zeigten eine starke Reduktion 
des Pex13-Gens sowie des PEX13-Proteins in mehr als 70% dieser Zellen. Der 
Pex13 KD führte zu der Mislokalisation der Katalase in das Zytoplasma in Leydig-
Zellen, was ein typisches Phänomen bei peroxisomalen Biogenesestörungen 
darstellt.   
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Die hCG-vermittelte Induktion der intramitochondrialen 30 kDa Form des StAR-
Proteins (steroidogenic acute regulatory protein) war in Leydig-Zellen mit 
Peroxisomenmangel herunterreguliert. Es wurde weiterhin nachgewiesen, dass der 
peroxisomale Knockdown in diesen Zellen nach Stimulation mit hCG sowie mit              
22(R)-Hydroxycholesterin (22R-HC) zu signifikant reduzierten Progesteron-, 
Testosteron- und Dehydroepiandrosteron (DHEA)-Synthesen führt.  
Im Gegensatz dazu war die 22R-HC-vermittelte Pregnenolon-Produktion in Leydig-
Zellen mit Peroxisom-Mangel unverändert. Diese Daten zeigen, dass neben StAR 
durch den Pex13-Knockdown auch 3β-Hydroxysteroid-Dehydrogenase (3-HSD) 
und vermutlich auch andere steroidogene Enzymaktivitäten abwärts der 
mitochondrialen Enzyme wie z.B. Cytochrom P450c17 (P450c17) und 17β-
Hydroxysteroid-Dehydrogenasen (17-HSDs) beeinträchtigt wurden, so dass eine 
starke Reduktion in Steroidsynthese daraus resultierte. Der molekulare 
Mechanismus, der zu der Hemmung der Androgensynthese durch eine verminderte 
Aktivität der oben erwähnten Enzyme in Leydig-Zellen mit peroxisomaler 
Biogenesestörung führt, muss in weiterführenden Studien noch geklärt werden.  
Die Ergebnisse dieser Dissertation zeigen auch, dass peroxisomale 
Biogenesestörungen sekundäre mitochondriale Dysfunktion und oxidativen Stress in 
Leydig-Zellen induzierten. Diese Biogenesestörungen beiden Zellorganellen zeigen 
ein wichtiges funktionelles Zusammenspiel in der Regulierung der ROS-Balance, 
dem oxidativen Metabolismus von Fettsäuren und vermutlich auch anderen, noch 
nicht identifizierten, funktionellen Interaktionen, von denen eine die Steroidsynthese 
sein könnte. 
Darüber hinaus führte der Knockdown von Mfp2/ 17-Hsd4 zu einer Hemmung der 
DHEA-Produktion, was darauf hinweist, dass Peroxisomen eine wichtige Rolle im 
Metabolismus von Steroiden spielen.  
Die in der Dissertation gemachten Beobachtungen unterstützen die 
Schlussfolgerung, dass der Pex13-Knockdown in MLTC-1-Zellen und in primären 
Leydig-Zellen die Steroidsynthese aufgrund einer funktionellen Störung von 
Peroxisomen und daraus resultierender sekundären Dysfunktion von Mitochondrien 
hemmt. 
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